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Membrane fusion requires a synchronized interplay between several proteins that form the 
membrane fusion machinery. SNAREs are the central component of this fusion machinery. 
Cognate SNARE proteins localized to transport vesicles and their target membranes 
interact with each other via coiled-coil interaction to form core complexes. Vesicle 
associated membrane protein-8 (VAMP8) or endobrevin is a mammalian R-SNARE that 
participates in the formation of two complexes. First, VAMP8 in a complex with syntaxin8, 
syntaxin7 and Vti1b, mediates the homotypic late endosomal fusion.  Second, VAMP8 
forms a complex with SNAP23 and syntaxin 4 and mediates exocytosis of zymogen 
granules in the pancreatic acinar cells. VAMP8 is also required for exocytosis of granules 
from mast cells and platelets. 
This study was aimed at understanding the physiological role of VAMP8 using VAMP8 
knock out mice. VAMP8-/- mice were normal at birth, however, by 10-12 days of age 
nearly one thirds of the mice were dead. These one third mice started to loose weight at 
postnatal day 8-9 (small not sick stage) and after 2-3 consecutive days of weight loss (small 
and sick stage), the mice died. The survivors became healthy adults but were lighter than 
littermates. The small and sick VAMP8-/- mice were half the weight of the littermates and 
had an extremely small thymus. The thymic medulla was reduced to mere remnants and 
there was no clear cortico-medullary boundary. The developing thymocytes including the 
CD4-CD8- DN1-4 subsets and CD4/CD8 populations showed a major maturational 
disturbance. The thymus of small and sick VAMP8-/- mice showed high number of dead 
cells and the thymocytes from small not sick VAMP8-/- mice were highly sensitive to 
apoptotic stimuli in vitro. Bone marrow derived hemopoietic progenitors from small and 
sick VAMP8-/- mice could develop into functional T and B lymphocytes in the RAG2 -/- γc-
/- mice, indicating that the thymic stromal cells could be defective in the VAMP8-/- mice 
but the thymocyte precursors are normal. Hence, VAMP8 is important in proper 
development and function of thymus in mice and the loss of VAMP8 has severe 
implications on the thymocytes and the thymic stroma. However processes such as 
endocytosis, endosomal traffic, phagocytosis and lysosomal degradation are not affected in 
the cells derived from VAMP8-/- mice, indicating that VAMP8 is probably not essential for 
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Chapter 1. Introduction 
 
 
1. Introduction  
1.1. Protein trafficking and the endosomal system 
The presence of functionally distinct membrane bound organelles is the hallmark of 
eukaryotic cells. This compartmentalization of the cytoplasm prevents interference between 
different intracellular pathways. Additionally, it allows the cell to provide appropriate 
environment for each process to operate most efficiently (Nunnari and Walter 1996; 
Rothman and Wieland 1996). Every organelle has a distinct composition and is assigned a 
specialized function. However, in order to maintain the flow of information, the organelles 















Figure 1.1. A scheme of membrane and protein trafficking through mammalian cells: The proteins are 
synthesized at the endoplasmic reticulum, modified in the Golgi and transported to their destination. The 
transport occurs via membrane bound vesicles by retro- and anterograde trafficking.  Largely, the 
endosomal system carries the proteins from the Golgi either to the lysosomes for degradation or to the 
outside of the cell for secretion. Vesicles can also directly bud off from the trans Golgi network and fuse to 
the plasma membrane to secrete their contents outside the cells. Substances entering into the cells are also 
carried to their respective destinations or recycled back to the plasma membrane via the endosomal 
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The proteins are synthesized on the ribosomes and are co-translationally transported into 
the lumen of endoplasmic reticulum (ER). The ER-resident proteins are retained in the 
organelle while the others are transported via vesicles to the Golgi apparatus. Through the 
cis-, medial- and trans- Golgi, the proteins undergo massive post translational 
modifications. At the exit from the Golgi, trafficking pathways get diversified (Figure 1.1) 
and are discussed later. The final destination of a protein is encoded within the molecule in 
the form of signal sequences (Blobel 1980). For example, the ER resident proteins carry a 
KDEL sequence that is recognized by the KDEL receptors. These KDEL receptors are 
primarily present on the vesicles shuttling between the ER and Golgi and retrieve the 
escaped ER resident proteins back to the ER (Lodish et al. 2001). Similary, the soluble 
lysosomal proteins carry a mannose-6-phosphate (M6P) motif that targets the proteins to 
the lysosome via binding to the M6P receptors (MPR) (von Figura et al. 1986).  
Except a few details that vary between different cell types, the basic flow organization of 
membranes at the sub-cellular level remains the same and is depicted in Figure 1.1. The 
different vesicular components and pathways by which a protein can be sorted are 
described in section 1.1.1 and 1.1.2 respectively. 
1.1.1. Compartments of the endosomal system  
Transport vesicles can either be formed on the donor membrane at special sites coated with 
special proteins (clathrin or caveolae) or by alterations of the cytoskeleton (phagocytosis). 
The Clathrin coated vesices (CCVs) are the most common means of receptor mediated 
endocytosis. The CCVs rapidly loose their coat proteins and undergo fusion with the early 
/sorting endosomes (EE).  
Early/sorting endosomes: The early endosomes are complex compartment with both 
tubulo-vesicular morphology. The vesicular components are typically 250-400 nm in 
diameter while the tubules radiating from these vesicles are 50-60 nm in diameter and 4-5 
µm in length (Geuze et al. 1983; Gruenberg et al. 1989; Marsh et al. 1986). They are 
slightly acidic (pH 6.0-6.8) and are primarily responsible for dissociation of the ligand-
receptor complex (Kornfeld et al. 1989). This environment of the early endosomes 
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cells for example by direct recycling to the cell surface (Mellman 1996). In addition, there 
exists a bidirectional vesicular traffic between the TGN and the early endosomes. Also, the 
early endosomes can undergo homotypic fusion with other endosomal vesicles and tubules. 
Recycling vesicles: The recycling vesicles (RVs) or recycling endosomes arise from the 
tubular extension of the EEs and are responsible for slower recycling of the freed receptors. 
Some RVs fuse to the plasma membrane while the others translocate to the perinuclear 
cytoplasm and accumulate as near the micro tubule organization centre (MTOC) (Hopkins 
1983; Yamashiro et al. 1984). The RVs are physically distinct from the sorting endosomes 
as seen by optical and electron microscopy (Dunn et al. 1989; Ghosh et al. 1994; Marsh et 
al. 1995; Mayor et al. 1993) and maintain a distinct pH environment. In addition, the 
perinuclear recycling vesicles act as an intracellular pool of recycling receptors.  
Late endosomes and lysosomes: The early endosomal vesicles carrying the ligand /cargo 
traverse the cytoplasm over the microtubules and fuse with the late endosomes (LEs). The 
LEs eventually give way to lysosomes. The pH drops to 4.5-5.0 and an array of degradative 
enzymes leads to degradation of the ligands in the lysosomes. The lysosomes appear as 
electron dense organelle called ‘dense body’ surrounded by a single membrane in electron 
microscopy.  The recycling from lysosomes is very slow. This explains why cells are able 
to accumulate large amount of internalized materials and also the dense appearance of the 
lysosomes (Mellman 1996)  
How does the transport between the EE, LE and lysosomes occurs is still under some 
debate. Two models were proposed for the passage of material between the compartments 
of the endosomal system. In the vesicle shuttle model, the EEs were seen as stable 
structures while the cargo was pinched off from EEs into small transport vesicles that 
would inturn fuse with the LEs. The maturation model on the other hand suggests that the 
entire EE moves as a unit and is transformed into the late endosomes (Lodish et al. 2001). 
There is an increasing evidence that supports the maturation model (Gruenberg et al. 1995).  
The LEs in thin section electron microscopy appear to have internal vesicles and have been 
named multi vesicular bodies (MVB) or multi vesicular endosmes (MVE). These are 
formed by inward invagination of the limiting endosomal membrane (Vandeurs et al. 
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sequestering the receptors (Di Fiore et al. 1999; Katzmann et al. 2002). Several receptors 
including the EGF-R have been localized to the internal membranes of the MVBs (Felder et 
al. 1990). MVBs are also implicated in forming cell specific organelles such as Weible 
pallad bodies (Blanchard et al. 2002), platelet dense granules (Heijnen et al. 1998) and 
melanosomes (Huizing et al. 2001). 
Secretory lysosomes: The lysosomes were though to be the end point of endocytic 
pathways. However, there is an increasing evidence that there of the existence of 
specialized lysosomes that can act as storage compartments and can exocytose the contents 
in a regulated fashion. Secretory lysosomes have been studied in specific cell types such as 
the cytotoxic T lymphocytes which secrete lytic granules (Burkhardt et al. 1990; Griffiths 
1996), melanocytes secrete melanosomes that gives rise to pigmentation of skin, eyes and 
hair (Griffiths 2002). Renal tubular cells secrete lysosomal hydrolases from specialized 
storage organelles (Gross et al. 1985). Recently it has been shown that the dendritic cells 
sequester the MHC-II molecules in specialized lysosomes (Mellman and Steinman 2001).  
Secretory vesicles and dense core secretory granules: These vesicles carry the proteins to 
be exported to the outside of the cells. The proteins to be exported are thought to be sorted 
into these vesicles under specific signals in the TGN. These vesicles bud from the TGN, 
become mature and are exocytosed either in a constitutive way in secretory vesicles (SVs) 
or in a regulated manner secretory granules (SG) (Blott and Griffiths. 2002; Bright et al. 
1997; Chidgey 1993).  
1.1.2. Endosomal pathways and their role in protein sorting 
Receptor mediated endocytosis mainly occurs via the formation of clathrin coated vesicles. 
The receptor-ligand complexes accumulate at specific region on the plasma membrane 
coated with clathrin molecules and the adaptor complex. Proteins are also trafficked from 
the golgi via CCVs budding from TGN. These clathrin coated pits invaginate and are 
pinched off by dynamin protein to form clathrin coated vesicles (Mukherjee et al. 1997).  
The non-clathrin proteins called adaptor proteins (AP) were found to be essential for CCV 
formation. It is speculated that AP binding induced membrane curvature and facilitates the 
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Besides, the APs also recruit membrane proteins that selectively localize to clathrin pits 
(Pearse 1988; Sorkin et al. 1995). So far four distinct AP complexes have been identified 
named AP1-4. In addition, AP-1 and AP-3 have cell specific isoforms AP-1B and AP-3B 
(Ohno 2006). The AP-1 complex is present on clathrin coated buds of the TGN and 
interacts with proteins that have to exit the golgi in the CCVs. AP-1A regulates the 
trafficking of mannose 6-phosphate receptor (MPRs) between TGN and endososmes (Ohno 
et al. 1995; Owen et al. 2004). AP-2 complex is localized to the plasma membrane coated 
pits and is involved in endocytosis of proteins (Collins et al. 2002; Owen and Luzio 2000). 
AP-2 also serves as cargo receptor for receptor mediated endocytosis of the transferrin 
receptor (TfnR) (Ohno 2006). The AP-3 A is believed to traffic cargo from an early 
endosomal compartment to late endosomes or multivesicular bodies (Nakatsu and Ohno 
2003; Owen et al. 2004). AP4 is implicated in traffic of some lysosomal proteins from TGN 
to lysosomes (Aguilar et al. 2001). In the polarized epithelium cells AP-4 is involved in 
basolateral tansport of the LDL receptor (Simmen et al. 2002). 
Besides the clathrin mediated uptake, there are several clathrin independent endocytic 
pathways. One such route is via small, flask shaped membrane invaginations called 
caveolae. The molecular machinery that differentiates caveolar endocytosis from clathrin 
mediated endocytosis is unknown. However, this pathway is important for the entry of 
bacterial toxins such as cholera toxin B (Orlandi et al. 1998), viruses (Marjomaki et al. 
2002) and bacteria as well as some growth factors and hormones (Lobie et al. 1999; 
Schubert et al. 2001), receptors such as the insulin receptor (Gustavsson et al. 1999) and 
glycosphingolipids (Singh et al. 2003). 
Phagocytosis involves internalization of large particles by binding to cell surface receptors. 
It is found in leukocytes such as neutrophils and macrophages involved in the uptake of 
pathogenic microorganisms and antigenic particles. The phagocytic stimulus induces 
localized polymerization of actin and extension of pseudopod around the particle 
(Greenberg et al. 1990). The phagosomes fuse rapidly to the endosomes and lysosomes 
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Cells such as macrophages, dendritic cells exhibit fluid phase endocytosis called 
macropinocytosis (Steinman and Swanson 1995). Macropinosomes are formed when the 
membrane folds fuse back into the plasma membrane thereby engulfing the extracellular 
fluid.   
1.2. SNAREs the central component of membrane fusion machinery 
Fusion of two lipid membranes in an aqueous medium such as the cytosol of the cell is an 
energetically unfavorable process due to the presence of repulsive electrostatic forces 
(Zimmerberg et al. 1993). It was suggested that ‘bridging’ proteins can act as scaffolds to 
bring the two membranes close together (Monck and Fernandez 1996).  The search for such 
scaffolds let to the identification of a huge number of proteins forming ‘fusion machinery’ 
and SNARE proteins constitute the core of this machinery.  
1.2.1. SNARE proteins: history, discovery and structure  
History: Several years of biochemical research lead to the discovery of SNARE proteins. 
The first breakthrough came with the observation that treatment with N-ethylmelamide 
(NEM) abolishes the intercisternal transport of the VSV encoded G protein through the 
Golgi (Rothman et al. 1984). This abolishment was rescued by the addition of cytosol 
fractions (Block et al. 1988). Eventually, the factor responsible for the rescue was purified 
from the cytosol and termed NSF for NEM sensitive factor. NSF is a 76 kDa  protein with 
the ability to hydrolyze ATP into ADP (Block et al. 1988).  
Following this, three more members of the membrane fusion machinery were identified and 
termed SNAP for soluble NSF attachment proteins namely, α-SNAP, ß-SNAP and γ-SNAP 
(Clary et al. 1990). Using NSF and SNAP as baits, three interacting proteins were isolated 
from crude bovine brain membrane fraction. These were termed SNAREs for SNAP-
receptors (Sollner et al. 1993b).  
Localization of these receptors revealed that all the three were associated with the synapse. 
VAMP1 (Trimble et al. 1988) also named synaptobrevin (Baumert et al. 1989) was located 
on the synaptic vesicles and SNAP25 (Oyler et al. 1989) and Syntaxin 1 were found on the 
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comprising of SNAP25 (Oyler et al. 1989), Syntaxin 1 (Bennett et al. 1992) and 
VAMP1/synaptobrevin  is so far the best characterized complex and forms the exemplar for 
most of the current knowledge of the SNARE proteins (Jahn et al. 2003).  
It was found that neurotoxic metalloendoproteases, botulinum toxin B (BoNT/B) and 
tetanus toxin (TeTx) inhibit exocytosis of synaptic vesicles by cleaving the neuronal 
SNAREs  synaptobrevin (Link et al. 1992; Schiavo et al. 1992) and SNAP25 (Blasi et al. 







Figure 1.2. A scheme showing assembly of 
neuronal SNARE proteins to form a core 
complex: Botulinum and tetanus toxin cleave 
the SNARE proteins at several cleavage sites 






Structure: All the members of the SNARE family have a characteristic ‘SNARE motif’ 
which is a stretch of about 60 amino acid residues, located close to the trans-membrane 
domain. This domain has a highly conserved heptad repeat pattern which forms α helical 
coil (Jahn et al. 2003; Weimbs et al. 1997). The a and d residues of the heptad are occupied 
by hydrophobic residues. Most of the SNAREs have a single C terminal trans-membrane 
domain close to the SNARE motif. While some SNAREs such as SNAP 25 and SNAP23 
are attached to the membrane by post translational modification such as palmitoylation of 
the cystein residues in the spacer region between the two SNARE motifs (Chen et al. 2001; 
Jahn et al. 2003) (Figure 1.3).   
The SNARE motifs are unstructured when the SNAREs are free in solution. However, 
when the proteins on opposing membranes interact, their SNARE motifs undergo 
spontaneous restructuring into a highly stable, elongated four helical coiled coil structure 
called the ‘core complex’ (Hanson et al. 1997; Lin et al. 2000).  
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Sutton and co-workers crystallized the first core complex of the synaptic SNARE complex 
comprising of syntaxin 1A, synaptobrevin-II and SNAP 25B at 2.4 Å resolution (Sutton et 
al. 1998). They observed a highly twisted and parallel bundle of four helices, two 
contributed by SNAP25 and one each by syntaxin 1 and synaptobrevin. The core bundle 
could be divided into 16 backbone layers numbered -7 to +8. Basic amino acid residues 
were found at the membrane proximal end of the core complex, which could interact with 
the negative charges on the surface of the membranes (Sutton et al. 1998). In addition, the 
ionic layer at the 0th position of the otherwise hydrophobic bundle comprised an Arginine 
residue contributed by VAMP and three Glutamine residues, two from SNAP 25 and one 
from syntaxin 1 (Sutton et al. 1998). 
 
Figure 1.3. The structure of neuronal SNARE proteins: VAMP2 and syntaxin1 have a transmembrane 
domain that anchors them to the membrane. SNAP25 is associated to the membrane through a stretch of 
cystein residues with attached palmitoylate moieties. VAMP and syntaxin have one SNARE motif each 
while SNAP25 has two coil domains. Syntaxin has an autonomously folding Habc domain at the N 
terminal. (adopted from Chen and Scheller 2001). 
 
 
Structural analysis of the core of the late endosomal SNARE complex comprising of 
syntaxin 7, syntaxin 8, vti1b and VAMP8/endobrevin confirmed the same structure 
(Antonin et al. 2002). It is therefore thought that the structure of the core complex is 
evolutionarily conserved and critical to the function of SNARE proteins as members of the 
fusion machinery.  
In addition to the SNARE motif, some of the SNARE proteins have an autonomously 
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SNAREs and other proteins involved in the fusion machinery. For example, syntaxin 1 has 
a three helix N-terminal Habc domain (Figure 1.3) that folds back and gives syntaxin a 
closed confirmation (Dulubova et al. 1999) and facilitate the binding of regulatory proteins 
such as Munc18 (Ref section. 1.2.3.5) (Hata et al. 1993).  
1.2.2. SNARE proteins: Classification 
The localization of the neuronal SNAREs syntaxin 1 and SNAP25 on the pre-synaptic 
membrane and VAMP1 on the synaptic vesicles suggested the existence of two distinct 
types of SNARE proteins. Based on their localization, SNAREs were classified as v-











Figure 1.4. Structure of SNARE core complex: (A) 
16 layers of the synaptic core complex with the 0th 
ionic layer in red (B) Arginine 56 from synaptobrevin-
II, Glutamine 226 from syntaxin1A and Glutamine 53 
and Glutamine 174 from the two SNARE motifs of 
SNA25B form the oth layer of the core (adopted from 










Subsequently, the involvement of SNARE proteins in many other membrane fusion events 
was discovered. The v/t classification was confusing for symmetric fusion events such as 
the homotypic fusion of yeast vacuoles or the fusion of late endosome and lysosome etc. 
Therefore the SNAREs had to be reclassified into a more comprehendible form. The 
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core of the SNARE complex was a highly conserved feature of the core complexs (Sutton 
et al. 1998) (Figure 1.4 A and B). Hence it served as a basis to reclassify SNARE proteins 
into Q SNAREs and R SNAREs depending on the amino acid residue they contribute to the 
0th layer of the core.  
Further, the three Glutamine contributing SNAREs were sub classified into Qa, Qb and Qc. 
In reference to the neuronal SNARE complex, Qa SNAREs are located at the position of 
syntaxin1 of the neuronal complex and Qb and Qc occupy the position of N- and C-
terminal motifs of the SNAP25 (Sutton et al. 1998). 
So far, most of the known v-SNAREs can be placed in the R SNARE family while most of 
the t-SNAREs are placed under the Q-SNARE family. There are a few exceptions such as 
the yeast Bet1p which is a Q SNARE and contributes a serine. Leech synaptobrevin (R 
SNARE) contributes a lysine to the 0th layer (Sutton et al. 1998). However, the functional 
classification into v/t SNAREs and structural classification into R/Q SNAREs both are 
widely used.  
1.2.3. Components of fusion machinery and their function 
Although SNAREs are central to membrane fusion, they are by no means singularly 
sufficient. There is a coordinated interplay between several proteins that leads to membrane 
fusion. Some of these proteins and their functions are discussed in the following section. 
1.2.3.1. Rab proteins: The rab cycle 
Rab proteins are small GTPases that shuttle between a GDP bound soluble inactive and a 
GTP bound membrane associated active state. Currently, 10 classical and one atypical Rabs 
are known in yeast while more than 60 have been identified in the mammalian genome 
(Pereira-Liel et al. 2001). Rab proteins regulate the assembly of the SNARE complex and 
mediate membrane attachment by recruiting docking and tethering factors (Pfeffer 1999; 
Ungar et al. 2003). Additionally, Rabs are present on the specific intracellular localization 
and can act as the ‘location tags’ (Jahn et al. 2003). Most Rabs are present at the surface of 
the membranes in a GTP bound active form. As the membranes destined to fuse approach 
each other, the active rab-GTP forms complexes with docking and tethering factors, thereby 
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protein (GAP) and the inactivated Rab protein is removed from the membrane by GDP 
dissociation inhibitor protein (GDI) (Jahn et al. 2003; Pfeffer 2003). The rab cycle acts in 
conjunction with SNARE cycle (Ref section 1.2.3.3.) to facilitate membrane fusion.  
1.2.3.2. Tethering and docking factors  
 The donor membrane first recognizes the correct acceptor membrane in a process termed 
docking or tethering. It is thought to confer specificity to the fusion events. Several 
tethering and docking proteins have been identified. One of the best studied tethering factor 
in mammalian cells is a peripheral Golgi membrane protein named p115 (Pfeffer 1999; 
Waters et al. 1992). The exocyst, a Sec6-Sec8 complex was identified as docking complex 
for exocytosis in Saccharomyces cerevisiae (Hsu et al. 1999; ter Bush et al. 1996), 
Rabaptin-5 interacts with Rab-5 and is implicated in docking during endocytosis (Stenmark 
et al. 1995) while EEA-1 is a docking factor during endosomal fusion  (Simonsen et al. 
1998).  
1.2.3.3. The SNARE cycle: 
Once the membranes are held together by the docking and tethering factors SNAREs can 
mediate the actual fusion event. SNARE motifs are unstructured in free SNARE proteins 
however when the opposing membranes carrying appropriate SNAREs approach each 
other, the  motifs undergo restructuring into helical domains (Hanson et al. 1997). The 
SNAREs on the opposite membranes ‘zip up’ together from the distal N terminal to the 
membrane proximal C terminal forming the core complex (Figure 1.5).  The orientation of 
the trans-SNARE complex pulls the two membranes close together. (Hanson et al. 1997). 
The force generated in the process overcomes the energy barrier for facilitating fusion 
(Hanson et al. 1997).  
The irreversible assembly of SNARE core complex is dependent on Ca2+. After the 
membranes fuse, all the SNAREs are present on one (acceptor) membrane in a so called 
cis-complex. This complex is dissociated by the chaperone ATPase NSF with SNAP as a 
co-factor thereby freeing the SNARE proteins for another round of membrane fusion (Jahn 















leading to fusion of 
membranes and 
eventual 
dissociation of the 
complex by 
ATPase NSF and 
SNAP (adopted 
from Rizo and 
Südhof 2002).  
 
1.2.3.5. Sec1/Munc18 family of proteins 
The activity of the SNARE proteins is tightly regulated in order to avoid any ‘accidental’ 
non specific membrane fusion. SM proteins or Sec1/Munc18 family of proteins are small 
60-70 kDa hydrophilic proteins (Rizo and Sudhof 2002) that act as regulators of SNARE 
proteins.  
Unc18 was the first SM protein to be identified in genetic screen of C. elegans for 
uncoordinated movement (Brenner 1974). The mammalian homologue of Unc18 called 
Munc18-1 interacts with the Habc domain of syntaxin 1 (Hata et al. 1993). This binding is 
thought to stabilize the closed confirmation of syntaxin 1 and inhibits fusion. The deletion 
of SM protein Munc18-1 leads to complete abolishment of synaptic vesicle release in the 
rat brain (Verhage et al. 2000). So far seven SM proteins have been identified in the human 
genome (Jahn et al. 2003) some of which bind to the SNARE complexs while others bind 
to the syntaxins. However their exact role has not yet been identified.  
1.2.3.6. Synaptotagmins 
The rapid release of the synaptic vesicles at the synapse was strictly coupled with calcium 
influx at the synapses. The search for calcium sensors led to Synaptotagmins. These are 
trans-membrane proteins containing tandem calcium – binding C2 domains (Brose et al. 
1992; Yoshihara et al. 2003) and have been implicated in calcium sensing during the 
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(Bennett et al. 1992) and the affinity of this interaction increased dramatically upon Ca2+ 
influx. This increase in affinity was proposed to be due to a Calcium induced 
conformational change in either syntaxin 1 alone or both in synaptotagmin and syntaxin 1 
(Chapman et al. 1995). 13 members of synaptotagmin family have been identified (Sudhof 
2004) however their physiological role is still under investigation. 
1.2.4. Mammalian SNAREs and their complexes 
Due to the inherent complexity of the mammalian system, it offers an enormous challenge 
to understand the fusion mechanism at molecular and functional level. Though several 
SNAREs have been identified in the mammalian cells, their physiological roles have not 
been confirmed. The problem is augmented since SNAREs are expressed at different levels 
in different tissues, some SNAREs show tissue specific expression and some interact with 
different partners to form different complexes in different tissues. In the following 
discussion, four mammalian SNARE families and their post Golgi proteins will be 
discussed in detail: Vesicle associated membrane proteins-VAMPs (R SNAREs), Vti1p 
homologues (Qb SNAREs), members of the syntaxin family (Qa / Qc SNAREs) and SNAP 
25 family (Qb and Qc SNAREs).  
1.2.4.1. VAMP Family with special emphasis on VAMP8/Endobrevin 
Vesicle Associated Membrane Proteins (VAMPs) are classified as R SNAREs since they 
contribute an Arginine residue to the 0th layer of the core complex.  Till date 7 mammalian 
VAMPS have been identified and are named VAMP 1-5, 7 and 8. VAMP 1-3 and 5 are 
toxin sensitive VAMPs while VAMP4, VAMP7 and VAMP8 (Endobrevin) are insensitive 
to tetanus toxin treatment. 
VAMPs 1-5 and 7: The first member of the R-SNARE VAMP family to be known was a 
120 amino acid long membrane protein, isolated from the synaptic vesicles of Torpedo 
californica (Trimble et al. 1988). Using cDNA clone of this VAMP, two related genes 
named VAMP1 and VAMP2 were identified in rat brain (Elferink et al. 1989). Eventually, 
VAMP1 was identified in bovine brain and was found completely identical to VAMP2 of 
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respectively and are highly expressed in neuron and endocrine cells. Synaptobrevins are 
involved in exocytosis of synaptic vesicles (Jahn and Sudhof 1994). 
A non neuronal homologue of synaptobrevins was identified and named 
VAMP3/Cellubrevin. It was found ubiquitously expressed in all the cells and tissues (hence 
the name cellubrevin) (Mcmahon et al. 1993a). Several independent studies have been done 
to assign a physiological role to VAMP3. It has been localized on the membranes of 
pancreatic secretory vesicles and is implicated in regulating the Ca2+ mediated secretion of 
insulin (Regazzi et al. 1995). VAMP3 was also been localized to platelets and implicated in 
release of platelet granules (Polgar et al. 2002). In line with these reports, recently VAMP3 
has been shown to possibly carry out exocytosis of platelet granules in the absence of the 
primary platelet v-SNARE VAMP8 (Ren et al. 2006).  
VAMP4 was identified in EST database search and has a broad tissue expression profile. It 
was localized to the Golgi-TGN in the NRK cells (Advani et al. 1998) and tubular and 
vesicular membranes of the TGN in PC12 cells (Steegmaier et al. 1999a). VAMP4 was 
shown to function in the SNARE complex that mediates retrograde trafficking from early 
endosomes to TGN (Ref section 1.2.5) (Kreykenbohm et al. 2002). 
VAMP5 was identified in EST database search.  It was found to be increased during in 
vitro myogenesis in C2C12 cells and was preferentially expressed in muscles and heart. 
VAMP5 was found associated with plasma membrane and intracellular vesicular structures 
in myotubes (Zeng et al. 1998a). 
VAMP7 also called toxin insensitive VAMP (TI-VAMP) was identified in EST database 
search (Advani et al. 1998). It was found to be abundant on the membranes of the trans 
Golgi network and the late endosomes (Advani et al. 1999) and mediates vesicular transport 
from the late endosome to the lysosomes (Ref section 1.2.5) (Advani et al. 1999; Ward et 
al. 2000). VAMP7 was shown to play a critical role in the onset of phagocytosis in 
macrophages (Braun et al. 2004) and vesicular transport in neurite outgrowth (Martinez-
Arca et al. 2000). 
VAMP8: VAMP8 also named endobrevin was first identified in EST database search 
(Wong et al. 1998). Vamp8 gene in mice comprises of four exons. The first exon is non-
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amino acid M1 (Methionine). Exon 3 encodes amino acid E2 (Glutamic acid) - T54 
(Threonine) and exon 4 encodes S55 (Serine)-T101 (Threonine) and the 3’UTR. The 
SNARE motif of VAMP8 is encoded in part by exon 3 (aa 13-54) and exon 4 (aa 55-62). 
The cytoplasmic domain is predicted to be encoded by residues 1-75 (Wong et al. 1998). 
The mouse Vamp8 gene was found positioned on chromosome 2 while in humans on 
chromosome 2 (Sikorra et al. 2006). 
VAMP8 is a 15kDa, integral membrane protein (Wong et al. 1998)  The amino acid 
sequence of VAMP8 was found to be 32% identical to synaptobrevin/VAMP1, 33% 
identical to synaptobrevin/VAMP-2 and had 31% identity to VAMP3/cellubrevin. It does 
not contain the conserved toxin cleavage site and is therefore insensitive to tetanus toxin 
and botulinum toxin (Wong et al. 1998). By immunogold labeling VAMP8 was found 
enriched on early endosomes  (Wong et al. 1998). Sub cellular fractionation revealed 
showed VAMP8 to be present in same fractions as asialoglycoprotein receptor 
corresponding to the early endosomes (hence the name endobrevin) (Wong et al. 1998). In 
line with these reports, using immunofluorescence staining, VAMP8 was localized 
abundantly at the membranes of early and late endosomes (Antonin et al. 2000b; Wong et 
al. 1998). Using two independent approaches, anti-VAMP8 antibody and recombinant 
VAMP8 protein for inhibiting SNARE assembly, VAMP8 was shown to mediate 
homotypic fusion of early and late endosomes in PC12 cells (Antonin et al. 2000c). Later, 
using content mixing assay it was shown that antibody against VAMP8 inhibits only the 
late endosomal fusion and not the early endosomal fusion. The same result was confirmed 
by microinjecting Fab fragments of VAMP8 as well as its complex partners syntaxin 8, 
syntaxin7 and Vti1b. The Fab fragments of each of VAMP8 and other three complex 
partners resulted in a profound delay in the trafficking of EGF to the lysosomes thereby 
confirming that VAMP8 is involved in late endosomal fusion (Antonin et al. 2000b). 
Besides the late endosomal trafficking, several studies have shown VAMP8 to mediate 
regulated exocytosis events in several cell types. Using pancreatic acinar cells from 
VAMP8-/- mice, VAMP8 was shown to be important for regulated exocytosis of zymogen 
granules in a complex with SNAP23 and synatxin4 (Wang et al. 2004). VAMP8 was found 





Chapter 1. Introduction 
 
 
granules (Polgar et al. 2002) and mast cells (Paumet et al. 2000b). In line with these 
suggestions, using platelets derived from VAMP8-/- mice it was shown that VAMP8 is the 
the primary R-SNAREs involved in the release from dense core granules, alpha granules, 
and lysosomes from the platelets (Ren et al. 2006). VAMP8 was also shown to be critical 
for the terminal step of cytokinesis in normal rat kidney (NRK) cells (Low et al. 2003).  
1.2.4.2. Mammalian Syntaxins 
Syntaxins fall into two distinct protein families depending on their position in the SNARE 
complex. The first type is the Qa syntaxins also called the ‘true syntaxins’ and occupy the 
position corresponding to syntaxin1 in the syntaptic SNARE complex. The second type is 
the Qc syntaxins that occupy the position corresponding to c terminal SNARE motif of 
SNAP25 in the synaptic complex.  
Currently, the Qa syntaxin family has 12 genes in mammals and 7 genes in the yeasts. 
Syntaxin 1, 2, 3, 5 and 16 also exist in alternatively spliced isoforms (Teng et al. 2001) 
(Table I). The first syntaxins to be described were 35 kDa neuronal syntaxins 1A and 1B 
present on the synaptic vesicles bearing 84% identity (Bennett et al. 1992). Among the non 
neuronal homologs are syntaxin 2, 3, 4 and 5 (Bennett et al. 1993). Syntaxins 6, 8 and 10 
are identified as Qc syntaxins. With the exception of syntaxin 11, all the other mammalian 
syntaxins have the membrane anchoring transmembrane domain (Teng et al. 2001). A 
summary of post Golgi mammalian syntaxins associated with endosomal pathway and their 
function is given in Table 1. 
Syntaxin 2 was localized to midbody during cytokinesis and was found to be important in 
the terminal steps of cytokinesis in mammalian cells (Low et al. 2003). 
Syntaxin 3 and syntaxin 4 localized to the apical and basolateral surface, respectively, of 
the polarized epithelial cells and were implicated in conferring specificity to membrane 
targeting (ter Beest et al. 2005). Syntaxin 4 in a complex with SNAP23 and Munc18c 
mediates the regulated exocytosis of tumor necrosis factor α during inflammation (Murray 
et al. 2005; Pagan et al. 2003). Syntaxin 3 and 4 are localized to plasma membrane and 
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Syntaxin 8 functions in late endosomal fusion. It was found to interact physically with 
cystic fibrosis transmembrane conductance regulator channel (CFTR) and regulate its 
channel activity (Bilan et al. 2004). Syntaxin 7 was shown to mediate late endosome-
lysosome fusion in vitro (Mullock et al. 2000). 
 
 
Table I.  Mammalian Syntaxins, their localization and function  
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Late endosome homotypic fusion, 
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Late endosome homotypic fusion, 
late endosome lysosome fusion 
 
Membrane dynamics in immune 
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early endosome fusion 
 
Early endosome-TGN transport 
 
 
Syntaxin 11 is an atypical member since it lacks the transmembrane domain but has 
carboxy terminal cystein residues that facilitate attachment to membrane lipids. Syntaxin 11 
was identified with maximum expression in lungs, heart and placenta. It is enriched in 
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system (Prekeris et al. 2000). Recent evidences suggest the role of SNARE Syntaxin 11 
together with Rab27a and Munc13-4 in the regulated exocytosis of the lytic granules in the 
activated cytotoxic T lymphocytes (Hong 2005).  
 Syntaxin 13 had the highest expression in the brain (Advani et al. 1998) and was found to 
regulate neurite growth from the axons in complex with SNAP25 (Hirling et al. 2000).  
1.2.4.3. Mammalian Vti1 homologs: Vti1a and Vi1b 
In their efforts to identify the interacting partner for Vps10p, a sorting receptor for vacuolar 
proteases in yeast, Fischer von Mollard and colleagues identified v-SNARE Vti1p (Vps10p 
tail interacting protein). Vti1p is involved in four different SNARE complexes and 
mediates the following  transport steps: Traffic from the trans Golgi network (TGN) to late 
endososmes, fusion with vacuole (vacuole in yeast is equivalent to lysosomes in 
mammalian cells), early endosomes to TGN and homotypic TGN fusion and retrograde 
traffic to cis-Golgi (von Mollard et al. 1997). 
Using EST database searches, a 232 residue long, human homolog (hVti1) of the yeast 
Vti1p was found. The protein displayed 29% homology with the yeast Vti1p and could 
functionally replace it in Vti1p deficient yeast cells.  Additionally, two mouse homologues 
mVti1a and mVti1b were found that exhibited 31% amino acid identity with each other 
(Lupashin et al. 1997; von Mollard et al. 1998). Due to their low identity, Vti1a and Vti1b 
were thought to take part in distinct fusion events. In line with this, antibody against Vti1a 
specifically blocked the fusion of early endosomes while anti Vti1b antibody blocked late 
endosomal fusion (Antonin et al. 2000b). Vti1a and Vti1b are Qb SNAREs occupying 
position corresponding to the N terminal SNARE motif of SNAP25 in the neuronal 
SNARE complex. 
Vti1a also called Vti1-rp2 (Vti1p related protein 2) is a 29 kD integral membrane protein 
with 217 amino acid residues. Vti1a localizes to perinuclear structures (Kreykenbohm et al. 
2002) and is particularly enriched in Golgi stacks and  trans-Golgi network (Kreykenbohm 
et al. 2002; Xu et al. 1998). Additionally, a brain specific variant of Vti1a called Vti1a-ß 
was identified which was enriched on the synaptic vesicles. Vti1a-ß does not interact with 
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Vti1b also called Vti1-rp1 is 233 amino acid residues long. Vti1b was found on early 
endosomes, multivesicular bodies and tubules and vesicles not associated with trans-Golgi 
network or plasma membrane (Kreykenbohm et al. 2002).  
1.2.4.4. Mammalian SNAP25 family members 
SNAP25 a 25kD protein was the first member of the synaptosomal associated protein 
family (therefore the name SNAP25) to be identified from mouse hippocampus (Oyler et al. 
1989). It contributes two SNARE motifs Qb and Qc to the neuronal exocytic SNARE 
complex (Sollner et al. 1993b). SNAP25 lacks a transmembrane domain but is attached to 
the membrane by palmitoylation of the cystein residues in the spacer region between the 
two SNARE motifs (Chen et al. 2001; Jahn et al. 2003). Recently, it has been assigned a 
second function as an endosomal Q-SNARE regulating the traffic between sorting 
endosome and recycling endosome (Aikawa et al. 2006). SNAP25 important for the 
regulated exocytosis of secretory vesicles in the neuroendocrine cells and for neurite 
outgrowth (Aikawa et al. 2006).   
Using yeast two hybrid screening, SNAP23, a 23 kD homolog of the SNAP25 was 
identified from the human B lymphocytes. It has 211 amino acid residues and bears 59% 
identity with SNAP25 (Ravichandran et al. 1996). It is ubiquitously expressed and there is 
increasing evidence of it being involved in exocytosis. The relocation of SNAP23 was 
found to be important for exocytosis of mast cell granules (Guo et al. 1998) (Puri et al. 
2003). SNAP23 was also shown to be involved regulated exocytosis of zymogen granules 
from pancertic acinar cells (Holt et al. 2006). 
SNAP29 was identified as a Syntaxin3 interacting protein. It bears 26% identity with 
SNAP25 and co-localizes with endosomal, lysosomal and Golgi markers. It does not have a 
cystein rich domain that anchors SNAP25 and SNAP23 to the membranes and is therefore 
implicated to participate in several trafficking events (Steegmaier et al. 1998). 
Recently, a 47 kD Qab SNARE named SNAP47 was identified from purified rat brain 
synaptic vesicles. SNAP47, like SNAP29 does not have a cystein rich anchoring region and 
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SNAP47 was shown to replace SNAP25 and interact with the neuronal SNAREs Syntaxin1 
and synaptobrevin although less efficiently (Holt et al. 2006). 
1.2.5. Mammalian SNARE complexes: emphasis on VAMP8 complexes 
The first SNARE complex to be identified was the neuronal SNARE complex involved in 
the fusion of synaptic vesicles to the pre-synaptic plasma membrane. It comprises of 
synaptobrevin (R), syntaxin 1A (Qa) and SNAP25 (Qb and Qc) SNAREs (Sollner et al. 
1993a). This complex is so far the best studied and is often used as a model for several 
SNARE related studies. In addition, five endosomal SNARE complexes have been 
described so far (Figure 1.6).  
By co-immunoprecipitation experiments from rat liver homogenates, Antonin and co-
workers identified the endosomal SNARE complex of VAMP8/endobrevin (R), syntaxin 7 
(Qa), syntaxin 8 (Qc), Vti1b (Qb). Fab fragments of antibodies against each of the SNAREs 
and exogenous recombinant proteins were shown to inhibit homoytpic late endosomal 
fusion in content mixing assay. Hence VAMP8 in a complex with syntaxin8, syntaxin 7 
and Vti1b mediates the homotypic fusion of late endosomes (Antonin et al. 2000b).  
Recently using co-immunoprecipitation VAMP8 (R) was shown to form a complex with 
syntaxin 4 (Qa) and SNAP23 (Qb and Qc) in the pancreatic acinar cells of mice. VAMP8 in 
this complex was implicated in mediating secretagogue stimulated exocytosis of zymogen 
granules (Holt et al. 2006) and exocytosis of secretory lysosomes (Polgar et al. 2002).  
Additionally, VAMP8 was proposed to exist in a complex with syntaxin 4 and SNAP23 
and possibly mediates the secretory exocytosis in mast cells (Paumet et al. 2000b).  
VAMP7 forms a complex with syntaxin 7 in the alveolar macrophages and was implicated 
in the late endocytic fusion events (Ward et al. 2000). Eventually, a complex of VAMP7 
(R), syntaxin 7 (Qa), syntaxin 8 (Qc) and Vti1b (Qb) was identified that mediates the 
heterotypic fusion between late endosomes and lysosomes (Pryor et al. 2004).  
A complex between Vti1a-ß (Qb), Syntaxin 6 (Qc), Syntaxin 16 (Qa) and VAMP4 (R) was 
identified in the synaptosomes from rat brain (Kreykenbohm et al. 2002). This complex 
was implicated in the retrograde trafficking from the early endosomes to the trans-Golgi 
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Recently a complex between syntaxin 13 (Qa), Vti1a (Qb), syntaxin 6(Qc) and VAMP4(R) 











































Figure 1.6. Mammalian 
endosomal SNARE complexes 
identified till date. Lys: 
lysosomes, RE: Recycling 
endosomes, E: early endosome, 




1.3. Thymus and its role in development of T-lymphocytes  
1.3.1. Thymus: structure and function 
Thymus is a primary lymphoid organ located in the upper anterior thorax just above the 
heart. It comprises of two lobes that are further divided into numerous lobules. The lobes 
are surrounded by a capsule and are structurally and functionally compartmentalized. The 
outer compartment is the cortex and the inner compartment is called medulla. The region 
close to the capsule is known as the sub capsular zone while the region between medulla 
and cortex is called the cortico-medullary junction (Figure 1.7).  Both, the cortex and the 
medulla have a three dimensional stromal cell network made up of epithelial cells. The 
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the medulla. Developing T lymphocytes, macrophages and dendritic cells are embedded in 










Figure 1.7. Structural organization of 
thymus. Differential localization of T-
lymphocytes in the thymus during 
different stages of development. (adopted 
from Immuno biology by Janeway et al. 
2001). 
 
The T-lymphocytes arise from common lymphoid progenitor cells that inturn differentiate 
from the pluripotent hematopoietic stem cells in the bone marrow. The T-cell precursors 
migrate from the bone marrow into the subcapsular region of the thymus (Lind et al. 2001) 
and undergo several stages of development (therefore the name Thymus dependent or T 
lymphocytes). Consequently, the thymic cortex is thickly packed with immature T-
lymphocytes. As the cells undergo selection and maturation, they move towards the 
medulla and finally exit into the systemic lymph circulation via lymphatic vesicles. 
Therefore, the medulla has a thin population of mature T-lymphocytes (Goldsby et al. 
2000; Janeway et al. 2001b). 
The role of thymus in the immune system was discovered with studies conducted on mouse 
models. The surgical removal of thymus in neonatal mice lead to immune deficiency with 
almost no circulating T- lymphocytes and reduced cell-mediated immunity (Miller and 
Osoba 1967). The importance of thymus is exemplified in a condition called DiGeorge’s 
Syndrome. It is a congenital birth defect in humans and occurs due to developmental failure 
of the third and fourth pharyngeal pouches. It leads to an abnormal thymus besides other 
symptoms.  Most of the effected infants die within the first two years of life, primarily due 
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1.3.2. T-cell development  
1.3.2.1. Developmental stages of T-lymphocytes  
The development of T-lymphocytes and thymic stroma is mutually interdependent (Shores 
et al. 2005). On one hand, the stromal cells create the right microenvironment for the 
sequential stages of maturation of the T-lymphocytes (Anderson et al. 1996). On the other 
hand, the presence of T-lymphocytes is critical for the developing medullary and cortical 
epithelial cells (Hollander et al. 1995; Shores et al. 2005).  Each developmental stage of the 
T lymphocytes is marked by the expression of distinct cell surface molecules and 
rearrangement of T-cell receptor genes. The markers that characterize the mature T-
lymphocytes are the CD4 or CD8 antigens, and the T-cell receptor (TCR):CD3 complex.  
The lymphoid progenitor cells are devoid of CD4, CD8 and most other markers present on 
mature T-lymphocytes, therefore they are called ‘double negative’ cells (CD4-CD8-). 
Additionally, their TCR genes are not rearranged and they do not express TCR on the cell 
surface.  
The development of the cells through the double negative stage can be further divided 
depending upon the expression of surface adhesion molecules CD44, CD25 and c-Kit 
(receptor for the hematopoietic cytokine, stem cell factor). The T lymphocyte progenitors 
that arrive in the thymus do not bear the surface markers CD44 and CD25. In the first stage, 
also known as DN1 (double negative stage 1), the cells express CD44 but not CD25 
(CD44+CD25-). In the second stage called DN2, the cells express CD44 and c-Kit and 
CD25 (CD44+CD25+). In the DN3 stage, the expression of CD25 is maintained while 
CD44 expression becomes low (CD44lowCD25+). Gradually, the expression of both CD44 
and CD25 is lost at the fourth stage, DN4 (CD44-CD25-). At this point, the ß chain of the 
TCR is rearranged and expressed to the surface of the cells.  
The cells that express a correctly rearranged ß chain are positively selected and loose the 
expression of CD25. The ones that fail to rearrange the ß chain undergo programmed cell 
death.  
The ß chain is expressed at the surface together with a surrogate α chain called pre- T-cell α 
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with CD3 signaling complex that stimulates proliferation of the cells. CD3 complex 
comprises of five subunits namely gamma chain (γ), delta chain (δ), 2 epsilon chains (ε), 
and 2 zeta (ξ) chains that are physically associated with the TCR. (Janeway et al. 2001a). 
The pre-TCR also stimulates the expression of the co-receptor molecules, CD4 and CD8 on 
the cell surface. At this stage the pre-TCR bearing cells are called double positives (DP) 
due to the presence of both CD4 and CD8 together on the surface (pre-TCR: CD4+CD8+). 
At this stage, the α chain of the TCR rearranges and is expressed together with the ß chain 
to form the α:ß TCR. Eventually, the big double positive T lymphocytes loose the 
expression of either CD4 or CD8 and become single positive (CD4+ CD8- or CD4-CD8+). 
The cells bearing α:ß TCR: CD3 together with either CD4 or CD8 molecules are the mature 
T-lymphocytes (Janeway et al. 2001a). In addition, these cells also express several other 
surface molecules some of which are involved in signaling while others are involved in cell 
adhesion. 
Besides the α:ß TCR, there exists a minor population of T-lymphocytes bearing an 
alternative receptor. This TCR receptor is a heterodimer of γ and δ chains. Very less is 
known about the structure of the γ:δ TCR and function of this cell repertoire in the immune 
system (Goldsby et al. 2000; Janeway et al. 2001a). 
1.3.2.2. Thymic selection of the T cells 
The T-lymphocytes are subjected to selection at several stages of development. Thymic 
stroma plays a critical role in the positive and negative selection of the maturing 
T.lymphocytes. It provides the right microenvironment for interaction between the 
lymphocytes and the epithelial and antigen presenting cells (van Ewijk 1991). Only the 
cells that successfully cross each selection stage survive while the others are subjected to 
apoptosis. More than 95% of the cells generated in the immune system undergo cell death 
during maturation.  
Positive selection:  The first step of selection occurs soon after the expression of the ß-
chain and formation of pre-TCR (von Boehmer 1994). Positive selection by correctly 
rearranged TCR-ß chain is essential for progression of the T cell development. The cells 
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rearrangement of the ß chain loci is suppressed in these cells in a process called ‘allelic 
exclusion’.The pre-TCR signals the accelerated rearrangement of the α chain of TCR. Only 
the cells that produce a functional α chain and express α:ß TCR on the surface are allowed 
to survive, while the others are subjected to programmed cell death (von Boehmer 1994). 
MHC restriction: In addition to the expression of a functional TCR it is important that the 
T-lymphocytes can distinguish between the ‘self’ and ‘non-self’ antigens. This occurs via a 
process called MHC (Major Histocompatibilty Complex) restriction (Miller and Osoba 
1967). The thymic stromal cells express MHC class I molecules and the antigen presenting 
cells of the thymus also express MHC II on their surface. The presentation of ‘self’ antigens 
by a MHC molecule serves as the basis of MHC restriction. The α:ß TCR bearing 
CD4+CD8+ cells that recognize the ‘self’ antigens on the MHC molecule with low affinity 
are positively selected. These cells eventually become single positive mature T-
lymphocytes while the others undergo apoptosis. 
Additionally, positive selection is also thought to coordinate the selective expression of 
either CD4 or CD8 on the cell surface. During MHC restriction the cells are double 
positives, CD4+CD8+ while at the end of the selection, they loose the expression of either 
one of the markers. The cells that bear CD4 receptor recognize the peptides presented by 
MHC II molecules and become cytokine secreting TH cells. While the cells with CD8 
receptor recognize MHC I presented peptides and become cytotoxic T killer cells (TC cells).  
Negative selection: The process of negative selection essentially eliminates self reactive T-
lymphocytes from the T cell repertoire.  The cells that either recognize the self MHC 
molecule or the self antigen presented by the MHC molecule with very high affinity or do 
not recognize the MHC molecules are clonally deleted (Goldsby et al. 2000; Nossal 1994). 
The removal of such cells is very important since they can become autoreactive and cause 
autoimmune disorders. According to a suggested model, strong TCR activation triggers 
calcium dependent activation of protein kinase C (PKC). This in turn upregulates the 
expression of Bcl-2 interacting mediator of cell death (Bim) (Cante-Barrett et al. 2006). 
Bim was shown to play a central role in the negative selection of T-lymphocytes (Bouillet 
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1.4. Background information and objective of the project 
1.4.1. Creation and analysis of Vti1b knock out mice 
 
(The creation and analysis of Vti1b deficient mice was done by Vadim Atlashkin. Zentrum Biochemie und 
Molekular Zellbiologie , Abteilung Biochemie II, Universität Göttingen). 
 
Vti1b is a Qc SNARE that forms a complex with VAMP8, syntaxin 7 and syntaxin 8 and 
mediates the homotypic fusion of late endosomes. Previously in our laboratory, Vti1b 
knock out mice were created in order to study the physiological role of vti1b and its role in 
late endosomal trafficking. Exon 4 of the Vti1b gene encodes most of the SNARE motif. 
This exon was disrupted by targeted insertion of a neomycin resistance gene. The targeting 
construct was electroporated into the mouse embryonic stem cell line 129/SvJ and clone 
with homologous recombination  were injected into blastocysts (Atlashkin et al. 2003). The 
chimeric mice so obtained were crossed with C57BL/6 female mice. Heterozygous mice 
were detected by PCR and crossed to get Vti1b homozygous null mice. Vti1b protein was 
completely absent in tissue extracts of knock out mice and the Vti1b heterozygous (+/-) 
mice had a reduced level of Vti1b protein (Atlashkin et al. 2003) 
Level of syntaxin 8 was reduced in all the tested tissues of the Vti1b knock out mice. 
However, northern blot analysis showed comparable expression of syntaxin 8 mRNA in the 
wild type and the knockout mice. The low level of protein was found to be due to increased 
degradation of the protein in the lysosomes of the knock out mice (Atlashkin et al. 2003).  
The mice showed heterogeneous phenotype with some of the mice being smaller than their 
littermates. Large amount PAS positive globules, containing glycogen, were found in the 
hepatocytes of the small vti1b knockouts. Some small mice showed enlargement of gall 
bladder and some mice, older than 15 months, showed liver cysts.  
Pulse chase experiments using Cathepsin D showed that there was no delay or blockage in 
the transport from Golgi to lysosomes. However, there was a slight delay in the lysosomal 
degradation of asialofeutin endocytosed by receptor mediated endocytosis in hepatocytes of  
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1.4.2. VAMP8 knock out mice  
VAMP8-/- mice were created by gene trapping by lexicon genetics, USA and were bought 
from Jackson Laboratory, USA. The SNARE motif of VAMP8 is encoded in part by exon 3 
(aa 13 to 54) and in part by exon 4 (55 to 62) of the Vamp8 gene. Random insertional 
mutagenesis into intron between exon 3 and 4 was done using gene trap vector VICTR20 
(Figure 1.8) (Zambrowicz et al. 1998). 
The gene trap vector VICTR20 used consists of a splice acceptor site, followed by an 
internal ribosome entry site, a galactosidase/neomycin phosphotransferase fusion gene and 
a polyadenylation signal yielding a first mRNA. The second part of VICTR20 contains a 
phosphoglycerate kinase-1 promoter, a puromycin N-acetyltransferase gene and a splice 
acceptor sequence generating a second mRNA, which was used to determine the point of 
insertion (Figure 1.8). This means that both mRNAs transcribed from the mutant locus 
encode only partial and non functional SNARE motif. 
 





aa 13 aa 62
ß-Geo Puro
 
Figure1.8. A scheme showing vector design for 3’ trapping of the VAMP8 gene:. SA, Splice Acceptor, 
fused to reporter gene ß-Geo, ß-galactosidase/neomycin phosphotransferase fusion gene; PA, Poly 
Adenylation sequence; PGK Phosphoglycerate Kinase–1 promoter; Puro, Puromycin N-acetylransferase gene; 
SD, Splice Donor site.  
 
 
In order to create double knockout mice for Vti1b and VAMP8, various crosses were made 
between VAMP 8 -/+ Vti1b -/- or Vti1b-/+ VAMP8 -/- mice. 
1.4.3. Initial findings  
(By Dr. Ralf Dressel, Department for Immunogenetics, Georg-August Universität Göttingen and Dr. Fayyazi, 
the Department of Pathology, Georg-August Universität Göttingen.) 
 
VAMP8 -/- Vti1b-/- mice were generated and analyzed with an aim to study the effect of 
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phenotypic onset in the early post natal life. 66% of the VAMP8 -/- Vti1b-/- mice became 
sick and died before reaching one month of age. Several organs from a VAMP8-/- Vti1b-/- 
small and sick 16 day old mouse were excised examined by histochemistry. Liver, kidney, 
spleen, intestine and brain from this mouse showed no defects. However there was a major 
defect in the morphology of the thymus (Figure 1.9). The thymus from the age matched 
control showed two clearly distinguishable areas: the medulla and the cortex (Figure A, B, 
C). In the thymus from VAMP8-/- Vti1b-/- mouse however, the cortico medullary boundary 




Figure 1.9. Morphological 
Defect in thymus 
fromVAMP8-/- Vti1b-/- mice: 
Histological staining of tymus 
sections from a VAMP8-/- 
Vti1b-/- small and sick mouse 
shows a gross defect in the 
thymus morphology compared 
to the wild type control. The 
thymus from the wild type 
mouse showed distinct areas: 
the lightly stained medulla and 
a darkly stained cortex (A) 
with a distinct boundary 
between the two areas (B). 
This demarcation was also 
seen in the fascein staining that 
specifically stains the dentritic 
cells (brown) present in the 
medulla (C). In the VAMP8-/- 
Vti1b-/- small and sick mouse 
there was no boundary 
between the cortex and 
medulla (D) and light pink 
stained medullary cells appear 
scattered between the purple 
stained cortex cells (E). This 
disruption was also observed in 
fascein stained sections. The 
medullary dendritic cells 
(brown) appear scattered 
between the cortex (blue) cells (F). (*Histological staining done by Dr. Afshin Fayyazi at the Department 
of Pathology, Georg-August Universität Göttingen. 
 







In addition, the thymus of this small and sick VAMP8-/- Vti1b-/- mouse also showed a very 









Figure 1.10. High 
number of dead cells in 
VAMP8-/- Vti1b-/- 
thymus: TUNNEL 
Staining to detect dead 
cells in the thymus 
sections from VAMP8-/- 
Vti1b-/- mouse and 
compare it to the wild type 
mouse. The thymus from 
VAMP8-/- Vti1b-/- mouse 
shows a very high number 
of dead cells that appear as black dots (B). In comparison, the thymus from wild type mouse shows very 
few dead cells (A). *Histological staining done by Dr. Afshin Fayyazi at the Department of Pathology, 
Georg-August Universität Göttingen. 
 
A B
Wild type VAMP8 Vti1b double knock out
 
To study if the disruption in thymus morphology effects the maturation of the T 
lymphocyte, thymocytes from VAMP8-/- Vti1b-/- mice were stained with antibodies against 
CD4 and CD 8 surface antigens. The cells were analyzed by FACS analysis. Out of three 
independent experiments, two experiments showed a high count for CD4-CD8- cells while 
the third experiment did not show this defect. Additionally it was noticed that the two mice 
that showed a difference in the CD4-CD8- cells also were much lighter than the mouse used 
in the third experiment. 
1.4.4. Initial findings 
 
(Masters Thesis submitted by Namita Kanwar to the Faculty of Biology at Georg August Universität 
Göttingen) 
 
In the initial work, live births and deaths of VAMP8-/- Vti1b-/- and VAMP8-/- Vti1b+/- mice 
were recorded. It was observed that VAMP8-/- Vti1b-/- and VAMP8-/- Vti1b+/- pups had 
high early post-natal mortality. First postnatal month resulted in the loss of nearly 67% of 
VAMP8-/-Vti1b-/- and 59% of VAMP8-/- Vti1b+/- mice. All the mice were born in normal 
Mendelian ratios and were normal at birth. However a large population of these mice 
started to loose weight between 12-29 days of age and after 2-3 days of constant weight 
loss, eventually died. At the time of death, these mice were very small (weighed 35-50% of 
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In this study, three ~one month old sick VAMP8-/- Vti1b-/- mice were analyzed just before 
death and compared to VAMP8+/- Vti1b+/- controls. The thymus from these sick mice 
showed a disruption in morphology as seen before and described in section 1.5.3. There 
was no cortico-medullary boundary in the thymii of these mice and the medullary region 
was reduced to remnants. The thymus from these sick VAMP8-/- Vti1b-/- mice were smaller 
in size and the cell count was reduced by around 10 folds compared to VAMP8+/- Vti1b+/- 
controls. FACS analysis showed a disturbance in the developing thymocyte subsets. There 
was upto 3 folds increase in the percentage of CD4+ cells while CD4+CD8+ cells were 
reduced by 2 folds the thymus from sick VAMP8-/- Vti1b-/- mice. However, unlike the 
findings of the first experiment by Dr. Dressel, there was no increase in the CD4-CD8- 
cells. The analysis of DN1-4 subsets showed a decrease in CD44+CD25- (DN1) and CD44-
CD25+ (DN3) cells in VAMP8+/- Vti1b+/- mice. In addition, these thymii also showed 
increased annexinV positive cells.  
The development of thymocytes was also analyzed in four 2 months adult VAMP8-/- Vti1b-
/- mice. However, there was no difference in the developing DN1-4 subsets as well as the 
more mature CD4/CD8 subsets in the thymii from the adult VAMP8-/- Vti1b-/- mice.  
In addition, three experiments were done to analyze the peripheral repertoire of T and B 
lymphocytes from adult VAMP8-/- Vti1b-/- mice. There was no defect in the populations of 
mature CD4+ and CD8+ T lymphocytes and B lymphocytes in the VAMP8-/- Vti1b-/- mice 
compared to VAMP8+/- Vti1b+/- controls.   
The activity of several lysosomal enzymes was checked in the liver and kidney of adult 
VAMP8-/- Vti1b-/- mice. There was no difference in the activities of β-hexosaminidase, β-
galactosidase, β-mannosidase and β-glucoronidase enzymes in either the liver or the kidney 
of VAMP8-/- Vti1b-/- mice compared to the VAMP8+/- Vti1b+/- controls. 
1.4.5. Objective of the study 
The main objective of this study was to understand the physiological role of the late 
endosomal SNARE protein VAMP8/endobrevin. The first experiments already gave an 
indication that VAMP8-/- Vti1b-/- mice had a developmental defect in the thymus and T 
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in the data obtained from different experiments. This study was focused on understanding 
the underlying mechanism that causes a defect in the thymus in the absence of VAMP8. 
The first aim of this study was to ascertain the defect in the thymus morphology and to 
study which populations of T lymphocytes are affected due to the loss of VAMP8-/- and 
Vti1b-/- in the VAMP8-/-Vti1b-/- mice. Several experiments were done on VAMP8-/- Vti1b-/- 
thymocytes adult and sick mice to get statistically significant data and establish that the 
defect is actually due to the knock out and not just by mere chance.  
 The second aim was to know whether the thymus defect is a consequence of the 
simultaneous loss of both VAMP8 and Vti1b or is primarily caused by the loss of either 
one of the two SNAREs.  Thymus and thymocyte development in the VAMP8-/- Vti1b+/+ 
and Vti1b-/- VAMP8+/+ mice were studied in detail and compared to the data from VAMP8-
/-Vti1b-/- mice.  
The initial experiments showed an increased cell death in the thymus of VAMP8-/-Vti1b-/- 
mice. Therefore the third aim of this study was to understand the reason for the increased 
death and the massive reduction in the thymus of the VAMP8-/-Vti1b-/- mice. Thymus and 
thymocytes from VAMP8 and Vti1b single knock out mice were also analyzed for cell 
death and the sensitivity to apoptotic stimuli.  
Additionally, it is known that ablation of some SNAREs such as Vti1b specifically 
destabilize other SNARE partners example syntaxin 8 and subject them to increased 
degradation. We wanted to study if the ablation of VAMP8 effects the expression or 
stability of other SNARE proteins especially in the thymus.  
Since VAMP8 is implicated in late endosomal homotypic fusion as well as in the regulated 
exocytosis of secretory granules in the acinar cells, mast cells and platelets. It was 
interesting to know whether deleting VAMP8 and Vti1b causes any defect in endosomal 
vesicular trafficking. Endocytosis, endosomal trafficking and phagocytotsis were studied in 
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2. Materials and Methods 
2.1 DNA Techniques 
2.1.1. DNA extraction from mouse tail biopsy 
To 0.5 cm long freshly excised tail tips, 500 µl NET buffer, 50 µl 10% SDS and 50 µl of 10 
mg/ml of Proteinase K were added with vigorous mixing after each addition. Tissue was 
digested by incubating at 56°C overnight with constant shaking at 800 rpm (Thermomixer, 
Eppendorf). The samples were centrifuged at 13,000 rpm for 10 minutes to pellet down the 
hair and other insoluble debris and the supernatant was transferred to fresh tubes. DNA was 
precipitated with 500 µl Isopropanol and isolated either by fishing out with a molded 
pasteur  pipette hook or by centrifuging the sample at 13,000 rpm for 5 minutes at room 
temperature. The DNA pellet was washed two times with 70% ethanol, air dried and finally 
resuspended in 100 µl of 10mM Tris-HCL pH 8.5. The DNA sample was stored at 4°C and 







2.1.2. PCR amplification of genomic DNA to determine genotype 
In order to determine the genotype, DNA from mouse tail biopsy was subjected to PCR 
amplification. Approximately 400 ng of DNA sample was mixed with PCR mix (Ref. Table 
II) to a final volume of 20µl. Amplification was carried out by placing the tubes in 
thermocycler, master cycler – gradient or personal Eppendorf. VAMP8H and VAMP8M 
were used as the forward and reverse primers for amplification of intact gene Vamp8 and 
PuroF and PuroR primers for amplification of the ß-geo cassette. While for vti1b, we used 
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AK30 for amplification of the neor disrupted gene fragment (for primer sequences ref. 
Table III). 
 
Table II. PCR mix composition and conditions for PCR amplification 
 
PCR Mix Components Volume/Sample 
dd H2O 15.5 µl 
10X PCR reaction buffer  2.0 µl 
 dNTP mix  0.4 µl 
 Forward primer   0.5 µl 
 Reverse primer  0.5  µl 
 Taq polymerase  0.1 µl 
* for amplification of the Puror disrupted fragment, 14.5µl of dd H2O and1µl of DMSO was added to the mix. 
 
 
Conditions for VAMP8 wild type PCR  
Temperature Time 
95°C 40 seconds 
61.4°C 30 seconds 




Conditions for VAMP8 puro PCR  
Temperature Time 
95°C 40 seconds 
52°C 40 seconds 
72°C 50 seconds 
30 cycles 
 
Conditions for vti1b wild type and vti1b neor PCR  
Temperature Time 
95°C 40 seconds 
52°C 40 seconds 
72°C 50 seconds 
30 cycles 
 
All the primers were bought from Iba GmBH, Göttingen and dissolved 1:20 with VS water. 
The primers were stored at -20°C. 
 
 
Table III.  Primers used for genotyping 
 
Primer PCR Sequence 
VAMP8 H  VAMP8 wild type CCGAAACAAGACAGAGGACTTG    
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Puro F  VAMP8 puro CCGAGTACAAGCCCACGGTG 
Puro R  VAMP8 puro CGCTGCCCAGACCCTTGCCC 
Seq 5    Vti1b wild type, neo CTCTTCTATGATTTCTGTACC 
Seq 50  Vti1b wild type GAGGGATCCAATACCTTCTC 
AK 30  Vti1b neo CGGATCAAGCGTATGCAGCCG 
2.1.3. Agarose gel electropheresis for DNA separation  
Depending upon the size of the DNA fragment to be amplified, 1% or 2% agarose gels 
were used. The required amount of agarose was weighed out and dissolved in 1xTAE 
buffer by boiling and stored at 60°C incubator. The gels were casted by pouring the agarose 
solution in the casting chamber with comb and allowing it to solidify. 6x DNA loading 
buffer was added to the PCR amplified products to an end concentration of 1x and the 
samples and DNA marker were loaded in the wells. The gels were run in 1x TAE buffer at 
90-95 volts (3-4V/cm2).  
In case of Vamp8 wild type PCR, the amplified products were run on gel containing 
ethidium bromide while for the puro PCR products, the gels were kept in ethdium bromide 
chamber for 10 minutes and the bands were visualized under UV. 
 
50 ml of 6X Sample buffer 
0,15% xylenecyanol FF 75 mg 
40% (w/v) Sucrose 20 g 
Make up volume to 50ml with 1x TAE buffer 
 
2.1.4. Determination of DNA concentration 
The DNA samples were diluted 1:10 in VS water and the DNA concentration was 
spectrometrically measured in a Quartz cuvette at 260 nm against VS water as blank in 
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2.2. Protein Techniques 
2.2.1. Tissue homogenate preparation 
Freshly cut organs were placed in cold pre-weighed tubes on ice. For every 100 mg of 
tissue 900µl of 1x TBS was added. The tissues were then homogenized in Ultra-Turrax 
homogenizer. Around half of this 10% homogenate was aliquoted  into eppendorf tubes. 
The remaining half was further divided. 1:10 and 1:100 dilutions were made with 0.05% 
(w/v) TritonX-100 and the remaining homogenate was supplemented with 1%Triton X-100 
and 1X protease inhibitors. All samples were aliquoted and stored at –20°C.  
50µl of 100x protease inhibitor cocktail 
PMSF (17.4mg/ml in ethanol stock) 25µl 
Leupeptin  (10mg/ml in water stock) 0.5µl 
Pepstatin (1mg/ml in methanol stock) 5.0µl 
Methanol 19.5µl 
2.2.2. Determination of protein concentration 
0.1mg/ml BSA was used to get a standard curve. 1, 2, 5, 10 and 20µg of BSA solution was 
pipetted into eppendorf tubes and made up to a volume of 200µl with water. Similarly, 2 
and 5 µl of homogenates were made up to a volume of 200µl with water. Bradford reagent 
®BIORAD stock solution was diluted 1:4 (200µl in 600µl VS water). 800µl of 1X reagent 
was added to each tube and samples incubated at room temperature for 20 minutes. 
Absorbance was measured at 595nm wavelength. A standard curve was plotted from the 
values of the BSA standards and the protein concentration of samples was determined by 
extrapolation from the standard curve. 
2.2.3. Measurement of lysosomal enzyme activities in tissue homogenates 
Three 2ml tubes per sample were prepared. In two tubes, appropriate amount of 10% 
homogenate (enzyme source) was pipetted and the volume was made up to 10µl (Ref. 
Table IV). 50µl of substrate (Ref. table V) was then added to the two sample tubes. The 
third tube was used as a control, it contained only the homogenate (same volume as test 
tubes) and substrate buffer to a total volume of 60µl without any substrate. The samples 
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incubation, the enzymatic reaction was terminated with addition of 2 ml of Stop solution 
(0.2 M glycine /NaOH pH 10.8). The readings were taken at extinction 365nm and 
emission 410 nm (Koster et al. 1993). 
 
Substrate buffer 
Sodium citrate 0.1M, pH 4.6 
Sodium Azide 0.08 % 
BSA 0.4 % (w/v) 
 
Table IV: Scheme of sample preparation for assaying the lysosomal enzyme activities 
Enzyme Treatment 
ß-Hexosaminidase 5µl of 1:100 diluted homogenate, 30mins at 37°C 
ß-Galactosidase 10µl of 1:100 diluted homogenate, 120mins at 37°C 
ß-Mannosidase 10µl of 1:100 diluted homogenate, 120mins at 37°C 
 
Table V: lysosomal enzymes and their substrates 
Lysosmal Enzyme  Substrate 
ß-Hexosaminidase (ß-Hex) 1mM 4-Methyl-Umbelliferyl-2Acetamido-deoxy-ß-D-
glucopyranosid
ß-Galactosidase (ß-Gal) 1mM 4-Methyl-Umbelliferyl-ß-D-galactopyranosid
ß-Glucoronidase(ß-Glu 1mM 4-Methyl-Umbelliferyl-ß-D-glucuropyranosid
ß-Mannosidase(ß-Mann) 1mM 4-Methyl-Umbelliferyl-ß-D-mannopyranosid
2.2.4. Triton X-114 extraction of proteins 
Protein concentration of the homogenate samples was determined (Ref. 2.2.2). Sample 
volume equal to 400µg of protein was transferred to fresh tubes. 1X PBS was added to 
make up the final volume to 720µl (end protein concentration of 0.5mg/ml). 80µl of 10% 
TritonX-114 was added and the samples incubated at 4°C for 15 minutes. The samples 
were then centrifuged at 4°C for 5 minutes at 13,000rpm. Supernatant was transferred to 
fresh tubes and incubated at 30°C with shaking. 500-800µl Saccharose solution was 
pipetted in fresh 2 ml tubes and the supernatant was carefully layered on top of the 
saccharose bed. The samples were centrifuged for 5 minutes at 13,000rpm at room 
temperature. The upper hydrophilic protein layer and the saccharose bed were removed. 
The drop of detergent containing the hydrophobic proteins was resuspended in 800µl of ice 
cold 1X PBS. 
The detergent was removed from the sample by acetone treatment: The 800µl of protein 
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acetone was added and samples incubated for 2 hours (or overnight) at –20°C. Later 
centrifugation was done for 10 minutes at 10,000rpm and the supernatant was removed. 
The pellet was washed with 80% acetone and dried. The dry pellet was resuspended in 70µl 
of 1X stop buffer with ß-mercaptoethanol (Bordier 1981). 
 
 
Saccharose solution  
Saccharose 6 % 
Triton X 114 0.6 % 
2.2.5. Preparation of protein samples for SDS page separation 
Protein concentration of the samples of interest was determined using Bradford assay (Ref. 
2.2.2) and the amount of proteins to be separated was calculated (between 30-60µg). The 
samples were mixed with 3x sample loading buffer containing bromophenol blue to a final 
concentration of 1X. The samples were boiled at 95°C for 5 minutes and then loaded on the 
wells of SDS gels. 
 
3x Sample buffer  
1 M Tris/HCl pH 6.8 18.8 ml 
Sucrose 15 g 
Bromophenol blue 5 mg 
SDS 4.5 g 
Dissolve in 45 ml of VS water, add 1:10 ß-mercaptoethanol before use 
2.2.6. SDS polyacrylamide gel separation of proteins 
Gel assembly was prepared by aligning two glass plates with spacers in between them. The 
sides of the plates were sealed off with 1% agarose. Freshly prepared separating gel was 
poured between the two plates (Ref. Table VI). The gel was layered with 1ml of water and 
allowed to set for around 30 minutes at room temperature. Later water was removed and 
stacking gel solution was poured (Ref. Table VII) and the comb was fitted in between the 
plates. The gel was left undisturbed till the stacking gel was set. Later the wells were 
washed with water. Samples were prepared (Ref. 2.2.5) loaded in the wells on the gel. The 
gel was run at 30 mA for around 2-3 hours in 1X SDS PAGE running buffer. 
 
10 x running buffer (Dissolve in 1 liter of VS water) 
Tris  30.2 g 
Glycine 144 g 











Ammonium Peroxidisulfate (APS) solution 
10% w/v APS in VS water 
 
Table VI: Composition of resolving SDS gel 
Resolving gel 
Components 15ml of 11% 15ml of 12.5% 15ml of 15 % 
1.5 M Tris/HCl pH 8.8 3.75ml 3.75ml 3,75ml 
Bis acrylamide 5.5ml 6.25ml 7,5ml 
ddH2O 5.45ml 4,65ml 3,4ml 
10% SDS 150µl 150µl 150µl 
10% APS 150µl 150µl 150µl 
TEMED 7.5µl 7.5µl 7,5µl 
 
Table VII: Composition of stacking SDS gel 
Stacking gel 
Components 7.5 ml of 5.5 % 
1.5 M Tris/HCl pH 8.8 936µl 
Bis acrylamide 1.39ml 
ddH2O 4.95ml 
10% SDS 75µl 
10% APS 150µl 
TEMED 7.5µl 
2.2.7. Semi dry protein transfer 
Nitrocellulose membrane was cut to the required size and soaked in 1X semidry buffer for 
2-3 minutes.  
 
10x Semi dry buffer 
Tris 58 g 
Glycine 29.2 g 
10% SDS 37 ml 
Make up volume to 1 liter with VS water 
1x buffer: 80ml 10x buffer in 200 ml methanol and 720ml VS water  
 
Six pieces Whattman paper, cut to size, were also soaked in 1X semidry buffer for around 5 
minutes. The gel was carefully removed from between the gel assembly and soaked in 1X 
semidry for 1-2 minutes. The western blot transfer assembly was then made by placing 3 
pieces of wet Whattman paper followed by the membrane, then the gel and finally the 
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remaining 3 pieces of paper were placed over it. Any air bubbles were removed by gently 
rolling a roller over the paper stack. The assembly was closed and transfer was allowed to 
occur at 116 mAmps for 1 hour. After transfer, the blot was transferred to a chamber for 
antibody staining. 
2.2.8. Western blotting 
The membrane was blocked with botto solution for 30 minutes at room temperature with 
slight rocking. Appropriate primary antibody dilution was made in blotto (Ref Table XII). 
The membrane was incubated in primary antibody solution for 2 hrs at room temperature or 
at 4°C overnight, depending upon the antibody used. Washing was done with 1X 
PBS+1%Tween three times for 5 minutes each. HRP-labeled secondary antibody was 
dilution in 1X PBS+1%Tween (1:10,000-1:20,000). Membranes were incubated with the 
secondary antibody solution for around 1hour 30 minutes with gentle rocking. The 
membranes were then washed 5 times with 1X PBS+1% Tween and 2 times with 1X PBS 
for 5 minutes each. The blot was developed using ECL Super Signal kit from PIERCE. The 
chemiluminiscence substrates were mixed in equal amounts just before use. The membrane 
was incubated in this solution for 1-2 minutes and exposed to luminescence image analyzer 
for varying lengths of time depending upon the intensity of the signal. 
 
 2% Blotto solution 
Dissolve 2g of milk powder in 100 ml of 1x PBS-1% TritonX-100 solution 
2.3 Tissue culture techniques  
The cells were cultivated in a 5% CO2 incubator (Heracell, Heraeus) at 37°C in DMEM 
supplemented with 10% Fetal Calf Serum and 100U/ml penicillin/streptomycin unless 
otherwise mentioned. 
2.3.1. Isolation of Primary fibroblasts from mouse embryos 
A female mouse in around 12.5-14.5 day of pregnancy was killed by spinal dislocation and 
the abdomen was carefully cut open. The uterus carrying the fetus was excised and washed 
in 1X PBS. The amnion layer was carefully removed and the released embryos were 
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sterile conditions. The head of each of the embryos was removed and stored at 4°C for 
genotyping. The liver and heart of the embryos was removed carefully. The remaining 
embryo was teased with a pair of forceps to break it into small sections. For each embryo, 
one 25 ml Erlenmeyer flask was prepared with sterile glass beads at the bottom and filled 
with 5 ml of trypsin solution. The pieces of each embryo were put into one sterile 
Erlenmeyer flask and placed at 37°C for 15 minutes on a shaking platform, for digestion.  
After the tissue was digested, 10 ml of DMEM medium was added to nullify trypsin and 
the cells were pipetted up and down to get single cell suspension. The cells from each 
embryo were collected in a sterile 15 ml falcon tube and centrifuged for 5 minutes at 1200 
rpm. The supernatant was discarded and the cell pellet was suspended in 10 ml of DMEM 
and plated out on 6 cm diameter petri dish. The cells were cultivated overnight at 37°C, 5% 
CO2 incubator. The next day, the medium was replaced with 10 ml of fresh DMEM and the 
cells were cultivated over night. The cells were allowed to grow till confluent. The primary 
cells were trypsinized and half the cells were frozen (Ref. 2.3.5) while the other half were 
cultivated to get immortalized cell lines (Ref. 2.3.3).  
Trypsin EDTA solution (from Gibco)  
Trypsin  0.05% w/v 
EDTA 0.02 % 
Dissolved in Puck’s modified salt solution 
2.3.2. Maintenance of cells 
Once the cells reached 80-90% confluence in the flasks, they were passaged. The old 
medium was removed and the cells washed once in pre-warmed sterile PBS. The cells were 
then trypnised with 0.5 ml of Trypsin-EDTA solution at 37°C for 5 minutes or till all the 
cells had detached from the surface of the flask. Following this, trypsin was neutralized 
with the addition of DMEM medium containing 10% fetal calf serum. The cells were 
resuspended well by pipetting them up and down several times. Finally, the desired number 
of cells was plated on to the cell culture flasks and cultivated at 37°C, 5% CO2.  
2.3.3. Immortalization of primary fibroblasts by passaging 
The primary mouse embryonic fibroblasts were cultivated in 25ml flasks and passaged 
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few cells overcame the cell cycle block and started to divide in a rather uncontrolled 
fashion i.e. they became immortalized. They were then mainitained in desired confluence 
as described in 2.3.2. 
2.3.4. Isolation of murine peritoneal macrophages 
Mice were killed by asphyxiation followed by spinal dislocation and fixed to the dissection 
board to stretch out the abdomen well. The skin over the abdomen was carefully removed. 
A small cut, just enough to let in the tip of a pasteur pipette, was made in the peritoneal 
membrane. A pasteur pipette was filled with ice cold sterile PBS and was inserted into the 
peritoneal cavity through the cut. PBS was released into the cavity with great care not to 
injure any internal organ. The abdomen was lightly massaged and the PBS with 
macrophages was retrieved into the Pasteur pipette. Several such rounds of PBS injection 
and recovery were done till around 10mls of PBS with cells were recovered from the 
abdominal cavity. PBS with cells was collected in 15ml polypropylene, non-pyrogenic, 
sterile tubes (red cap, from Sarstedt AG and Co. Nümbrecht Germany) and always kept on 
ice. It was important to use this tube since the isolated macrophages have a tendency to 
adhere strongly to the surface of any other plastic tubes. It was also important to keep the 
cells on ice since it circumvents the cells from attaching themselves to the tubes. The cells 
were pelletted by centrifugation at 900 rpm for 4 minutes at 4°C. The pellet was 
resuspended in 500µl of cold DMEM medium. Cells were counted in a neubauer chamber 
and 2x105 cells were seeded on coverslips in a 24 well plate and supplemented with 1 ml of 
pre-warmed DMEM+10% FCS. After 2-3 hours, the medium was replaced with fresh 
DMEM+10% FCS to remove the non-sticking cells (which are not macrophages). The cells 
were left over night in 37°C, 5% CO2 incubator.  
2.3.5. Cryoconservation of cells 
The cells to be preserved were cultivated till they were around 70%-80% confluent. The 
cells were trypnised and the detached cells were collected in 10 ml of DMEM medium. The 
cells were collected by centrifugation at 1000rpm for 7 minutes. The cell pellet was 
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FCS and penicillin/ streptomycin). The cells were immediately divided into 1 ml aliquots 
and frozen at -80°C. After 1-3 days, the cells were transferred to liquid nitrogen storage 
tanks or -170°C freezer for long term storage. 
2.3.6. Histological analysis  
Tissue samples were fixed in 4% formaldehyde and embedded in paraffin. 5 to 10µM thick 
sections were obtained as described (Fayyazi et al. 2000). Deparaffinized sections were 
stained by haematoxylin and eosin (H&E). In situ end labeling (ISEL) was done to 
visualize the dead cells as described in Fayyazi et al. 2000. 
For the detection of dendritic cells, fascein staining was performed. The deparaffinized 
sections were incubated three times for 5 minutes each in 0.01 mol/L citrate buffer (pH 6.0) 
at high power (600-700 Watt) in a microwave. The sections were incubated with 1:50 
diluted anti-fascein antibody (DAKO, Hamburg, Germany) for 1 hour and visualized a 
biotinylated secondary antibody, a peroxidase conjugated streptavidin, and di-
aminobenzidine as chromogen (Biogenex, Hamburg, Germany) according to 
manufacturer’s instructions. The sections were counterstained in Super Mount Medium 
(Biogenex) and analyzed by light microscopy.  
2.4. FACS techniques 
2.4.1. Preparation of T- lymphocytes from thymus 
Mice were killed by asphyxiation followed by spinal dislocation. Thymus was excised and 
lymph nodes were carefully removed. The organ was homogenized in 10ml of complete 
RPMI-1640 medium supplemented with 10% FCS, 2mM L-glutamine and 100U/ml 
penicillin and streptomycin, in Tenbroek glass homogenizer with 10 strokes to obtain a 
single cell suspension. 10µl of single cell suspension was diluted in 90µl of 1% acetic acid 
(1:10 dilution). The thymocytes were counted in a neubauer chamber (Fortuna W.G. Co).  
2.4.2. Preparation of T- lymphocytes from spleen 
Mice were killed by asphyxiation followed by spinal dislocation. Spleen was excised and 
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2mM L-glutamine and 100U/ml penicillin and streptomycin, in Tenbroek homogenizer 
with 10 strokes to obtain a single cell suspension. The cells were treated with erythrocyte 
lysis buffer for 5-7 minutes at room temperature to lyse the erythrocytes. Later the cells 
were centrifuged at 1200 rpm for 7 minutes (Multifuge 1L,Heraeus). The supernatant (lysed 
erythrocytes) was drained and the pellet containing the T-lymphocytes was resuspended in 
5 ml of RPMI-1640 supplemented medium. 10µl of single cell suspension was diluted in 
90µl of 1% acetic acid (1:10 dilution). The T-lymphocytes were counted in a neubauer 
chamber. 
 
Erythrocyte lysis buffer 
Ammonium chloride (NH4Cl) 155mM 
Potassium hydrogen carbonate  (KHCO3) 10mM 
EDTA 0.1mM 
Adjust the pH to 7.4-7.8  
2.4.3. Phenotyping of primary T- lymphocytes  from Thymus or Spleen 
1x 106 Thymocytes were transferred to FACS tubes (BD Falcon) and washed once with 1x 
PBS. The cells were collected at the bottom of the FACS tube by centrifugation (Multifuge 
1L,Heraeus) at 1200 rpm for 7 minutes. 1µl of chromophore (Fluorescein isothiocyanate-
FITC, Phycoerythrin-PE or Tricolor-TC) conjugated antibodies against T-lymphocyte 
surface antigens were added to the samples and incubated for 1 hour at 4°C (Ref. Table 
VIII for staining scheme, Table X for antibody source and concentrations). Anti CD44 and 
anti CD4 antibodies were conjugated with biotin, therefore we used a two step detection 
method. Following staining with these antibodies, the cells were washed in PBS and 
incubated with TC labeled streptavidin for 45 minutes at 4°C. After staining, the cells were 
washed with 1x PBS and finally resuspended in 200µl of 1x PBS. The cells were counted in 
fluorescence assisted cell counter (Becton Dickinson-FACScan) and evaluated using 
CELLQuest software (Becton Dickinson).  
For staining with anti Annexin V antibody, the cells were washed in 1x Binding buffer (10x 
Binding buffer, BD pharmingen) and at the end resuspended in 200µl of 1x Binding buffer 
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Isotype control staining and quadrant setting: For each antibody staining for a surface 
marker, a parallel sample was stained with isotype control specific for that surface marker 
antibody. Isotype controls are monoclonal antibodies not directed against any antigen 
normally expressed on the cells of the test organism but they belong to the same 
immunoglobulin subclass and are conjugated with the same fluorochrome as the 
monoclonal antibody against the marker. An isotype control antibodies for mouse should 
therefore not bind to any specific antigens on mouse derived cells.  This staining with 
isotype control is used for two purposes: First for detection of any non-specific staining 
from the immunoglobulin.  Any signal obtained from isotype control staining was 
subtracted from the corresponding anti-marker antibody staining. Second, for setting up the 
quadrant locations on dot plots. The cells not stained with the isotype control appear in the 
lower left region of the dot plot. Thus the lower left (LL), upper left (UL), upper right (UR) 
and lower right (LR) quadrants were set in reference to the isotype control staining. 
Compensation: Since the excitation-emission spectra of FITC (em 525nm), PE (em 576nm) 
and TC (em 665nm) chromophores are close it is possible that a single laser could excite 
more than one chromophore. Compensation is the process by which this fluorescence 
‘spillover’ originating from a fluorochrome other than the one specified is subtracted as a 
percentage of the signal from specific chromophore. For example, spectral overlap between 
FITC and PE produces light which is detected by both the FL1 and FL2 detectors. The 
amount of FITC fluorescence being detected by the FL2 detector (i.e. PE detector) can be 
regarded as excess fluorescence and is therefore compensated out. 
For doing compensation, one sample of cells was stained only with anti CD8a-FITC, anti 
CD4-TC or anti CD4-PE antibody. Each chromophore was excited using all the three 
excitation wavelengths and the spillover from one fluorescence channel to the adjacent was 
subtracted by observing the dot plot while the sample was running.  
Gating: 10,000-30,000 cells were counted for each staining. Of all the counted cells, 
specific cells of interest were selected in a process called ‘gating’.  Gating is based on 
usage of antibodies tagged with different chromophores (FITC, PE or TC). For example, 
cells stained with anti-FITC conjugated antibody can be specifically chosen or gated on, 
leaving out the cells that fluoresce in the PE or TC channel. 
For CD4/CD8 phenotyping, the cells were gated according to their light scattering 
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erythrocytes have light scattering properties different from medium sized thymocytes. Thus 
from the forward scatter (FSC) and side scatter (SSC) plots it is possible to specifically gate 
on the region of thymocytes. The thymocytes were then analyzed on the basis of signal 
intensity for CD4 (anti-CD4-PE) and CD8 (anti-CD8-FITC) staining in the PE and FITC 
channels respectively. The CD8 cells in FITC fluorescence channel were plotted on X axis 
while the CD4-PE on the Y axis. Therefore, CD4+ cells appeared on lower right quadrant of 
the dot plot, CD8+ appeared on upper left quadrant while CD4+CD8+ cells appeared in the 
upper right quadrant of the dot plot. The unstained CD4-CD8- cells appeared in the lower 
right quadrant (Ref section 3.3.2 for representation picture).  
For CD4-CD8- DN cells, two step gating strategy was used. In the first step, the cells were 
gated according to their light scattering properties just as for the CD4/CD8 cells. In the 
second gating step, all the cells except the DN1-4 were excluded. The cells bearing the 
CD4 and CD8 markers (mature T lymphocytes), B220 (marker for B lymphocytes), NK1.1 
and DX5 (markers for natural killer cells) were stained with specific antibodies conjugated 
with Phycoerythrin (PE).  The anti CD44 antibody was conjugated with tricolor (TC) and 
CD25 antibody to fluoro-isothio cyanin (FITC). Therefore we could specifically gate on the 
DN cells labeled with FITC (CD25) and TC (CD44) and exclude the cells bearing PE label. 
The DN1-4 subsets were then analyzed for CD44 and CD25 expression depending on the 
signal intensity for FITC and TC fluorescence similar to CD4/CD8 analysis. 
 
Table VIII: Scheme for FACS staining with chromophore conjugated antibodies for phenotyping of T 
lymphocytes 
 
Staining   Fluorescent 
Channel I : FITC 
Fluorescent Channel II : 
PE 
  Fluorescent Channel 
III : TC 
1 Blank control   
2 rIgM rIgG2a rIgG2b 
3 mIgM mIgG2a  
4 CD8a CD4  
5 CD25 CD4, CD8a, CD3, B220, 
NK1.1, DX5 
CD44* Biotin 
6 MHC-II CD8b CD4 
7 Annexin V  PI 
8 Annexin V CD8a CD4 
9 TCR αβ CD3  
10 Hamster IgG   
* Primary antibody against CD44 was biotin labelled. Therefore, Tricolor (TC) labelled streptavidin was used for 
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2.4.4. Induction of apoptosis by dexamethasone treatment 
1x 106 T-lymphocytes were transferred to FACS tubes, one test and one control tube for 
each time point (0hr, 3hr, 6hr, 24hr). The control (un-induced) samples were resuspended 
in 200µl of RPMI-1640 (Gibco BRL) medium while the test (induced) samples were 
resuspended in 200µl of 0.1µM dexamethasone (Sigma Aldrich) diluted in RPMI-1640 
medium. Both the test and control sample tubes were placed at 37°C, in 5% CO2 incubator 
for the respective time points. For the 0hr time point, we had only untreated samples which 
were immediately washed in 1x PBS and stained to visualize dead cells. After each time 
point, the dead cells were counted either by Annexin-V/ propidium iodide staining (Ref. 
2.4.5) or by Sub-G1 peak assay (Ref. 2.4.6) in both the test and control samples. 
 
 
Preparation of 1mM dexamethasone stock solution 
Dexamethasone 3.92 mg 
100% Ethanol 1.0 ml 
DMEM culture medium 9.0 ml 
Dilute 1mM stock to 0.1µM with RPMI-1640 medium freshly before the experiment. 
2.4.5. Annexin V and propidium Iodide co-staining to visualize dead cells 
After incubation for appropriate time, the cells were washed with 1x Binding buffer (BP 
Pharmingen) and incubated with 1µl of FITC labeled annexin V and 10 µl of 1µg/ml 
propidium iodide diluted in 1x PBS for 1 hour at 4°C. The cells were washed in 1x Binding 
buffer (BD Pharmingen) and collected by centrifugation at 1200 rpm for 7 minutes. Finally 
the cells were resuspended in 200µl of 1x binding buffer and counted in FACS SCAN 
(Becton Dickinson) and evaluated using CELL Quest software (®Becton Dickinson). 
2.4.6. Sub G1 peak assay to determine dead cells 
After incubation for appropriate time, the cells were transferred very quickly into a 15ml 
falcon tube with 10 ml ice cold 99% ethanol. The cells were left overnight at –20°C for 
fixation. After fixation, the cells were centrifuged at 1200 rpm, 10 minutes at room 
temperature, transferred to FACS tubes and washed once with 1x PBS. The cells were 
stained for 1 hour with 200 µl of 1µg/ml propidium iodide at 37°C.The cells in Sub G1 
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(Becton Dickinson) and evaluated using CELL Quest software (Becton Dickinson). 
Doublet discrimination mode is used to rule out the possibility that two attached G1 cells 
passing through the laser beam will create fluorescent peak with height and pulse areas 
similar to a single G2 cell.  
2.4.7. Induction of apoptosis by plate bound anti CD3ε and CD28 antibodies.  
2.4.7.1. Preparation of ELISA plates:  
The assay was done as described by Thien and co-workers (Thien et al. 2005b). An 
antibody mix was prepared with 10µg/ml each of anti CD3ε (Purified, clone 145-2C11, BD 
Pharmingen) and CD 28 (Biotinylated, clone 37.51, BD Pharmingen) antibodies or 10 
µg/ml anti CD3ε  alone in filter sterilized coating buffer.  50µl of the antibody mix (i.e. 0.5 
µg of each antibody / well) was pipetted into the wells of a 96-well ELISA plates (F96 
Maxisorp, Nunc, Roskilde, Denmark). The plates were left overnight at 4°C. The wells for 
unstimulated control samples were incubated with 50µl of coating buffer. Just before the 
experiment, the wells were washed once with sterile PBS.  
2.4.7.2. Induction of apoptosis: 
The freshly excised thymii were homogenized with sterile homogenizer in 10ml of 
supplemented RPMI-1640 medium. The cells were counted in Neubauer chamber. 2 x 106 
cells were transferred to the ELISA plates: in the uncoated well for unstimulated controls 
and in the antibody coated wells to induce apoptosis. The plates were incubated for 3, 6 and 
24 hours at 37°C in 5% CO2 incubator. The 0 hour sample was immediately washed and 
stained with annexin-V and propidium iodide to visualize the initial apoptosis. After each 
time point, the cells were washed and stained with annexin V and propidium Iodide 
(Ref.2.4.5).  
 
ELISA Plate Coating Buffer 
Solution A 0.2 M Na2CO3
Solution B 0.2M NaHCO3
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2.4.8. Induction of apoptosis using Anti-FAS (CD95) antibody 
The freshly excised thymii were homogenized in RPMI-1640 medium and the cells were 
counted. 1x 106 cells were transferred to FACS tubes in duplicates for every time point. 
One tube of cells was treated with the antibody to induce apoptosis, while the cells in the 
other tube were left un-induced in order to study spontaneous apoptosis with time. 1 µg of 
anti FAS antibody (Jo2 BD Pharmingen, Cat no. 554254) was added to the cells for 
induction and 200µl of RPMI-1640 was added to tubes with untreated control samples. 
Both, the test and control tubes for each time point were placed in 37°C incubator with 5% 
CO2. After the end of each time point, the cells were washed once in the annexin V binding 
buffer and incubated with 1µl of FITC conjugated annexin V and propidium iodide for 1 
hour at 4°C. The cells were counted in FACS Scan (®Becton Dickinson) and evaluated 
using Cell Quest software (Becton Dickinson). 
2.4.9. Preparation of cells for bone marrow and transplantation 
The mice were killed by spinal cord dislocation and the both the femur bones (thigh bones) 
was carefully removed. With the help of syringe and needle, 5-10 mls of DMEM 
(supplemented with 10% FCS and penicillin/ streptomycin) was flushed through the shaft 
of the bone. The medium containing cells was collected under sterile conditions. The cells 
were counted in a neubauer chamber and frozen in 1 ml of cryomedium (10% v/v DMSO in 
DMEM supplemented with 10% FCS and penicillin/ streptomycin). 1x 106 bone marrow 
derived pluripotent cells were transplanted into irradiated (5psi) RAG2 -/- γc -/- mice. 
Transplantation was done at the central animal facility and irradiation of the RAG-/- mice 
was carried out at Strahlentherapie und Radionkologie by Dr. Mirko Nitsche. Development 
of lymphocytes derived from the transplanted bone marrow in the RAG-/- mice was studied 
for 4, 7 and 9 weeks after transplantation.  
2.4.10. Analysis of transplanted RAG2 -/- γc -/- mice 
 
(RAG2 -/- γc -/- mice were obtained from Professor Dr. Rodewald, from the Institite of Immunology, University 
of Ulm) 
 
After 4, 7 and 9 weeks of transplantation, ~50-100µl blood was collected from the 
transplanted RAG2 -/- γc -/- mice and erythrocytes were lysed as described in 2.4.2. The 





Chapter 2. Materials and methods 
 
 
minutes. The cells were stained with 1µl of chromophore conjugated antibodies against 
markers: CD3, CD4, CD8, B220, NK1.1, DX1.5 and CD19 (Ref. Table X) for 1 hour at 
4°C. The cells were washed in PBS and resuspended in 100µl of PBS. The cells were 
counted in FACScan (Becton Dickinson) and analyzed using CellQuest software.  
2.5. Immunofluorescence techniques 
2.5.1. Growing cells for immunofluorescence 
Cover slips were sterilized at 180°C for 4 hours and placed in a 24 or 4 well plate with a 
flame sterilized forceps. Mouse embryonic fibroblasts were trypsinized (or freshly obtained 
macrophages), collected and counted. Required number of cells were pipetted on to the 
coverslips and supplemented with 200µl of pre-warmed DMEM medium. The plates were 
swirled around to avoid clustering of the cells on the coverslips. The cells were allowed to 
seed on the coverlips for 1-2 days at 37°C, 5% CO2 incubator, till the right confluence was 
achieved.  
2.5.2. Uptake of fluorescently labeled LDL 
The VAMP8-/- and VAMP8-/+ control immortalized mouse embryonic fibroblasts were 
grown on coverslips till they were 70% confluent. Cells were washed twice with PBS and 
starved in serum free DMEM + 1% BSA for 2h at 37°C to allow maximal recycling of the 
LDL receptors to the cell surface. The medium was then replaced with cold DMEM+ 1% 
BSA with 200µl of 10µg/ml fluorescently labeled low-density-lipoprotein (BODIPY® FL 
LDL, Invitrogen™ Molecular Probes™, Eugene, Oregon, USA). The cells were 
immediately placed on ice in dark for 1 hour to allow receptor binding. The cells were 
washed with sterile PBS twice at room temperature and incubated at 37°C in DMEM + 1% 
BSA for different chase times: 0min, 15min, 30min, 1hour and 3 hours. After the chase 
period, the cells on the coverslips were washed twice with PBS at room temperature and 
fixed in 3% PFA in PBS for 30 min at room temperature. The cells were washed twice with 
PBS and rinsed with water. Finally, the coverslips were mounted on glass slides with 
DAKO® mounting medium. The cells were viewed under Leica DM5000B fluorescence 





Chapter 2. Materials and methods 
 
 
2.5.3. Uptake of fluorescently labelled beads by peritoneal macrophages 
Peritoneal macrophages were isolated (Ref. 2.3.4.) and seeded at a concentration of 2x105 
cells / coverslip and cultivated in DMEM+ 10% FCS at 37°C, 5% CO2 overnight. 1µM 
diameter fluorescent beads (Flouresbrite® BB carboxylate microspheres Polysciences Inc.) 
were coated in 10% goat serum for better uptake into the cells. The beads, at a 
concentration 50 beads per cell, were pipetted in an eppendorf tube, supplemented with ~ 
500µl of 10% goat serum and held on a rotating wheel for half an hour. Before the 
experiment, the cells were starved in DMEM-FCS for 2 hours at 37°C. The cells were the 
fed with the pre-coated beads (50 beads/cell) and incubated for several periods of pulse (10, 
15, 20 and 30 minutes). After pulsing, the medium was replaced by fresh DMEM medium 
and chased at 37°C for 30 minutes and 60 minutes (Ref. table IX). After the respective 
pulse and chase times, the cells were washed with ice cold 1x PBS. The cells were fixed 
with methanol (Ref. 2.5.4) and stained with anti lamp2 antibody (Ref.2.5.6). The cells were 
viewed under Leica confocal laser scanning microscope TCS SP5 (Leica microsystems) at 
the excitation wavelength of 360nm.  
 
Table IX.  Pulse chase times to study uptake of BB fluoresbrite beads(® Polysciences Inc.)  
Pulse time Chase time Following treatment 
10 minutes - Fix and immunofluorescence 
15 minutes - Fix and immunofluorescence 
20 minutes - Fix and immunofluorescence 
30 minutes - Fix and immunofluorescence 
30 minutes 30 minutes Fix and immunofluorescence 
30 minutes 60 minutes Fix and immunofluorescence 
2.5.4. Methanol fixation 
Cells, seeded on the coverslips, were washed once with 1x PBS at room temperature. 1ml 
of methanol (-20°C) was added to each of the wells and left for 5 minutes at room 
temperature. After fixation, methanol was removed and immediately replaced with 1 ml of 
PBS. It is important not to let the cells dry out. The cells were washed twice with 1x PBS 
and immunofluorescence was performed as described in section 2.5.6. 
2.5.5. PFA fixation 
Cells seeded on the coverslips were washed once with PBS at RT and incubated for 30 
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with dd H2O and the coverslips mounted on glass slides or immunoflorescence was 
performed as described in section 2.5.6. 
2.5.6. Immuofluorescence for lamp1/2 and DAPI staining 
After fixation, either with methanol or PFA, the cells were washed twice with PBS and 
blocked with 50mM NH4Cl solution in PBS for 10 min. Then cells were permeabilized 
with 0,05% Triton X-100 in PBS 2 times 5 minutes each and blocked with 1% BSA in PBS 
solution for 20 minutes. Following this, the cells were stained with primary antibody. The 
primary anti lamp1/2 antibody was diluted 1:100 in 1% BSA PBS solution. 20 µl of the 
antibody solution was pipetted onto a parafilm. Coverslips were placed with cell side down 
on the drop of antibody solution in a dark humid chamber. Cells were incubated with the 
antibodies for 1h in a humid dark chamber. After incubation, the coverslips were placed 
back into the wells with the cell side up. The cells were washed 3 times for 5 minutes each 
with 1x PBS and incubated with 10% goat serum in PBS for 20 min. Secondary antibody 
anti-rat Cy3 was diluted 1:200 in 10% goat serum solution and 20 µl was pipetted on fresh 
parafilm. The cells were again placed upside down on the drop of antibody solution for 45 
minutes at room temperature in a dark humid chamber. Cells were then washed 5 times for 
5 minutes each with 1xPBS and rinsed twice times with water. The coverslips mounted in 
DAKO mounting medium containing DAPI stain (DAKO®, Carpinteria, CA) and allowed 













Chapter 2. Materials and methods 
 
 
Table X: List of antibodies used for FACS analysis 
Surface staining of T-lymphocytes 
Antibody Conjugate Concentration Source Marker  for 
Primary antibodies 
Anti Mouse CD 4 PE 50µg/500µl Caltag T lymphocyte 
Anti Mouse CD 4 TC 100µg/500µl Caltag T lymphocyte 
Anti Mouse CD8a FITC 100µg/1ml Caltag T lymphocyte 
Anti Mouse CD8a PE 50µg/500µl Caltag T lymphocyte 
Anti Mouse CD8b PE 50µg/500µl Caltag T lymphocyte 
Anti Mouse  CD3 PE 50µg/500µl Caltag T lymphocyte 
Anti Mouse CD25 FITC 0.5 mg/ml BD 
Pharmingen 
Immature thymocyte 
Anti Mouse CD44 Biotin 100µg/1.0ml Caltag Immature thymocyte 
Anti Mouse B220 PE 50µg/500µl Caltag B lymphocyte 
Anti Mouse DX5 PE 0.5 mg/ml BD 
Pharmingen 
Natural killer cells 
Anti Mouse MHCI FITC 100µg/1.0ml Caltag MHC I+ cells 
Anti Mouse TCRαβ FITC 100µg/1.0ml Caltag TCRαβ+mature T- 
lymyphocytes 
Anti Mouse Annexin V FITC 50µg/500µl BD 
Pharmingen 
Apoptotic cells 
Anti Mouse CD19 FITC 100µg/1.0ml Caltag B lymphocyte 
Anti Mouse NK1.1 FITC 100µg/1.0ml Caltag Natural killer cells 
Anti Mouse MHCII FITC 100µg/1.0ml Caltag MHCII+dendritic cells 
Isotype controls Control for 
Anti Rat IgG2a PE 50µg/500µl Caltag CD8a (FITC and PE), CD4 
(PE and TC), B220 (PE), 
CD3(PE) 
Anti Rat IgG2b Biotin 50µg/500µl Caltag CD44 (Biotin) 
Anti Rat IgM FITC 50µg/500µl Caltag CD25(FITC),DX5 (PE) 
Anti Mouse IgG2a PE 50µg/500µl Caltag NK1.1 (PE) 
Anti Mouse IgM FITC 50µg/500µl Caltag MHCII (FITC) 
Hamster anti Mouse IgG FITC 50µg/500µl Caltag TCRαβ (FITC) 
Secondary antibody for Biotin conjugated anti-CD44 antibody and its isotype control  rIgG2b 
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Table XI: List of antibodies used for apoptosis induction assays 
Plate bound CD3ε and CD28 induced apoptosis assay    
      Concentration Antibody 
Stock Working 
Source 
Purified hamster anti-mouse 







Biotnylated anti-mouse CD28 
(37.51) 
500µg/ml 10µg/ml BD Pharmingen 
 
Anti FAS antibody  induced apoptosis assay 
Antibody Concentration Source  
Purified anti mouse Fas monoclonal  
Clone Jo2 (Cat no 554254) 
1.0mg/ml BD Pharmingen 
 
Table XII: List of antibodies used for western blot analysis and immuno fluorescence 
Antibodies against SNARE proteins for western blotting 
Protein Name Mol. 
weight 
Type Dilution Source 
Vti1a 56 27 Polyclonal 
(Rabbit serum) 
1:3000 Antonin et al. 2000c 
Vti1b 55 29 Polyclonal 
(Rabbit serum) 
1:3000 Antonin et al. 2000c 
Endobrevin 
/VAMP8 
 16 Polyclonal 
(Rabbit serum) 










Syntaxin 8 60 27 Polyclonal 
(Rabbit serum) 
1:1000 Antonin et al. 2000b 
Syntaxin 7 Sx7/8 30 Polyclonal 
(Rabbit serum) 
1:1000 Antonin et al. 2000b 
SNAP 29 Sn29/1 29 Polyclonal 
(Rabbit serum) 
1:1000 Antonin et al. 2000b 
Syntaxin16 ODTH 37 Polyclonal 
(Rabbit serum) 
1:1000 Kreykenbohm et al. 2002 
VAMP4 136 19 Polyclonal 
(Rabbit serum) 
1:1000 Kreykenbohm et al. 2002 
 
Antibodies for immunofluorescence 
Antibody Dilution Source
Lamp1 (Rat monoclonal ID4B) 1:200 Hybridoma Bank, Iowa, USA 
Lamp2 (Rat monoclonal ABL93) 1:200 Hybridoma Bank, Iowa, USA 
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List of commonly used buffers 
Buffer Composition 
NET Buffer 100mM NaCl, 10mM Tris/HCl pH8.0, 25mM EDTA 
TBS 150mM NaCl, 50mM Tris/HCl pH7.4 
TE 1mM EDTA, 10mM Tris/HCl pH 7.4 
10x PBS 1.5M NaCl, 160mMNa2HPO4, 40mM NaH2PO4
1M Tris/HCl (1000ml) 
 
121g Tris base dissolved in 800 ml bidistilled H2O, pH adjusted with HCl 
and volume was made up till 1000 ml 
50x TAE 2M Tris-base, 0.1M EDTA, adjust pH 8,0 with acetic acid 
1x TAE 50x stock solution dissolved 1:50 in VS water 
 
List of media used for cell culture 
Dulbeccos Modified Eagle Medium - DMEM   
Component  Source Volume/Concentration 
DMEM PAN biotech, GmBH 1000ml 
Fetal calf serum Gibco BRL, Eggenstein 10% 
L-glutamine Gibco BRL, Eggenstein 2mM 
Penicillin/streptomycine Gibco BRL, Eggenstein 100 U/ml 
Mix the components and pre warm the medium before use 
 
Starvation Medium 
Component  Source Volume/Concentration 
DMEM PAN biotech, GmBH 1000ml 
L-glutamine Gibco BRL, Eggenstein 2mM 
Penicillin/streptomycin Gibco BRL, Eggenstein 100 U/ml 
Mix the components and pre warm the medium before use 
 
Medium for cryoconservation of cells  
Component  Volume (for 10ml medium) 
DMEM complete (ref table ) 7 ml 
Fetal calf serum 2 ml 
DMSO  1 ml  









Roswell Park Memorial Institute medium - RPMI 1640 
Component  Source Volume/Concentration 
RPMI 1640 Gibco BRL, Eggenstein 1000ml 
Fetal calf serum Gibco BRL, Eggenstein 10% 
L-glutamine Gibco BRL, Eggenstein 2mM 
Penicillin/streptomycin Gibco BRL, Eggenstein 100 U/ml 














3.1 Ablation of VAMP8/endobrevin causes partial early mortality 
3.1.1. Progressively degenerating health and early death in VAMP8-/- mice 
The birth and death of VAMP8-/- Vti1b-/-, VAMP8-/- Vti1b+/-, VAMP8-/- and VAMP8+/- 
Vti1b-/- pups was recorded. It was seen that all the VAMP8-/- genotypes had a high rate of 
mortality before the age of one month. During the initial work (Ref. section 1.4.4) 30 out of 
45 (66%) VAMP8-/- Vti1b-/- and 20 out of 34 (58%) VAMP8-/- Vti1b+/- were reported dead 
before the age of one month (Figure 3.1). In this work, similar recording of births and death 
for VAMP8-/- showed that 20 out of 55 i.e. 36% VAMP8-/- mice were dead before one 
month of age (Figure 3.1). In comparison only 2.2% deaths were observed in VAMP8+/- 

















Total animals Dead before 1 mth  Older than 1mth
Total animals 45 34 88 55
Dead before 1 mth 30 20 2 20
 Older than 1mth 15 14 86 35
VAMP8-/- Vti1b-/- VAMP8-/- Vti1b+/- VAMP8+/- Vti1b-/- VAMP8-/- 
 
Figure 3.1. High early mortality in VAMP8/endobrevin-/- genotypes: There was a high early mortality 
in VAMP8-/- mice compared to the VAMP8+/- mice. While 30 out of 45 VAMP8-/- Vti1b-/- and 20 out of 34 
VAMP8 -/- Vti1b-/+ mice died before reaching the age of 1 month. The VAMP8 single knock out mice had 
an early onset of death and 20 out of 55 mice died before the age of weaning. VAMP-/+ mice however were 
more like the wild type mice with a very low rate of mortality (less than 2%).  
 
VAMP8-/- and VAMP8-/-Vti1b-/- mice were born in expected Mendelian ratios indicating a 
normal pre-natal development. The mice also showed a normal post natal development up 
to day 7. After the 8th day, 36% of the VAMP8-/- mice began to loose weight and became 
smaller than the littermates. Loss of weight was observed till up to 2-3 days accompanied 






















VAMP 8 Knock out 1 VAMP 8 Knock out 2
VAMP 8 Heterozygous 1 VAMP 8 Heterozygous 2
Small not sick Small and sick
 
Figure 3.2. Weight gain pattern in VAMP8-/- mice: Characteristic pattern of weight gain of a 
representative litter shows heterogeneity in the phenotype of VAMP8-/- mice. One out of the two VAMP8-
/- pups lost weight starting post natal day 8 for 2-3 consecutive days, became sick and eventually died. 
While the other VAMP8-/- pup survived the weaning and became adults. At the first day of weight loss, 
the mice were smaller than their littermates but were apparently active and did not look sick. This stage is 
called small not sick. While after 2-3 days of weight loss, the mice looked very weak and sick and this 
stage is described as small and sick. 
 






















































Figure 3.3. Massive weight loss in small VAMP8-/- mice : A 11 day old VAMP8-/- mouse (right) 
weighing 3.6 grams on the day of death compared to a VAMP8+/- littermate (left) weighing 6.3 grams on 
the same day (A). The average weight of small and sick mice is reduced at an average by 1.9 folds (n=7, 
age 8-12 days, left graph) while the mice at the preceding small not sick were lighter by 1.5 folds (n=4, age 
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Following this, there was a progressive decrease in weight such that at the time of death, 
the VAMP8-/- small and sick mice weighed almost half (average 1.9 fold decrease) that of 
the heterozygous littermates (Figure 3.3 A, B). The mice were very weak with a shivery 
and unstable gait  
Similar pattern of weight loss and early mortality was previously observed in the VAMP8-/-
Vti1b-/- and VAMP8-/-Vti1b-/+ (Ref. section 1.4.4). However in contrast to VAMP8-/- mice 
that had a much early and sudden onset of the phenotypic manifestation and most of the 
VAMP8-/- Vti1b-/- mice died between post natal day 15-30. At the end of one month, just 



















VAMP8-/- Vti1b-/- VAMP8-/- Vti1b+/- Figure 3.4. VAMP8
-/- Vti1b-/- 
mice show high early 
mortality: 
Record of birth and death of 
VAMP8-/- Vti1b-/- double 
knock out and VAMP8-/- 
Vti1b+/- mice. The VAMP8-/- 
Vti1b-/- knock out mice showed 
the highest number of deaths 
with just about 33% surviving 
mice at the end of one month. 
The VAMP8-/- Vti1b -/+ mice 
also had a high death rate with 
about 41% survivors after one 
month. 
 
The VAMP8-/- and VAMP8-/- Vti1b-/- mice that survived past the initial one month of post 
natal life, reached adulthood and were fertile. However, they were in most cases lighter and 
smaller than their heterozygous littermates.  
3.1.2. Heterogeneity in the VAMP8-/- phenotype 
There was heterogeneity in the phenotype among the VAMP8-/- mice. For further reference, 
the mice have been divided into three categories based on their health status.  
The first stage is called ‘small not sick’ stage. This stage marked the beginning of health 
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The second category is ‘small and sick’ stage, when the mice had lost weight for 2-3 days 
consecutively and looked very weak and small and eventually died.  
The third category comprises of the ‘adult’ VAMP8-/- that did not loose weight and became 
adults that were fertile and healthy.  In all the experiments, VAMP8+/- littermate mice were 
used as controls for the VAMP8-/- test mice.   
3.2. Ablation of VAMP8 causes defects in Thymus 
3.2.1. Morphological defect  
*Histological staining done by Dr. Afshin Fayyazi at the Department of Pathology, Georg-August Universität 
Göttingen. 
 
Several organs from a small and sick VAMP8-/- Vti1b-/- mouse were examined 
histologically. While kidney, intestine, brain, spinal cord, spleen and heart appeared 
normal, the thymus showed a morphological defect.  The pancreas of VAMP8-/- Vti1b-/ 
mice also showed a defect. The pancreas of small as well as adult VAMP8-/- Vti1b-/- mice 
looked enlarged and creamy. This defect was probably due to the loss of VAMP8 similar to 
what was previously described by Wang and co-workers in their VAMP8-/- mice. (Wang et 
al. 2003). However we concentrated on studying the thymus 
During the initial work (Ref. section 1.4.3, 1.4.4), thymus of a few VAMP8-/- Vti1b-/- mice 
was studied by histochemistry and compared to the wild type mice. The normal 
morphology of thymus section from an adult wild type mouse is depicted in Figure 3.5A. 
The cortex (C) and medulla (M) appear as distinct compartments in Giemsa staining 
(Figure 3.5A). On higher magnification, a clear boundary defining the thymic cortex and 
the medulla was observed (Figure 3.5B). Dendritic cells are strictly confined to the medulla 
and the cortico-medullary junction and can be seen by Fascein staining of thymus sections. 
As seen in Figure 3.5C, the yellow stained dendritic cells are present only in the medulla 
within a well defined boundary and are excluded from the cortex. In addition, thymus from 
2 months old adult VAMP8-/- Vti1b-/- mouse showed a normal morphology (analysed 
during master’s thesis) with a clearly defined medullary and cortical boundary (Figure 3.5D 
and E) and dendritic cells strictly confined to the medullary region (Figure 3.5F). However, 
thymus from small and sick VAMP8-/- Vti1b-/- mice showed no distinction into cortex and 




















VAMP8 -/- small and sick
VAMP8 -/- Vti1b -/- small and sick
VAMP8 -/- Vti1b -/- small and sickWild type
Wild type










Figure 3.5. Morphology of thymus 
is disrupted in VAMP8-/- small and 
sick mice: HE stained sections from 
the thymus of a wild type mouse 
showed a distinction into two 
compartments, the cortex (C) and the 
medulla (M) (A,B). Fascein stained 
thymus sections from wild type 
mouse showed the dendritic cells 
strictly confined to the medullary 
region (brown E). Thymus from a 
healthy adult VAMP8-/- mouse also 
showed a clear distinction into cortex 
and the medulla (C-D). In contrast, 
the thymus section from small and 
sick VAMP8-/- Vti1b-/- (G-H) and 
from a 8 day old VAMP8-/- (I,J) mice 
did not show the characteristic 
compartmentalization into cortex and 
medulla with medullary cells (pink) 
scattered through the thymic cortex 
(blue). Fascein stained thymus 
sections from a small and sick 
VAMP8-/- Vti1b-/- mouse showed a 
scattered pattern of dendritic cells 
(brown F). The pictures were taken 
by Leica-DM IRB microscope at the 
indicated magnifications. 
*Histological staining done by Dr. 
Afshin Fayyazi at the Department of 
Pathology, Georg-August Universität 
Göttingen. 
 
On higher magnification, complete disruption of the cortico-medullary boundary was more 
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cortical cells (Figure 3.5H). Dendritic cells were also scattered in these thymii, as seen by 
fascein staining (Figure 3.5I).  
During this work, the disruption of thymus morphology in VAMP8-/- Vti1b-/- mice was 
confirmed by analysis of thymii from several small and sick and adult VAMP8-/- Vti1b-/- 
mice. In addition the thymus from small and sick VAMP8-/- mice were also analyzed. 
Thymii from small and sick VAMP8-/- mouse showed a morphological defect similar to the 
VAMP8-/- Vti1b-/- mice. There was no distinct compartmentalization into cortex and 
medulla and a few medullary cells appeared scattered throughout the cortex (Figure 3.5J).  
In addition, thymus from a 9 day old small not sick VAMP8-/- mouse was analyzed 
histologically. There was a no disruption of the cortico-medullary boundary in the thymus 
of this mouse and the two regions were clearly demarcated. Hence, it was confirmed that 
the disruption of thymus morphology was a characteristic feature of the small and sick 
stage of both VAMP8-/- and VAMP8-/- Vti1b-/- mice, while the thymus is normal at the 
small not sick stage. 
3.2.2. Reduction in thymus size and total cell count  
Total cell count of thymus was analyzed from several VAMP8-/- small and sick, small not 
sick and adult mice. The thymii were homogenized in 10ml of RPMI-1640 supplemented 
medium and the cells counted in a neubauer chamber. It was seen that the thymus 
cellularity in the VAMP8 -/- mice was reduced quite rapidly with the progression of 
phenotypic manifestation. While the small not sick mice already showed a signs of 
reduction in thymic cellularity, the most severe reduction was seen in the thymii from the 
small and sick mice.  
The VAMP8-/- small not sick mice had an average of 140 million cells compared to 260 
million in the VAMP8+/-controls i.e. a reduction by around 1.8 fold (Figure 3.6). The cell 
count in the small and sick VAMP8-/- mice rapidly reduced by upto 10 folds. There were 
just about 26 million cells in the thymus of the small and sick mice compared to 260 
million in the controls (Figure 3.6). Thymus from the adult VAMP8-/- mice also showed a 
slight reduction by around 1.4 folds compared to littermate controls (Figure 3.6).  
As previously observed, similar reduction was observed in the total thymus cell count of 
VAMP8-/- Vti1b-/- mice at the small and sick stage. On an average, the small and sick 
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littermate controls i.e. a reduction of up to 13 fold in the total cell count (Ref. section 1.4.4 
and Figure 3.7A). 







































Figure 3.6. Thymus cellularity is progressively reduced in VAMP8-/-small and sick mice: The size of 
the thymus is highly reduced in the VAMP8-/- small and sick mice (A). The total cell count is also reduced 
by around 10 folds in the VAMP8-/- mice (n=7 age8-12 days) at the small and sick stage. The reduction in 
cell number can also be seen in the small but not so sick stage (n=5 age 8-12 days) and in the adults (n=3 age 
1.5-2 months), (1.8 fold, 1.4 fold respectively) (B). 
 
Figure 3.7. The cellularity of 
thymus is reduced in small and 
sick VAMP8-/- Vti1b-/- but not 
in Vti1b-/-mice: Small and sick 
VAMP8-/- Vti1b-/- mice (n=5,12-
25 days) show up to 13 fold 
reduction in total cell count (A). 
*Onset of phenotype was spread 
over first 1 month of age in  
VAMP8-/- Vti1b-/- mice compared 
to 7 days in the VAMP8-/- mice. 
The data shown here is from 
VAMP8-/- Vti1b-/- mice between 
days 12-25. Hence the control 
VAMP8+/- Vti1b+/- have a higher 
number of total cell count 
compared to VAMP8-/+ controls. 
Vti1b small mice (10-12 days, 
n=4) do not show any reduction in 
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However in Vti1b-/- mice aged day 10-12, there was no reduction in the thymus cellularity 
compared to littermate Vti1b -/+ control mice (Figure 3.7B). The control mice had an 
average of 220 million cells compared to average 200 million cells in the Vti1b-/- mice.  
Table XIII: A summary of reduction in total cell count in different studied genotypes. 
Test Genotype Test 
Thymocytes 
(Mio) 





VAMP8-/- small and sick 26 260 10 x 
VAMP8-/- small not sick 140 266 1.8 x 
VAMP8-/- adult 170 242 1.4x 
**VAMP8-/- Vti1b-/- small and sick 40 510 13x 
Vti1b -/-  200 220 - 
 
*Vamp8 +/- littermates were used as controls for the Vamp8-/- mice , Vamp8+/- Vti1b+/- littermates for the 
Vamp8-/- Vti1b-/- and Vti1b +/- littermates for the Vti1b-/- mice. The same number of control and test mice was 
used. ** The window of phenotypic onset is extended over post natal days 11 to 29 in the Vamp8-/- Vti1b-/- 
small and sick mice. The mice analyzed were aged 12-25 days and therefore the corresponding controls have 
a higher total cell count compared to the Vamp8+/- aged between 8-12 days.   
 
Additionally, the spleen was severely reduced in the VAMP8-/- Vti1b-/- and VAMP8-/- small 
and sick mice. The total count of T lymphocytes in the spleen of VAMP8-/- Vti1b-/- small 
and sick mice was 13.8 million compared to 135 million in the controls i.e. a reduction by 
10 folds. However there was no reduction in the T lymphocytes cell count in the spleen of 
VAMP8-/- adult mice (263 million) compared to the controls (266 million). 
The above data indicates that VAMP8 is important for development of the thymus in mice 
and possibly for early postnatal survival. It was also confirmed that the previously observed 
phenotype in the VAMP8-/- Vti1b-/- mice is contributed entirely by the loss of VAMP8 
while the loss of Vti1b does not affect thymus development. 
3.2.3. SNARE proteins in the thymus 
In order to confirm that the VAMP8tm1Lex mice do not have VAMP8 protein, protein levels 
in the VAMP8+/+, VAMP8+/- and VAMP8-/- mice were checked by western blot. VAMP8 
was present in thymus of VAMP8+/+ and VAMP8+/- mice while VAMP8 was not detect in 
thymii from the VAMP8-/- mice (Figure 3.8A). From previous work in our lab it was 
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al. 2003). Therefore, we wanted to know if levels any of the SNARE proteins are changed 
due to the loss of VAMP8.  
Deficiency of VAMP8 did not have a considerable effect on the amount of its complex 
partners syntaxin7, syntaxin8 and Vti1b nor of the early endosomal Vti1a or SNAP-29. 
Western blot analysis showed a reduced amount of syntaxin 8 in the thymus from VAMP8-
/- Vti1b-/- mice (Fig. 3.8B) as expected for Vti1b-deficient tissue (Atlashkin et al. 2003). 
The loss of the late endosomal SNARE complex could possibly be compensated for by the 
early endosomal SNARE complex. However, there was no major change in the amounts of 
the early endosomal SNAREs VAMP4, Vti1a or syntaxin16.  









Figure 3.8A. SNARE profile of the thymus from 
healthy VAMP8-/- mouse aged ≥ 1.5 months in 
comparison to the VAMP8-/+ and wild type mice. 
There was no difference in the expression level of 
SNAP29, Vti1b, syntaxin 8 and Vti1a in thymii of 


















Figure 3.8B. SNARE profile of thymus from 
VAMP8-/- Vti1b-/- mouse (≥1.5 months) and littermate 
wild type mouse. There was no difference in the 
expression of Vti1a, VAMP4, SNAP29, syntaxin 7 and 
syntaxin 16 between the two samples. There was no 
Vti1b detected in the double knock out thymus while 
syntaxin 8 was reduced due to the deficiency of Vti1b 
in the VAMP8-/- Vti1b-/- mouse. 
3.3. Deficiency of VAMP8 leads to defective T-cell maturation 
The compartmentalization of thymus into functionally distinct areas: the cortex and the 
medulla, is critical for the development of the T-lymphocytes. The developmental stages of 
T lymphocytes can be divided on the basis of sequential expression of markers CD44, 
CD25, CD4 and CD8. The T cell progenitors that arrive in the thymus are devoid of most 
of the Thymocyte markers especially CD4 and CD8 and are therefore called double 
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sequence and are divided into four stages of development DN1-4 as: CD44+CD25- (DN1) 
CD44+CD25+ (DN2)           CD44-CD25+ (DN3)          CD44-CD25- (DN4).  
The DN4 cells start expressing both the CD4 and CD8 molecules called CD4+CD8+ (DP) 
stage. This is followed by the loss of expression of either CD4 or CD8 thereby maturing 
into CD4+ (SP) or CD8+ (SP) cells. The progression of each subset to the next one is under 
strict selection mediated by a constant crosstalk between the T lymphocytes and the stromal 
cells. We wanted to know if the observed disruption of the thymus morphology affects the 
T-lymphocyte development adversely in the small VAMP8-/- mice.  
Freshly excised thymus from VAMP8-/- small and sick, VAMP8-/- small not sick and adult 
mice were homogenized. Thymocates were stained with antibodies (linked with fluorescent 
conjugates) against T cell surface markers CD4, CD8, CD44, CD25 and T cell receptor 
(TCR). The labeled cells were counted in cell sorter (BD FACScan) and the expression of 
these markers on the surface was analyzed. The percentage of cells counted in the isotype 
controls was subtracted from the samples to avoid errors due to non-specific staining and 
auto-fluorescence.  
3.3.1. Development of CD4-CD8- DN1-4 subsets is disturbed in sick VAMP8-/- mice 
At first, detailed phenotyping of the CD44/CD25 thymic precursor subsets was performed 
on CD4-CD8-(DN) cells. The objective was to analyze the CD44+CD25- (DN1), 
CD44+CD25+ (DN2), CD44-CD25+ (DN3) and CD44-CD25- (DN4) subsets in the thymii 
from VAMP8-/- mice and compare to the VAMP8+/- controls. Two step gating strategy was 
used to analyze just the DN thymocytes (Figure 3.9). In the first step, the cells were gated 
according to their light scattering properties. The larger and more granulated cells like the 
granulocytes and smaller cells like erythrocytes scatter light differently when compared to 
the medium sized thymocytes. Thus from the forward (FSC) and side scatter (SSC) dot plot 
it is possible to specifically gate on the region of thymocytes (Figure 3.9A). In the second 
gating step, the cells bearing the CD4 and CD8 markers (mature T lymphocytes), B220 
(marker for B lymphocytes), NK1.1 and DX5 (markers for natural killer cells) were stained 



































































VAMP8-/- Small and sick VAMP8+/- control
VAMP8-/- Small and sick 33.3 16.7 9.1 40.8
VAMP8+/- control 4.9 55.5 21.3 18



















VAMP8-/- small and 
sick






Figure 3.9. Analysis of DN1-4 
thymocyte precursor subsets in small 
and sick VAMP8-/- mice: Single cell 
suspension from thymus of VAMP8-/- 
small and sick mice were stained with 
antibodies against CD44 and CD25 
markers to visualize DN1-4 subsets.Two 
step gating strategy was used for analysis 
of DN subsets. At first, the cells were 
gated according to their light scattering 
characteristics. Very large and granular 
cells such as granulocytes and very small 
cells such as leukocytes as well as debris 
are excluded out. While the cells in the 
size range of thymocytes are included in 
the region of interest R1 shown in yellow 
FSC: Forward scatter, SSC: Side scatter 
(A). Further, the mature T lymphocytes 
bearing lineage markers CD4, CD8; 
natural killer cells with DX5, NK1.1 and 
B lymphocytes bearing B220marker were 
excluded. These cells show high signal 
intensity in the PE channel and appear as 
large peaks seen in the right corner of the 
area plots in figure B. While the cells with 
low or no signal for these markers are the 
DN cells and are gated under marker M. 
Relative intensity of fluorescence are 
plotted along the X and Y axis. While the 
area under the curve shows the cell count 
(B). These DN cells were further analyzed 
for the distribution of DN1-DN4 subsets. 
A representative dot plot data from a 10 
day old small and sick VAMP8-/- mouse 
compared to a VAMP8-/+ mouse. The X 
and Y axis show the relative intensities of 
signal in the fluorescence channels plotted 
on log scale (C). Each dot represents a 
cell. The number of cells in the DN1 and 
DN4 stage was massively increased while 
the DN2 and DN3 cells were reduced (C). 
A histogram plot of six experiments (age 
10-12 day) comparing the DN1-4 subsets 
on VAMP8-/-small and sick mice to 
VAMP8-/+ littermate controls (D) There 
was a massive desrease in the absolute 
cell number of DN subsets with DN2 and 
DN3 being most severely reduced (E). 
 
 
The anti CD44 antibody was conjugated with tricolor (TC) and CD25 antibody to fluoro-
isothio cyanin (FITC). Therefore we could specifically count the DN cells labeled with 
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DN1-4 subsets were then analyzed for CD44 and CD25 expression depending on the signal 
intensity for FITC and TC fluorescence (Figure 3.9C). 
Although we could detect all the DN subpopulations (DN1-DN4), there was a considerable 
difference in the percentage of these cells in the VAMP8-/- small and sick mice compared to 
the VAMP8+/- controls (Figure 3.9C, D). The absolute cell count of all the DN subsets was 
massively reduced with DN2 and DN3 cells being reduced by upto 13 and 12 folds 
respectively. DN1 and DN4 subsets were reduced by 1.2 and 1.4 folds respectively (Figure 
3.9 E). The percentage of DN1 and DN4 cells progressively increased by 6.8 fold (33% 
compared to 5% in controls) and 2.3 fold (40% compared to 18% in controls) respectively 
in the VAMP8-/- small and sick mice (9-12 days of age n=6) compared to the littermate 
VAMP8+/- controls. The DN2 cells were reduced on an average by 3.3 (17% compared o 
55% in controls and DN3 by 2.3 folds (9% compared to 21% in controls) (Figure 3.9D). By 




















VAMP8 -/- small not sick VAMP8+/-
 
 
Figure 3.10. Analysis of 
DN1-4 thymocyte precursor 
subsets in small not sick 
VAMP8-/- mice aged 10-12 
days n=3. There was no 
difference in the distribution 
of the DN1-4 subsets in the 
thymus of VAMP8-/- small 
not sick mice compared to 
VAMP8+/- controls. 
 
These results indicate that the ablation of VAMP8 causes a maturational defect in the 
thymocytes. There seems to be a transitional block at the DN1 and DN4 stages leading to 
an increased percentage of these cells. This could also explain the reduced percentage of 
cells in the DN2 and DN3 stages. The defect is characteristic of the very late stage of the 
phenotypic development i.e. in the small and sick mice.  
3.3.2. Development of CD4/CD8 subsets is disturbed in sick VAMP8-/- mice 
Since the DN4 cells progress to CD4+CD8+ (DP) and eventually into CD8+ or CD4+, the 
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cells. Therefore, we checked the distribution of the CD4+CD8+ and CD4+/CD8+ cells in the 
thymii of VAMP8-/- small and sick, VAMP8-/- small not sick and VAMP8-/- adult mice. 
Anti CD4 antibody was conjugated with PE and anti CD8 antibody with FITC. Therefore 
we could study the developmental stages of CD4/CD8 subsets depending on the signal 
intensity in the FITC and PE channel. The reduction in thymus cellularity (mentioned 
before) reflected in a reduced absolute cell number of all the CD4/CD8subsets Table XIV.  
 
Table XIV: Despite the increase in the percentages, the absolute number of thymocyte subsets was reduced in 
the small and sick mice (n=5) compared to the littermate controls  
 
CD4 CD8 DN(106) CD4 CD8 DP (106)        CD4 SP (106)       CD8 SP (106)
VAMP8 -/- small 
and sick 
2.4 (±1.4) 17.4 (±18.4) 7.9 (±2.0) 1.7(±0.4) 
VAMP8 +/-
Control 
9.5 (±1.7) 225.2 (±4.3) 21.7 (±3.7) 6.8 (±1.7) 
 
A B





































VAMP8-/-small and sick VAMP8+/- control
VAMP8-/-small and sick 8.2 51.1 32.3 8.3
VAMP8+/- control 4.1 85.1 8.0 2.5
CD4-CD8 DN CD4-CD8 DP CD4 SP CD8 SP
 
Figure 3.11. CD4/CD8 phenotyping of developing T lymphocytes from small and sick V AMP8-/- mice 
Thymus from VAMP8-/- small and sick mice were stained with antibodies against CD8 and CD8 surface 
markers and analyzed for the CD4/CD8 expressing subsets.(n=5, 8-11 days) There was a massive decrease 
in the CD4+CD8+ (CD4 CD8 DP)and increase in the CD4+ (CD4 SP)and CD8+ (CD8 SP) cells in the 
VAMP8-/- thymus of small and sick mice compared to the controls (A). A representative dot plot data shows 
the distribution of the CD4/CD8 subsets. The CD4+ cells appear in the upper left quadrant (UL), the CD8+ 
cells appear in the lower right quadrant (LR), the CD4+CD8+ cells appear in the upper right quadrant (UR) 
while the CD4-CD8- cells can be seen in the lower left quadrant (LL). The VAMP8-/-small and sick mice 
clearly have an increased number of cells in the UL (CD4+), LR (CD8+) and LL (CD4-CD8-) quadrants 
while there is reduced number of cells in the UR (CD4+CD8+)(lower dot plot) compared to the respective 
quadrants in the control (top dot plot) (B).  
 
As seen from Figure 3.11, we could detect CD4/CD8 populations in the VAMP8-/- small 
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(Figure 3.11). The percentage of CD4+ and CD8+ and CD4- CD8- cells showed a progressive 
increase. There were around 32% CD4+ cells in the thymus of small and sick VAMP8-/- 
mice compared to 8% cells in the controls i.e. a 4 fold increase (Figure 3.11). VAMP8-/- 
small and sick mice had 8% CD8+ cells compared to 2.5 % in VAMP8+/- (3.3 fold 
increase). There were 8% CD4-CD8- in the sick mice compared to 4% in the controls (2 
fold increase). The CD4+CD8+ cells were drastically reduced. The VAMP8-/- small and sick 
mice (n=5, 8-11 days) had 51% CD4+CD8+ cells while the control mice had 85% of these 
cells i.e. a decrease of upto 1.6 fold (Figure 3.11).  
This disturbance in the CD4/CD8 bearing subsets of the developing T lymphocytes was 
found to be characteristic for the small and sick stage. The VAMP8-/- small not sick mice 
(Figure 3.12) and the adult mice (Figure 3.13) showed a normal percentage of developing 




















VAMP8 -/- small not sick VAMP8+/- control 
VAMP8 -/- small not sick 3.48 87.46 6.79 1.98
VAMP8+/- control 4.14 86.85 6.88 2.14




Figure 3.12. CD4/CD8 
phenotyping from 
small not sick VAMP8 -
/- mice (n= 3, age 8-12 
days). There is no 
difference in the 
percentage of CD4/CD8 
subsets between the test 



















VAMP8 -/- adult VAMP8 +/- control 
VAMP8 -/- adult 5.8 77.6 12.1 4.4
VAMP8 +/- control 4.70 84.30 7.80 2.60





Figure 3.13. CD4/CD8 
phenotyping from 
adult VAMP8 -/- mice 
(n= 5, age ≥ 1.5 
months). There is no 
difference in the 
percentage of CD4/CD8 
subsets between the test 
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3.3.3. Development of CD4/CD8 subsets is disturbed in sick VAMP8-/- Vti1b-/- mice 
Initial experiments on small and sick VAMP8-/- Vti1b-/- mice showed a similar disturbance 
in T lymphocytes development as the small and sick VAMP8-/- mice (Ref. section 1.4.4). 
Further experiments were done on the thymus from small and sick as well as small not sick 
VAMP8-/- Vti1b-/- to confirm the results and generate statistically significant data sets. In 
this study it was confirmed that the small and sick VAMP8-/- Vti1b-/- mice also showed a 
disturbance in development similar to the small and sick VAMP8-/- mice.  There was a 
massive increase in the percentage of CD4+ cells in the small and sick VAMP8-/- Vti1b-/- 
mice. There were around 49% CD4+ cells in the sick mice compared to 20% in the control 







Figure 3.14. CD4/CD8 
phenotyping of 
thymocytes from 
small not sick 
VAMP8-/- Vti1b-/- 
mice. CD4-CD8- (CD4 
CD8 DN), CD4+ (CD4 
SP) and CD8+ (CD8 
SP) were highly 
increased in the small 
and sick VAMP8-/- 
Vti1b-/- mice (n=5, 
aged 12-25 days) 
compared to the 
controls. CD4+CD8+ 
cells were reduced in 
these mice (A). This 
defect was not observed 
in the VAMP8-/- Vti1b-
/- mice at the small but 
not sick stage (n=3, age 
















VAMP8-/- Vti1b-/- small and sick VAMP8+/- Vti1b+/-control 
VAMP8-/- Vti1b-/- small and sick 29.4 11.9 48.5 10.5
VAMP8+/- Vti1b+/-control 19.4 54.5 20 5.95














VAMP8-/- Vti1b-/- small not sick VAMP8+/- Vti1b+/- control 
VAMP8-/- Vti1b-/- small not sick 5.42 78.14 13.47 2.63
VAMP8+/- Vti1b+/- control 5.01 79.72 12.19 2.83
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A similar two fold increase was seen in the CD8+ cells. The CD4+CD8+ cells were reduced 
by around 5 folds. The small and sick mice had 12% double positive cells (CD4+CD8+) 
compared to 55% in the control mice. However, no such difference was seen in the small 
but not sick stage of the VAMP8-/- Vti1b-/- mice (Figure 3.14B).  
3.3.4. Vti1b-/- mice do not show defect in T lymphocyte maturation 
 Further, it was interesting to know whether the loss of Vti1b in Vti1b-/- mice also causes 
disturbance in T cell maturation. Thymocytes from 10-12 day old Vti1b-/- mice were 
stained with antibodies against CD4 and CD8 surface markers (Figure 3.15). There was no 
difference in the percentage of CD4/CD8 bearing immature and mature T-lymphocytes 









thymii from Vti1b-/- 
mice (n=3, age 10-
12 days) stained for 
CD4 and CD8 
surface markers. 
There is no 
difference in the 
distribution of 
CD4+ (CD4 SP), 
CD8+ (CD8 SP), CD4- CD8- (CD4 CD8 DN) and CD4+ CD8+ (CD4 CD8 DP) cells in the Vti1b deficient 















Vti1b-/- 5.33 84.97 6.19 2.46
Vti1b+/- control 6.38 83.89 6.51 2.38
CD4CD8 DN CD4CD8 DP CD4 SP CD8 SP
 
3.3.5. T cell receptor expression unaltered in VAMP8 -/- small and sick mice 
T cell receptor (TCR) is essential for signal transduction during T-cell development. It was 
interesting to study whether the loss of VAMP8-/- causes any defect in the expression of the 
TCR molecules on the surface of cells derived from small and sick mice. Thymocytes from 
test and control mice were stained with FITC labeled antibodies against αβTCR. At first, 
the percentage of TCR positive cells was analyzed in both the VAMP8 -/- and VAMP8 +/- 









VAMP8-/- small and sick mice. This could be explained due to the massive increase in the 
percentage of αβTCRhighCD4+ and αβTCRhighCD8+ cells in the thymii of these mice as 
discussed previously (Figure 3.16A, B).  
 
 
Figure 3.16.  
Analysis of TCR 
expression on the 
thymocytes from 
small and sick 
VAMP8-/- mice: 
A representative 
area plot. (–) line 
depicts intensity 
signal from 




The area under the 
– line curve shows 
the percentage of 
cells stained for 
TCR while the 
fluorescence 
ity is 
depicted along the 
X axis. As seen 
from the area plot 
on left, the 
percentage of 
TCRhigh cells is 
higher in the 
VAMP8-/- small and sick mice compared to the control. However, the intensity of signal as seen along the 
X axis is similar for the VAMP8-/- small and sick mice and test mice (A). Graphical depiction of data from 
n=3 VAMP8-/- small and sick mice aged 9-12 days showing an increase in the percentage of αβTCRhigh 
cells (B). However, the mean intensity of TCR on the surface of the TCR positive cells is not significantly 
altered in the VAMP8-/- small and sick mice compared to the VAMP8-/+ control mice (C). 
 



























































VAMP8+/- control 33.8 319.8










VAMP8 -/- Small and sick VAMP8 -/+ Control
A
Secondly, in order to study the surface expression of the TCR to the surface of the 
developing T lymphocytes, the intensity of TCR was quantified on the TCR+ T 
lymphocytes (Figure 3.16C). The reason behind these experiments was that if the 
trafficking of TCR to the surface of the thymocytes was blocked due to the lack of the late 
endosomal SNARE VAMP8, it could reflect as an altered intensity of TCR signal on cells. 
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3.3.6. VAMP8 deficiency does not cause defect in adult peripheral T-cell reservoir 
d in 
3.16C). Hence, the lack of VAMP8 does not cause a defect in the surface expression of 
TCR on the T-lymphocytes. 
In order to know whether the peripheral repertoire of mature T lymphocytes was affecte
the adult VAMP8-/- mice, lymphocytes from the spleen of several adult (≥ 3.0 months) 
VAMP8-/- mice were analyzed. The spleens were excised, homogenized and the 
erythrocytes were lysed. The remaining cells were stained with fluorescently labeled 
antibodies against CD4, CD8, CD3 surface markers for mature T lymphocytes, B220 
marker for the B-lymphocytes and DX5 marker for the natural killer (NK) cells. Cells were 
also stained with annexinV and propidium iodide to visualize the extent of apoptosis in the 
cells from adult VAMP8-/- spleens. We observed no significant difference in the repertoire 
of peripheral mature CD4+CD3+ and CD8+ CD3+ T lymphocytes, B-lymphocytes and NK 
cells in the adult VAMP8-/- mice and the controls. The extent of annexin V and PI stained 
dead cells was also comparable between the adult VAMP8-/- mice and the littermate 













VAMP8-/- adult 32 13 44 3 6





B lymphocyte NK Cells Dead cells
Figure 3.17. Analysis of peripheral repertoire of lymphocytes and natural killer cells from adult 
- -VAMP8-/- mice: Adult VAMP8 /  mice (n=4, age ≥3 months) show no difference in the distribution of 
mature T-lymphocyte populations CD4+ CD3+ and CD8+ CD3+, B lymphocytes stained with B220 surface 
marker, natural killer (NK) cells stained DX5 marker and dead cells co-stained with annexinV and 
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3.4. Thymocytes show high cell death 
3.4.1. Thymus from small and sick mice have high cell death in vivo  
The initial analysis of VAMP8-/- Vti1b-/- mice showed a high number of dead cells in the 
thymus. Figure 3.18A is a TUNNEL stained thymus section from a 2 month old wild type 
mouse showing basal level of apoptosis present in the thymus at any point of time (Ref. 
section 1.4.4 and Figure 3.18A, black spots represent dead cells). The thymus from 2 
months old VAMP8-/- Vti1b-/- adult mouse appeared very similar to the wild type, with a 
few scattered dead cells (Ref. section 1.4.3 and Figure 3.18B). However, the thymus of ~1 
month old small and sick VAMP8-/- Vti1b-/- mouse showed a  massive number of dead 
cells either localized to the periphery or scattered out in the lobe in TUNNEL staining (Ref. 
section 1.4.3 and Figure 3.18D). 
 
Wild type VAMP8 Vti1b double knock  
out small and sick




Figure 3.18. Thymus from small and sick VAMP8-/- Vti1b-/- mice show high number of dead cells: 
Histological staining of thymus sections to detect dead cells. TUNNEL staining of thymus sections from a 
2 months old wild type (A) and VAMP8-/- Vti1b-/- (B) mouse show a few dead cells stained in 
black.TUNNEL staining of sections from small and sick VAMP8 Vti1b double knock out mouse also 
shows a massive amount of dead cells (C). *Histological staining done by Dr. Afshin Fayyazi at the Department 
of Pathology, Georg August Universität Göttingen. 
 
 
In this work, apoptosis was studied in thymus from small and sick VAMP8-/- mice. Freshly 
prepared single cell suspensions of thymus were stained with annexinV and propidium 
iodide (PI) (Figure 3.19). Under normal conditions, phosphatidylserine (PS) is almost 
completely confined to the inner leaflet of the plasma membrane by ATP dependent 
translocases called flippases. However, as one of the first hallmarks of apoptosis, the 
activity of flippases is down regulated resulting in exposure of PS residues to the outer 
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protein that can bind to the exposed PS. Therefore, chromophore (FITC) conjugated 






































VAMP8-/- adult VAMP8+/- adult 
control
 
Figure 3.19. Analysis of dead cells in the thymus of small and sick VAMP8-/- mice: A representative 
dot plot data showing dead cells stained with annexinV (LR Quadrant), propidium iodide (UL), annexinV 
and propidium iodide (UR) and live cells in the LL quadrant. The VAMP8-/-small and sick mice clearly 
have an increased number of dead cells cells in the UL, UR and LR quadrants and massively reduced live 
cells (right dot plot) compared to the control (left dot plot (B) Thymocytes from small and sick mice (n=4, 
age8-13 days) show a much lower number of live cells compared to heterozygous littermate controls. This 
high cell death was not seen in the thymocytes from VAMP8-/- small but not sick (n=3, age10-12 days) 
and the adult mice (n=6, age 1.5-2.5 months). 
 
Secondly, in the intact cells, the plasma membrane in impermeable to dyes that can 
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becomes increasingly permeable such that dyes like propidium iodide (PI) can readily enter 
the cell and intercalate into the DNA. Hence cells in later apoptotic stages can be identified 
by PI staining (Figure 3.19, dot plot: upper right (UR) quadrant). Generally late apoptosis is 
detected by co-staining the cells with annexinV and PI. Necrotic cells on the other hand do 
not expose PS to the outer membrane and are hence not detected by annexinV staining. 
These cells are stained only for PI (Figure 3.19, dot plot: lower right LR quadrant). The live 
cells with intact membrane and DNA remain unstained and appear in the lower left LL 
quadrant of the dot plot (Figure 3.19).  
Quantification of the live cells from the lower left quadrant of the dot plots revealed that 
there were just around 41% live cells in the VAMP8-/- thymii compared to 83% live cells in 
the controls (Figure 3.19B). The remaining cells in the VAMP8-/- thymii were stained 
either with annexinV or PI or both, indicating a massive cell death in the thymus of the 
small and sick VAMP8-/- mice. This high cell death was not observed in the thymocytes 
from VAMP8-/- small but not sick and VAMP8-/- adult mice (Figure 3.19B). 
The observed reduction of cellularity and increased cell death could be caused due to an 
increased susceptibility of the thymocytes to physiological apoptotic stimulus. In order to 
investigate this possibility, the sensitivity of the thymocytes towards induced apoptosis was 
studied in vitro using several cell death inducing factors. 
3.4.2. Dexamethasone induced apoptosis 
3.4.2.1. Thymocytes from VAMP8-/- small not sick are sensitive to apoptosis 
At first, dexamethasone, a synthetic glucocorticoid hormone, was used as the apoptosis 
stimulus. Glucocorticoid hormones are known to induce apoptosis in the thymus under 
physiological conditions and are especially important during the retraction of thymus at 
adulthood.  
Thymocytes from VAMP8-/- small and sick, small not sick and adult mice were treated 
with 0.1µM dexamethasone for 0hr, 3hr and 6 hr in a time course apoptosis assay. 
Additionally, at each time point there was an untreated control to study spontaneous 
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Two parallel methods were used for the detection of dead cells. In the first method, after 
each time point the apoptotic and dead cells were stained with annexin V and propidium 
iodide (PI) and counted in BD FACScan. The live cells were quantified from the lower left 
quadrant of the dot plot. In the second method, the cells were subjected to sub G1 peak 
analysis. The cells were fixed in ethanol after each time point and stained with PI.  The 
extent to which PI intercalates in the DNA depends on the DNA content of the cells. 
Therefore the cells in the normal cell cycle appear as distinct peaks corresponding to the 
G1, S, or G2 stages. The dead cells on the other hand have small, fragmented DNA that 
appears as a G0 peak just before the G1 peak in the area plot.  
The thymocytes from the VAMP8-/- small but not sick mice aged day 10-12 were more 
susceptible to dexamethasone induced cell death compared to the littermate VAMP8+/- 




















3 hr ut 3 hr ut
3 hr- Dex 3 hr- Dex
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Figure 3.20. Thymocytes from small not sick 
VAMP8-/- mice show high sensitivity to cell death 
(dexamethasone treatment): A representative dot 
plot data for dexamethasone induced apoptosis in 
VAMP8-/- small not sick mice. For each time point 
there was one un-induced (ut) sample and one 
sample treated with 0.1µM Dexamethasone (Dex) 
for 0, 3 and 6 hours. The cells were stained with 
FITC labeled annexin V and PI. The annexinV 
labeled apoptotic cells appear in the lower right 
quadrant, The propidium iodide stained cells appear 
in the upper left quadrant, the annexin V/PI co 
stained cells appear in the upper right quadrant while 
the unstained live cells appear in the lower left 
quadrant. The live cells were quantified from the 
lower left quadrant and the induction was measured 
by subtracting the live cells in the treated sample 
from the untreated sample at the same time point. It 
was observed that after 3 and 6 hours of treatment, a 
larger number of cells underwent apoptosis  in the 
VAMP8-/- small and sick mouse compared to the 
VAMP8-/+ control mouse. The affect being most 
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There were lower number of live cells after 3 and 6 hours of treatment in thymus from 
VAMP8-/- small not sick compared to the control mice. The affect was most pronounced 
after 3 hours of treatment. A dot plot data for dexamethasone induced apoptosis assay is 
shown in figure 3.20. A lower number of live cells can be seen in the lower left quadrant of 
the dot plots in the treated samples of a small not sick mouse compared to the controls 
(Figure 3.20).   
Several independent experiments confirmed this result. On an average, the live cells in the 
VAMP8-/- thymus were reduced by 29% points (from 77% to 48%) compared to 14% 
points reduction (from 78% live cells to 65%) in the controls after 3 hours of treatment 
(Figure 3.21). After 6 hours of treatment, the VAMP8-/- mice showed average 27% live 




Figure 3.21. Thymocytes 
from small not sick VAMP8-
/- mice show high sensitivity 
to cell death (dexamethasone 
treatment):The thymocytes 
from small not sick VAMP8-/- 
mice (n=3, 10-12 days old) 
were treated with 0.1µM 
dexamethasone for several 
time points. The samples were 
fixed stained with annexin V 
and propidium iodide. The live 
cells were quantified. The 
thymus from VAMP8-/- small 
but not sick mice showed a 
lower number of live cells 
after treatment with 
dexamethasone. After 3 hours 
of treatment the effect was 
most pronounced, there was 
29% point reduction in live 
cells in VAMP8-/- thymii 
compared to around 14% 
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The increased susceptibility of thymocytes from VAMP8-/- small and sick mice was 
confirmed by Sub G1 peak assay. In this method of detection, the most pronounced effect 
was observed after 6 hours. While apoptosis was induce in 13% cells in the VAMP8-/- 
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Figure 3.22. Thymocytes from small not sick VAMP8-/- mice show high sensitivity to cell death 
(dexamethasone treatment): The thymocytes from small not sick VAMP8 mice treated with 0.1µM 
dexamethasone for several time points. The samples were fixed in ethanol and stained with propidium 
iodide. The dead cells under the G0 peak were counted. The – line shows untreated control samples while 
the – line shows the treated samples. The area under the curve represents the cell counts while the 
intensity of PI staining is depicted on the X axis. The thymus from VAMP8 small but not sick mice had a 
higher number of dead cells after treatment with dexamethasone for 3 and 6 hours (A). On an average, 
after 3 hours of treatment, cell death was induced in 13% of thymocytes in thymus from VAMP8-/- mice 
(n=3, 10-12 days old) compared to 9.8% in the wild type. The effect was more pronounced after 6 hours 
of treatment, VAMP8-/- thymoctes showed average 33% induction of cell death compared to 16% 
















VAMP 8 controlVAMP 8 small but not 
sick
Treatment





























Chapter 3. Results 
 
 
treatment, the induced cell death increased by around 33% points in the thymus from small 
and sick mice compared to 18% points in the control mice (Figure 3.22). 
The two detection methods give slightly varying results because we detect different 
populations of apoptotic cells with the two methods. Since exposure of phosphatidylserine 
is one of the earliest hallmarks of apoptosis, annexin V stains the early apoptotic cells. 
Hence we visualize high numbers of early apoptotic cells within 3 hours after the treatment 
with annexinV staining method. In the sub G1 peak assay however, the cells are stained 
with the DNA intercalating dye PI. DNA fragmentation is a feature of late apoptotic stage, 
hence in this method of detection, late apoptotic cells with highly fragmented DNA are 
counted. Therefore there were low number of sub G1 cells early on and higher number sub 
G1 cells after longer periods of induction with Dexamethasone. These experiments clearly 
show that the thymocytes from VAMP8-/- small not sick mice shows increased 
susceptibility apoptosis upon dexamethasone treatment. 
3.4.2.2. Few live thymocytes in VAMP8-/- sick mice: not sensitive to induction 
The next question was whether the thymocytes from the small and sick mice were also 
susceptible to dexamethasone induced apoptosis. Thymocytes from VAMP8-/- small and 
sick mice aged day 8-13, were treated with 0.1µM dexamethasone for several time points 
and analyzed. 
As described before, we observed very few live cells in the thymus of VAMP8-/- sick mice 
at the start of the experiment (i.e. 0hr time point). There were only around 41% live cells 
compared to 88% in the control mice.  After treatment with dexamethasone, the live cells 
from the control mice showed a reduction both after 3 hours (~ 10% points) and 6 hours (~ 
27% points) compared to untreated samples. In small and sick mice however, there was no 
substantial induction of apoptosis by dexamethasone after 3 hours. There was a reduction in 
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Figure 3.23. Few live thymocytes in small and sick VAMP8-/- mice: not exceptionally sensitive to 
(dexamethasone treatment): The thymocytes from VAMP8-/- small and sick (n=4, aged 8-13 days) and 
littermate control were treated with 0.1µM dexamethasone for several time points. The dead cells were 
stained with annexinV and PI and the percentage of live cells were calculated by subtracting the percentage 
of dead cells from the percentage of total counted cells. Around 60% of the cells were dead in the thymus 
of small and sick mice at the beginning of the experiment compared to just about 12% in the control mice.  
The treatment induced apoptosis in the thymocytes from control mice with time. However, there was no 
induction of apoptosis in the thymocytes from small and sick mice after 3 hours of treatment and around 
induction 16 % compared to 27% induction in the control thymocytes after 6 hours.  
 
In the second detection method by sub G1 peak analysis, we had similar observations. 
There were around 20% dead cells in the thymus from small and sick mice compared to 
less than 2% in the controls. But we could not induce any substantial apoptosis in the 
already few live cells in the thymii of small and sick mice. (Figure 3.24).  
This is possibly because the most susceptible populations of the thymocytes in the VAMP8-
/- small and sick mice were already dead at the time point 0h and the remaining live cells 
could withstand the dexamethasone treatment.  
It is possible that the cells at the VAMP8-/- small not sick stage become increasingly 
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also explain why most of the cells are dead by the time the mice reach the small and sick 
stage and the surviving cells are more resistant to the treatment. Therefore we carried out 
the experiments with other apoptotic stimuli only on the thymus from VAMP8-/- small not 




Figure 3.24. Few live 
Thymocytes in small and 
sick VAMP8-/- mice: not 
increasingly sensitive to 
(dexamethasone 
treatment): Thymocytes 
from VAMP8-/- small and 
sick (n=4, aged 8-13 days) 
and littermate control were 
treated with 0.1µM 
dexamethasone for several 
time points. The cells were 
fixed in ethanol and stained 
with PI. The dead cells 
stained in PI were counted 
in cell sorter and analyzed 
for a Sub G1 DNA peak. At 
the start of the experiment, 
there were around 20% dead 
cells in the VAMP8-/- mice 
compared to less than 2% in 
the control thymii (10 fold 
higher). The number of 
dead cells rose steadily with 
induction in the control 
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3.4.2.3. Thymocytes from adult mice: no increased sensitivity to apoptosis 
The susceptibility of thymocytes from the adult VAMP8-/- mice towards dexamethasone 
induced apoptosis was also checked.  Single cell suspensions of thymocytes from adult 
VAMP8 mice age ≥ 1.5 months were treated with 0.1µM dexamethasone for different time 
points and analyzed. The number of live cells after each time point of treatment were 
similar in both the samples indicating a comparable amount of apoptosis in thymocytes of 
both, VAMP8-/- adult and VAMP8+/-control mice. (Figure 3.25).  After 3 hours of 
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VAMP8-/- adult and control mice. After 6 hours of treatment, live cells were reduced by 
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Figure 3.25. Thymocytes from adult VAMP8-/- mice do not show high sensitivity to cell death 
(dexamethasone treatment): Thymocytes from adult VAMP8-/- (n=6, age ≥ 1.5 months) and littermate 
control mice treated with 0.1µM dexamethasone. The dead cells were stained with annexinV and propidium 
iodide and the live cells were calculated by subtracting dead cells from the total counted cells. There is no 
difference in the percentage of live cells after the treatment between the two genotypes. 
 
We could confirm the same finding in the sub G1 assay. The number of dead cells, after 
treatment at different time points, was comparable between the VAMP8-/- adult and the 
control mice (Figure 3.26). After 3 hours around 6% cells and after 6 hours, around 28% 
cells were induced to undergo apoptosis in both, the thymocytes from VAMP8-/- adult and 
the VAMP8 heterozygous controls. 
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Figure 3.26. Thymocytes from adult VAMP8-/- mice do not show high sensitivity to cell death 
(dexamethasone treatment): Thymocytes from adult VAMP8-/- (n=6, age ≥ 1.5 months) and littermate 
control mice treated with 0.1µM dexamethasone. The cells were fixed in ethanol and stained with 
propidium iodide. There was no difference in the percentage of dead cells in the VAMP8 null adult and 
the control mice after different time points of treatment.  
3.4.2.4. Thymocytes from Vti1b-/- mice: no increased sensitivity to apoptosis 
The next question was whether the thymocytes from Vti1b-/- mice are also more susceptible 
to dexamethasone induced apoptosis. Thymii from Vti1b-/- mice day 10-12 (n=4) were 
treated with 0.1µM of Dexamethasone and detection was done using annexin V and PI 
staining and by Sub G1 peak assay.  
There was no difference in the number of live cells in the Vti1b+/+ control and the Vti1b-/- 
mice after several time points. Apoptosis was induced in around 12% cells after 3 hours and 
36% after 6 hours in both, the Vti1b+/- control and Vti1b-/- out mice (Figure 3.27). 
This was confirmed in the Sub G1 peak assay. The number of dead cells after several 
intervals of dexamethasone treatment was similar in the Vti1b-/- mice and the Vti1b+/-











Figure 3.27. Thymocytes 
from Vti1b-/- mice do not 
show high sensitivity to cell 
death (dexamethasone 
treatment) Thymocytes from 
Vti1b-/- 10-12 days mice (n=4) 
and littermate controls were 
subjected to 0.1µM 
dexamethasone treatment for 
several intervals of time. The 
cells were stained with 
annexin V and propidium 
iodide and counted in 
cytometer. The live cells were 
calculated by subtracting the 
dead cells from the total 
counted cells. There was no 
difference in the number of 
live cells between Vti1b-/- and 
Vti1b+/- controls after 







Figure 3.28. Thymocytes 
from Vti1b-/- mice do not 
show high sensitivity to cell 
death (dexamethasone 
treatment) Thymocytes from 
Vti1b-/- 10-12 days mice 
(n=4) and littermate controls 
were subjected to 0.1µM 
dexamethasone treatment for 
several intervals of time. The 
cells were fixed in ethanol and 
propidium iodide. There was 
no difference in the number of 
cells undergoing induced 
apoptosis between the Vti1b 
knock out mice and the 
controls, after treatment at 3 
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3.4.3. FAS induced apoptosis 
Under physiological conditions, several cells in the thymus undergo apoptotic death via 
FAS mediated pathway. In order to see if the thymocytes from the VAMP8-/- small not sick 
stage were also more susceptible towards FAS induced cell death, thymocytes were treated 
with 1.0µg of anti-FAS antibody.  The exogenously applied antibody cross links the FAS 
receptors on the surface of the cells and induces the death cascade. Detection of dead cells 
was done by annexinV and propidium iodide co-staining. Live cells were quantified from 
the lower left quadrant of the dot plot and the percentage of induction was calculated by 
subtracting the percentage of live cells in the treated samples from that of the untreated 
samples at each time point.  
Thymocytes from VAMP8-/- small not sick mice were more susceptible to FAS induced 
cell death. After 3 hours of treatment there was 11.4% induction in VAMP8-/- thymocytes 
compared to 3.8% in the control (i.e. 7.6% points higher induction). After 6 hours of 
treatment, the effect was even more pronounced. The percentage of apoptosis induction in 
the controls was 5.7% compared to 16.7% in the VAMP8 -/- mice, a 3 fold higher induction 
in the small not sick VAMP8-/- mice (Figure 3.29). This confirmed our previous findings 
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VAMP8-/- small but 
not sick (n=4, 8-
10days) and littermate 
control mice treated 
with anti-FAS antibody 
for several time points. 
The thymocytes from 
the VAMP8-/- small 
not sick mice show a high sensitivity to 1.0µg of anti FAS antibody treatment after 3 and 6 hours of 
treatment. After 3 hours there was 11% induction in the small not sick mice compared to 3.8% in the 
control mice i.e. 7.6% more induction. After 6 hours of treatment there was a 10% more induction in the 
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3.4.2. Apoptosis by crosslinking with anti CD3 and anti CD28 antibodies 
Further the thymocytes were checked for their sensitivity to apoptosis by crosslinking with 
CD3and CD28 antibodies. This treatment mimicks the physiological condition where a 
very strong cross-linking of TCR-CD3 leads to enhanced signaling, which in turn commits 
the T lymphocytes to cell death. Thymocytes were incubated in ELISA plated pre-coated 
with anti-CD3 or anti-CD3+CD28 antibodies. Dead cells were detected by staining with 
annexinV and propidium iodide. Live cells were quantified from the lower left quadrant of 
the dot plot. The percentage of induction of apoptosis was calculated by subtracting the 
percentage of live cells in the treated samples from the untreated samples at each time 
point. 
We also tried to induce apoptosis by treating the cells with antibodies solution. However, 
there was no induction of apoptosis after treatment for 3-6 hours by this method. This could 
possibly be because there is not enough physical interaction between the thymocytes and 
the antibodies when they are left free in the solution. In addition, in some previous studies 
it was seen that the use of anti-CD28 together with anti-CD3 suppresses the induction 
effect. In order to check this possibility, initial experiments were done where anti CD3 
antibody alone as well as anti- CD3 and CD28 together were was used to induce apoptosis 
in parallel samples of  thymocytes of VAMP8-/- small not sick and VAMP8+/- controls. It 
was seen that the induction with anti-CD3 alone was much less compared to co-stimulation 
with anti CD3+CD28 antibodies. Also there was a large variation in the data obtained from 
several different experiments. Hence it was confirmed that CD28 does not suppress in-vitro 
induction of apoptosis, rather it strengthens the stimulus. Therefore, the next experiments 
were done with anti-CD3 and CD28 co-stimulation. 
The thymocytes from VAMP8-/- small not sick mice were more sensitive to anti CD3-
CD28 treatment. After 6 hours, there was 18% induction of apoptosis in thymocytes from 
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thymocytes from VAMP8 -/- small not sick mice had more than 44% induction compared to 
22% in the controls (Figure 3.30). Thus we confirm that the thymocytes from the small but 
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Figure 3.30. Thymocytes from small not sick VAMP8-/- mice show high sensitivity to cell death (anti-
CD3+CD28 antibody treatment): Freshly excised thymocytes from small not sick VAMP8-/- mice (n=4, 
age 8-10 days) were co-stimulated with anti CD3 and CD28 antibodies for 3, 6 and 24 hours. Thymocytes 
from small not sick VAMP8-/- mice showed a higher susceptibility to apoptosis after 24 hours of treatment 
compared to controls. The control mice showed a 20% induction after 24 hours in comparison to 44% in the 
VAMP8-/- mice i.e. a 24% higher induction compared to the control mice. 
 
A delayed response to CD3-CD28 treatment is possibly because CD3 crosslinking induces 
a different apoptotic pathway than FAS or dexamethasone. However, irrespective of the 
stimulus used, the thymocytes from VAMP8 -/- small not sick mice are always more 
sensitive to cell death.   
3.5. Thymic stroma is affected due to the lack of VAMP8 
A constant bidirectional crosstalk between the thymic stroma and the developing T 
lymphocytes is critical for the survival of both. Reduced thymus cellularity in the VAMP8 -
/- small and sick mice could be due to a defect of the thymocyte precursors to proliferate or 
in the thymic stromal cells that fail to signal the developing thymocytes. In order to 
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transplanted the bone marrow derived stem cell of VAMP8 -/- small and sick and 
VAMP8+/- control mice into RAG2-/- γc-/- recipient mice. The hematopoetic stem cells have 
a potential to differentiate into T- as well as B-lymphocytes when subjected to the right 
environment and stimulus.  
The RAG2-/- γc-/- mice inturn, have a fully functional thymic stroma capable of providing 
the right microenviroment for the development of the T-lymphocytes. However, these mice 
do not have any functional T and B lymphocytes because Rag2 (recombinase activating 
enzyme 2) encodes the DNA recombinase enzyme required for VDJ recombination of the 
B-cell receptor and T-cell receptor gene loci and thereby the production of BCR and TCR 
proteins. Additionally, the common gamma chain (γc) is a subunit of the cytokine receptors 
for IL-2, -4, -7, -9, and -15 on the lymphocytes. The γc can combine with other ligand-
specific receptors to direct lymphocytes to respond to different cytokines. Therefore, 
lymphocyte development is greatly compromised in the γc-/- mice. These mice lack natural 
killer (NK) cells and produce very few T and B lymphocytes. The double knock out mice 
for RAG2 and γc therefore completely lack T and B lymphocytes and NK cells. These mice 
were obtained from Professor Dr. Rodewald, from the Institite of Immunology, University 
of Ulm and kept in the C57BL/6J x C57BL/10SbSnAi background.  
In three independent experiments, bone marrow derived from 10-12 day old small and sick 
VAMP8-/- mice and VAMP8+/- littermates were transplanted into irradiated RAG2-/- γc-/- 
mice. After 4 weeks, 7 weeks and 9 weeks of transplantation, blood was collected from the 
recipient RAG2-/- γc-/- mice and lymphocytes were stained with antibodies against CD4, 
CD8, CD3 to visualize T-lymphocytes, B220 and CD19 for the B-lymphocytes and NK1.1 
for NK cells. Parallel samples were stained with isotype controls. 
After 4 weeks of transplantation, there were B220 positive (B220+CD19+) B-lymphocytes 
in all the RAG2 -/- γc-/- recipients (Figure 3.31). However, there were no T lymphocytes in 
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Figure 3.31. Bone marrow cells from VAMP8-/- sick mice develop into normal B-lymphocytes in 
RAG2 -/- γc-/- mice: Dot plots showing the development of B and T lymphocytes in the blood from RAG2 -
/- γc-/- mice transplanted with bone marrow from VAMP8+/- control and VAMP8-/- small and sick mice 
after 4 weeks. B lymphocytes developed within 4 weeks in the recipient of both types of bone marrow 
(Top panel). However, there are no CD4+CD3+ (bottom panel) or CD8+CD3+ (middle panel) T 
lymphocytes in the RAG2 -/- γc-/- mice transplanted either with bone marrow from VAMP8-/- small and 
sick or VAMP8+/- control mice. RAG2 -/- γc-/- untransplanted control mice show no B- and T-lymphocytes. 
*Transplantation was done at the central animal facility and irradiation of the RAG2 -/- γc-/- mice was 
carried out at Strahlentherapie und Radionkologie by Dr. Mirko Nitsche and analysis was done with Dr. 
Ralf Dressel at Department for Immunogenetics, Georg August Universität Göttingen. 
 
Analysis of blood of all the RAG2 -/- γc-/- mice transplanted with bone marrow from 
VAMP8+/- control mice, showed CD4+CD3+ and CD8+CD3+ T lymphocytes by 6th- 9th 
week after transplantation.  
In first experiment, there were few T lymphocytes in the RAG2 -/- γc-/- recipient of 
VAMP8-/- bone marrow after 6 weeks, however, these mice developed CD4+CD3+ and 
CD8+CD3+ T lymphocytes after 9 weeks of transplantation in comparable numbers to the 
control mice (Figure 3.32). The RAG2 -/- γc-/- recipient of VAMP8+/- bone marrow 
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RAG2 -/- γc-/- mouse transplanted with control bone marrow died with symptoms of Graft-
versus-Host Disease where ‘Graft’ was the donated bone marrow and the ‘Host’ was the 
recipient RAG2 -/- γc-/- mouse. This indicates that this recipient mouse developed a 
functional immune system that eventually recognized the host as non-self and triggered a 
severe immune response leading to the death of the recipient.  
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Figure 3.32. Bone marrow cells from 
VAMP8-/- sick mice develop into 
normal T-lymphocytes in RAG2 -/- γc-/- 
mice: Dot plot data showing the 
development of T-lymphocytes in blood 
from RAG2 -/- γc-/- recipients of bone 
marrow from VAMP8-/- small and sick 
(10 day old) and VAMP8+/- littermate 
control mice. While CD4+CD3+ and 
CD8+CD3+ T lymphocytes developed in 
the VAMP8+/- bone marrow recipient 
RAG2 -/- γc-/- mouse after 6 weeks (A) 
there were almost no T lymphocytes in the 
VAMP8-/- bone marrow recipient at this 
stage (B). However, after 9 weeks, these 
mice developed both CD4+CD3+ and 
CD8+CD3+ T lymphocytes (C) in numbers 
comparable to the C57BL/6 control mice 
(D). *Transplantation was done at the 
central animal facility and irradiation of 
the RAG2 -/- γc-/- mice was carried out at 
Strahlentherapie und Radionkologie by 
Dr. Mirko Nitsche and analysis was done 
with Dr. Ralf Dressel at Department for 
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By contrast the other two experiments, the RAG2 -/- γc -/- recipients of bone marrow from 
VAMP8-/- small and sick mice developed CD4+CD3+ and CD8+CD3+ cells in similar to the 
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Figure 3.33. Bone marrow cells from 
VAMP8-/- sick mice develop into 
normal T-lymphocytes in RAG2 -/- γc-/- 
mice: Blood analysis of transplanted 
RAG2 -/- γc-/- mice to look for the 
development of T- and B- lymphocytes 6 
weeks after transplantation. All the 
RAG2 -/- γc-/- recipient mice transplanted 
with VAMP8+/- or VAMP8-/- bone 
marrow developed CD4+CD3+ and 
CD8+CD3+ T lymphocytes and B220 
bearing B-lymphocytes in similar 
numbers. *Transplantation was done at 
the central animal facility and irradiation 
of the RAG2 -/- γc-/- mice was carried out 
at Strahlentherapie und Radionkologie 
by Dr. Mirko Nitsche and analysis was 
done with Dr. Ralf Dressel at 
Department for Immunogenetics, Georg 
August Universität Göttingen. 
 
These experiments show that the T-lymphocytes progenitors of the VAMP8-/- mice do not 
have an inherent maturational defect. It is quite likely that the stromal cells of the thymus in 
VAMP8-/- small and sick mice are abnormal hence they fail to support the development and 
maturation of the thymocyte precursors.  
3.6. Studies on mouse cells derived from VAMP8-/- mice 
Since VAMP8 is involved in homotypic late endosomal fusion and in the fusion of 
secretory granules with the plasma membrane, the loss of VAMP8 could result affect 
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endosomal system and process such as endocytosis, endosomal transport and lysosomal 
degradation in cells derived from VAMP8-/- mice.  
3.6.1. Lamp staining VAMP8-/- MEFs 
Lamp 1 is the lysosome associated membrane protein 1 that is commonly used as a marker 
to visualize the lysosomes and late endosomes. In order to determine whether the lack of 
the SNAREs VAMP8 and Vti1b affects the morphology of the endosomal system, lamp1 
staining was done on fibroblasts derived from VAMP8-/- Vti1b-/-, VAMP8-/- and 
VAMP8+/+ Vti1b-/+ embryos (Figure 3.34). Primary mouse embryonic fibroblasts (MEFs) 
were isolated from 13.5 day old VAMP8-/- Vti1b-/-, VAMP8-/- embryos and were 
immortalized by continuous passaging. MEFs isolated from VAMP+/+ Vti1b+/- littermate 
were used as controls. The immortalized MEFs were seeded on a coverslip overnight and 
fixed with methanol prior to immunostaining. In all the three cell lines, lamp1 staining 
appeared in the form of punctuated dots, with higher perinuclear localization in reference to 
dapi stained nucleus and also spread out in the cell. This shows that there is no defect in the 
morphology of lysosomes and endosomes in the absence of VAMP8 and Vti1b. 
 
VAMP8 -/- Vti1b -/-VAMP8 +/+ Vti1b +/- VAMP8 -/- Vti1b +/+ 
4x enlarged 4x enlarged 4x enlarged
Figure 3.34. The morphology of endosomal system is normal in VAMP8-/- fibroblasts: Lamp1 and Dapi 
staining of MEFs from VAMP8-/- (middle panel) and VAMP8-/- Vti1b-/- mice (bottom panel) in 
comparison to VAMP8+/+ Vti1b-/+ (top panel). In all the three cell types, the lamp1 staining was localized 
most densely close to the perinuclear region while there was also some punctuated staining spread through 
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3.6.2. Uptake and degradation of fluorescently labeled LDL 
Next, we wanted to analyze whether the loss of VAMP8 causes a defect in the kinetics of 
endocytosis, endosomal transport and lysosomal degradation. Fluorescently labeled LDL is 
commonly used for such studies since its trafficking can be easily followed by fluorescence 
microscopy.  LDL is taken up into the cells by receptor mediated endocytosis. Following 
this, the receptor is recycled back to the surface while LDL is targeted for degradation in 
the lysosomes via passage through the early and late endosomes.  
Endosomal trafficking was studied in MEFs derived from VAMP8-/- by following the 
uptake of fluorescently labeled LDL into the cells, its passage through endosomes to the 
lysosomes and eventual degradation in the lysosomes. The cells were starved in serum free 
medium for 1 hour and later pulsed with 200µl of 10µg/ml (2µg/coverslip) BODIPY 
labeled LDL at 4°C for 1 hour to allow receptor binding. Following this, LDL was chased 
into the cells at 37°C for 0, 15, 30, 60 and 180 minutes. The cells were fixed in para-
formaldehyde and analyzed by fluorescence microscopy.  
Soon after pulse, at the 0hr time point, LDL is bound to its plasma membrane receptors. In 
the VAMP8+/- MEFs, there were a large number of small dot like structure spread all over 
the cells. There was a slightly reduced amount of staining at the plasma membranes in the 
VAMP8-/- MEFs at 0hr. This could indicate lower expression of LDL receptors on the 
surface of the VAMP8-/- MEFs (Figure 3.35). The punctuated staining at 0hr could be due 
to clathrin coated pits. After 15 minutes of chase, LDL was expected to reach the 
endosomes. The BODIPY staining was organized into distinct vesicles spread out in the 
wild type cells with a slight tendency towards perinuclear localization. In the VAMP8-/- 
cells, there were fewer fluorescent vesicles compared to the control cells which were spread 
all over the cells (Figure 3.35).  
After 30 minutes of chase LDL was expected to reach the lysosomes. There was a slight 
difference in the appearance and distribution of the fluorescently labeled vesicles between 
two cell lines at this time point. The wild type cells showed a strong fluorescent signal in 
large vesicular structure while in the knock out cells, LDL was still present in small 
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Figure 3.35. Endocytosis, endodomal transport and lysosomal degradation of LDL not affected in 
VAMP8-/- fibroblasts:  MEFs from VAMP8 wild type and VAMP8 knock out mice were pulsed with 
200µl of 10µg/ml BODIPY labeled LDL and chased for different time points. At 0 minute time point, the 
fluorescent LDL located largely at the periphery of the cells probably bound to the LDL receptors at the 
cell surface. There was a lower fluorescent staining in the VAMP8 knock out cells at this time point 
compared to the control cells. After 15 minutes while the LDL seemed taken up into distinct vesicles in the 
wild type cells, the vesicles were much less distinct and smaller in the knock out cells. After 30 minutes, 
the vesicles appear largely localized at the perinuclear region of the wild type cells, there is no such 
localization in the knock out cells. After 1 and 3 hours, the LDL was degraded in the lysosomes in both the 
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After 60 minutes most of the LDL was expected to be degraded in the lysosomes and by 3 
hours the whole of the protein should be degraded. We observed that most of the 
punctuated vesicles disappeared after 1 hour with almost no remaining perinuclear staining 
in the wild type cells. In the knock out cells too, the fluorescent staining got weaker after 1 
hour and was completely lost after 3 hours of chase in both the cell types (Figure 3.35). 
Thus it seems that could be a minor defect in the transport of LDL between the endosomes 
and the lysosomes in the knock out cells that appears most prominently after 30 minutes of 
chase. However, once inside the lysosomes, the proteins are degraded at similar rate 
indicating that the lysosomal function are not compromised in the knock out mice. 
3.6.3. Bead uptake in VAMP8-/- Vti1b-/- peritoneal macrophages 
The next step was to analyze the kinetics of phagocytosis and fusion of phagosomes with 
lysosomes. Phagocytosis differs from the clathrin mediated endocytosis as it involves 
uptake of large particles at the cell surface by binding to cell surface receptors and dynamic 
remodeling of the actin cytoskeleton. It was interesting to know whether the loss of 
VAMP8 and Vti1b causes a defect in phagocytic pathway. Fluorescently labeled 1µM latex 
beads were used to follow phagocytosis in peritoneal macrophages isolated from VAMP8-/- 
Vti1b-/- and VAMP8+/-Vti1b+/- control mice. The beads were coated with bovine serum 
albumin before the experiment in order to increase the uptake. The cells were starved for 1 
hour in serum free medium. Following this, they were pulsed with fluorescently labeled 
beads at a concentration of 50 beads per cell and chased for several time points at 37°C. 
The cells were fixed with methanol and immunostained with late endosome/lysosomal 
marker lamp 2. In order to see if the beads were trafficking to the late endosomes and 
lysosomes, co-localization was done between the beads and lamp2 staining.  
The kinetics of bead uptake and co-localization with the lamp2 staining was similar in the 
macrophages derived from the VAMP8-/- Vti1b-/- and the control wild type mice. After 10 
minutes of pulse, the beads appeared attached to the cells, however as expected there was 
no co-localization with the lamp2 staining (Figure 3.36). After 30 minutes of pulse, the 
beads started to localize close to the lamp2 staining in both the cells types. After 30 minutes 





Chapter 3. Results 
 
 
(average 7-10) and the beads co-localized with the lamp2 staining (Figure 3.36). After 60 
minutes of chase, there were even larger number of beads in the cells and the co-
localization between the beads and the lamp2 staining was complete (Figure 3.36). This 
indicated that there was no major difference in the uptake of beads and their transport to the 
lamp2 stained vesicles in both the cell types. 
 














Figure 3.36. Phagocytic uptake and lysosomal delivery is not affected in VAMP8-/- Vti1b-/-
macrophages: Phagocytosis of bright blue fluorescent beads (1µm diameter) by mouse peritoneal 
macrophages derived from VAMP8-/- Vti1b-/- mouse (right panel) and the control wild type mouse (left 
panel). The cells were pulsed with the beads for 10, 20 and 30 minutes and chased for 30 and 60 minutes 
following 30 minutes pulse. Following this, the cells were fixed with methanol and immunostained with 
fluorescent antibody against lamp2 and observed under Leica confocal microscope by z-scanning. After 10 
and 20 minutes of pulse, there was an increasing uptake of beads into the cells with no colocalization with 
lamp2 staining. After 30 minutes of pulse the beads start to colocalize with the lamp2 staining. With 30 and 
60 minutes of chase times, there was an increasing colocalization of beads with the lamp2 staining both in 
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3.7. Level of lysosomal enzymes 
Lysosomal enzymes are synthesized in the ER in an inactive form and then transported to 
the lysosomes via endsomes. The proteins get activated in the lysosome largely due to the 
acidic pH (~4.5).  If the homotypic fusion between late endosomes or heterotypic fusion 
between late endosomes and lysosomes was affected due to the loss of VAMP8, the level of 
active lysosomal enzymes could be disturbed. Therefore, lysosomal enzymes, ß-
Hexosaminidase, ß-Mannosidase and ß-Glactosidase present were tested in the liver of 
VAMP8-/- mice. 
Initial studies on adult VAMP8-/- Vti1b-/- mice showed normal lysosomal enzyme activity 
in the liver and kidney of these mice (Ref. section 1.4.4). In that study it was confirmed that 
there is no difference in the activities of ß-Hexosaminidase and ß-Glactosidase between the 












































VAMP8-/- small and sick
VAMP8+/- control
Figure 3.37. Lysosomal enzymes function normally in small VAMP8-/- mice: The activities of three 
lysosomal enzymes, ß-Hexosaminidase (ß-Hex), ß-Galactosidase (ß-Gal) and ß-Mannosidase (ß-Mann) 
expressed in mU/mg in 10 day old (n=2) VAMP8-/- small and sick (A) and 8 day old small not sick (n=3) 
(B). There was no difference in the activities of all the three enzymes between the VAMP8-/- and the 
VAMP8+/- controls in the liver homogenates. 
 
It is possible that the VAMP8-/- mice at the small and sick and small not sick stage have a 
defect in the lysosomal transport even though the adult VAMP8-/- mice showed no obvious 
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activity (Ref. section 1.4.4). Therefore, activity of lysosomal enzymes β hexosaminidase, β 
galactosidase and β mannosidase was analyzed in liver homogenates from small not sick 
VAMP8-/- and small and sick VAMP8-/- and compared to age matched VAMP8+/- controls. 
The activities were calculated in mU/mg. There was no major difference in the activity of 
any of the tested enzymes in the liver of test and control samples (Figure 3.37), indicating 
that the activity of the lysosomal enzymes is not compromised due to the lack of VAMP8 






































































4.1. Heterogeneity in phenotype manifestation 
VAMP8-/- and VAMP8-/- Vti1b-/- mice were born in expected mendelian ratios, suggesting 
a normal embryonic development. However, 36% VAMP8-/- died within 10-12 days after 
birth while 66% VAMP8-/- Vti1b-/- and 58% VAMP8-/- Vti1b+/- were dead between 12-29 
days after birth. On the other hand, the VAMP8+/- Vti1b-/- mice did not show elevated 
mortality in the first three weeks after birth. Not all VAMP8-/- mice were affected, rather 
there was a well marked heterogeneity in the phenotypic manifestation. There were two 
distinct pools of mice in both VAMP8-/- and the VAMP8-/- Vti1b-/- genotypes. The first 
pool of mice showed progressive loss of weight at ~ 8-9 days in VAMP8-/-. After two-three 
days of weight loss, the mice were half the weight of their VAMP8+/- littermates and these 
mice eventually died. By contrast the second pool of mice did not loose weight and became 
healthy adults although they were smaller and lighter than their littermates.  
Wang and coworkers reported the same findings in their VAMP8 -/- mice (Wang et al. 
2004). They observed that upto one thirds of VAMP8-/- mice were dead before weaning 
and these mice were half the weight of their littermates at the time of death. They also 
observed growth retardation in the surviving mice similar to the findings in this study. In 
addition, they reported a defect in the pancreas of the surviving VAMP8-/- mice (Wang et 
al. 2004). These mice extremely enlarged pancreas that had a creamy appearance rather 
than translucent pancreas as seen in the VAMP8+/- controls. In this study also we observed 
that the same abnormalities in the pancreas of VAMP8-/- adult as well as small mice. 
The mice analyzed by Wang and co-workers in their study were real knock out mice  
created by replacement of the second exon of the VAMP8 gene with a neor cassette, while 
the VAMP8-/- mice used in this study were created by genetrapping . Since our genetrap 
mice behave just as the real knock out mice it shows that the heterogeneity in the phenotype 
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Rather, it appears that there is a critical point in the lives of the VAMP8 -/- mice soon after 
the first week of birth. The mice which successfully overcome this threshold become 
healthy adults while the ones that fail to overcome it, eventually die.  
The observed heterogeneity can atleast in part be explained due to the mixed background of 
the mice. The genetrap was inserted into VAMP8 gene of embryonic stem cells derived 
from 129S5/SvEvBrd while the blastocyst was from C57BL/6-Tyrc-Brd/c-Brd strain 
(Zambrowicz et al. 1998). Similarly, the Vti1b gene was knocked out in 129S5/ SvOle ES 
cells and injected into C57BL/6-Tyrc-Brd/c-Brd blastocyst (Atlashkin et al. 2003). This means 
that the off springs acquire genetic information from two different parental background 
strains. The traits are randomly distributed among the different pups of a litter that could 
explain why some VAMP8 -/- pups could be more resistant to the factors that cause the 
phenotype than the others in the same litter. 
4.2 Thymus specific effect of VAMP8 ablation  
The results from this study point primarily towards the importance of VAMP8 for 
development of T lymphocytes and maintenance of thymic integrity. The lack of VAMP8 
causes severe disruption of the thymus morphology and thymocytes maturation.  
4.2.1. Effect of VAMP8 ablation on T cell development and thymic stroma 
Thymus is a structurally complex organ comprising of epithelial cells derived from ecto- 
and endoderm as well as cells from hemopoietic bone marrow origin such as dendritic cells 
and T lymphocytes. The epithelial cells, dendritic cells, fibroblasts and macrophages 
together form the stroma of the thymus and are organized into well defined structure 
comprising of histologically distinct cortical and medullary regions. Depending on their 
location, the thymic epithelial cells are termed medullary thymic epithelial cells (mTECs) 
or cortical epithelial cells cTECs (Takahama 2006). This compartmentalization provides 
distinct micro-environments to the T-lymphocytes at different stages of maturation.  
The T lymphocytes on the other hand migrate from the bone marrow into the thymus. The 
maturation stages of T lymphocytes are highly sequential and are characterized by the 
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development is as follows: CD44+CD25- (DN1), CD44+CD25+ (DN2), CD44-CD25+ (DN3), 
CD44-CD25- (DN4), CD4+CD8+ (DP), CD3+CD8+ (SP) or CD3+CD4+ (SP). The bone 
marrow derived CD3-CD4-CD8- triple negative cells arrive at the sub-capsular zone. The 
DN1-DN4 subsets mature in the cortex while the DP cells migrate into the thymic medulla 
and mature into SP cells there. The intrathymic development of T lymphocytes is a series of 
lessons each provided by a distinct region of microenvironment and are under several 
stringent checkpoints (Ritter and Boyd 1993; Takahama 2006). The developing T-cells are 
given signals for proliferation, receptor gene rearrangement, positive selection for MHC 
restriction, negative selection for deletion of self reactive cells and molecular and 
functional maturation by the stromal cells.  
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However, signaling in the thymus is not monologous. Studies have established that there is 
a constant dialogue between the maturating T lymphocytes and stromal cells either by cell-
cell interaction or by soluble molecules (Ritter and Boyd 1993).  Interaction between 
chemokines secreted by stromal cells in their specific micro environments with their 
receptors on the developing T cells is pivotal for guiding the thymocytes (Shores et al. 
1991; Takahama 2006). The thymic epithelial cells and thymocytes secrete cytokines such 
as IL-1, IL-4, IL-6, IL7 and tumor necrosis factor α  (TNF α) and express the 
complimentary receptors  IL-1R, IL-4R, IL-6R, IL7R and TNFR (Ritter and Boyd 1993). 
Chemokine receptors CXCR4, CCR4, CCR7 and CCR9 are involved movement of 
immature thymocytes (Ref. Table XIII). In addition, adhesion molecules such as 
CD2/CD58, CD54/CD11a, and CD18 also mediate the lympho-stromal interaction (Ritter 
and Boyd 1993). 
4.2.1.1. Defect in thymic stroma 
The thymii from VAMP8-/- sick mice had all the subpopulations of developing T 
lymphocytes, indicating that thymocyte differentiation is not completely blocked in the 
absence of VAMP8. This view was also supported by the data from bone marrow 
transplantation experiments. The bone marrow derived hemopoeitic precursors from 
VAMP8-/- small and sick mice were transplanted into RAG2-/- γc-/- recipient mice. The 
RAG2-/- γc-/- mice inturn, have a fully functional thymic stroma capable of providing the 
right microenviroment for the development of the T-lymphocytes. However, these mice do 
not have any functional T and B lymphocytes because Rag2 (recombinase activating 
enzyme 2) encodes the DNA recombinase enzyme required for V(D)J recombination of the 
B-cell receptor and T-cell receptor gene loci and thereby the production of BCR and TCR 
proteins. The common gamma chain (γc) is a subunit of the cytokine receptors for IL-2, -4, 
-7, -9, and -15 on the lymphocytes. The γc can combine with other ligand-specific receptors 
to direct lymphocytes to respond to different cytokines. Therefore, lymphocyte 
development is greatly compromised in the γc-/- mice. These mice lack natural killer (NK) 
cells and produce very few T and B lymphocytes. The double knock out mice for RAG2 
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The idea was to transplant the stem cells from the VAMP8 -/- sick mice into RAG2-/- γc-/- 
mice and analyze whether or not the stem cells from the sick mice can develop in the right 
environment of RAG2-/- γc-/- mice. If the bone marrow cells from VAMP8-/- sick fail to 
develop into T lymphocytes in the RAG2-/- γc-/- mice, it would indicate towards an inherent 
maturational defect of the T lymphocyte precursors. On the other hand, if the RAG2-/- γc-/- 
recipients are populated from the donor derived T lymphocytes, it would indicate that the 
thymic phenotype in the VAMP8-/- small and sick mice could be due to a defective thymic 
stroma. Through three independent experiments it was established that bone marrow from 
VAMP8-/- small and sick mice successfully gave rise to CD4+CD3+ and CD8+CD3+ T 
lymphocytes in the RAG2-/- γc-/- mice in similar numbers as the control C57BL/6 mice. 
This shows that lack of VAMP8 does not cause an inherent defect in the T lymphocytes.  
Rather it seems that the thymic stromal cells are abnormal and probably fail to support the 
development of thymus and T lymphocytes.  
4.2.1.2. Defect in DN subsets 
First striking observation was a massive disturbance in DN1-4 subsets in the thymus from 
VAMP8-/- small and sick mice. There was an accumulation in DN1 and DN4 thymocytes 
and a reduction in the succeeding DN2 and DP subsets respectively. As discussed above, 
signals from cortical stromal cells are critical for the maturation of DN thymocytes.  
The survival of DN1 and DN2 thymocytes is mediated by initially by stem cell factor 
(SCF) and intereukin 7 (IL-7), both of which are secreted by the thymic stromal cells while 
the DN thymocytes express c-Kit (receptor for SCF) and IL7-R.  Later these cells express 
preTα protein which is critical to the survival of these cells. In DN3 stage, the cells enter 
G1/G0 phase and start to rearrange the TCRβ locus and the β chain is expressed together 
with preTα protein (Moroy and Karsunky 2000). This is a critical event for the DN cells 
since the first major checkpoint arises at the transition from DN to DP. It is largely 
influenced by the preTCRα:β signaling and  cTECs (Lacorazza et al. 2001; Minter and 
Osborne. 2003). The cells that fail to rearrange a functional a β chain are cleared from the 
T-cell repertoire (Owen and Venkitaraman 1996; von Boehmer 1992). Since the lympho-
stromal interaction is so critical to DN differentiation, a failure in thymic stromal cells to 
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a stromal defect in VAMP8 -/- small and sick mice could cause a transitional block from 
DN1 to DN2 and from DN4-DP. 
4.2.1.3. Defect in CD4/CD8 subsets 
Further there was an accumulation of the CD4+ and CD8+ (SP) cells in the thymii from 
VAMP8-/- small and sick mice. The DP cells rearrange the α chain locus and express it 
together with the β chain to form a TCRαβ. The second important checkpoint occurs in 
transition from CD4+CD8+ (DP) to SP and is controlled by signals via the αβTCR-CD3 
complex. This selection of the T lymphocytes is under a strict vigilance of the medullary 
stromal cells, especially the antigen presenting cells (APC): the dendritic cells and 
macrophages. The APCs process the self peptides and together with MHC molecules, 
present these peptides to the developing T lymphocytes. Only the T lymphocytes that are 
able to recognize MHC/peptide complexes via their TCRαβ with medium avidity are 
selected positively in a process termed MHC restriction. While the cells that that show a 
hypo- or hyper- responsiveness to MHC-self peptide complex are committed to cell death 
(positive or negative selection) (Owen and Venkitaraman 1996; von Boehmer 1992).  A 
defect in either positive or negative selection of DP cells would possibly result in a 
reduction of SP cells. However, since we do not see a reduction in CD4+ and CD8+ SP cells, 
these processes are less  likely to be affected in the VAMP8-/- small and sick mice. 
The accumulation of CD4+ and CD8+ SP cells could possibly result from the observed 
morphological defect of the thymus in VAMP8-/- small and sick. The thymii of these mice 
had a substantial cortical region as seen by histological staining however; the medullary 
region was reduced to mere remnants. The SP cells stay in the medulla for around 12 days 
and undergo maturational process characterized by the expression of CD62L and CD69. 
The CD62LlowCD69high SP cells are semi mature and susceptible to several apoptotic 
signals such as Dexamethasone (Takahama 2006). These cells mature into functional and 
Dexamethasone resistant CD62LhighCD69low SP cells and finally exit into the systemic 
circulation (Takahama 2006).  It is possible that the loss of medullary region in the thymii 
from VAMP8-/- mice leads to migrational blockage of SP cells from the thymus.  In order 
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T lymphocytes in the VAMP8 -/- small and sick mice.  However, these mice had very small 
spleen and did not have enough blood to get adequate T lymphocytes for this analysis.  
Our arguments are also supported by several other knock out mouse models such as Rho-/- 
(Henning et al. 1997), STAT3-/- (Sano et al. 2001; Shen et al. 2004), Eph4A-/- (Muñoz et al. 
2006) (Ref. section 4.2.3). These mice show a disrupted compartmentalization of the 
thymus into cortex and medulla. This was accompanied by a T lymphocyte maturation 
defect and in some models it could be explained in part due to a block at certain transition 
stages and loss of signaling between the stromal cells and thymocytes.  
4.2.1.4. Loss of cortico-medullary morphology 
It is a well known that the medullary stroma can not survive without the medullary 
thymocytes. Treatment with cyclosporine A blocks the interface between DP to SP cells 
that results in massively reduced medulla. However, cortex comprises of normal immature 
thymocytes and has a normal structure even after treatment (Sprent et al. 1988). Similar 
findings were made in TCR α knock out mice. These mice have a developmental block at 
DP stage as consequence medullary stromal cells are reduced to remnants while cortical 
epithelial cells are normal (Philpott et al. 1992).  
The VAMP8-/- small and sick mice had a massively disturbance in DN1-4 subsets and a 
marked reduction DP cells. This reduction in DP populations could possibly result in 
reduced medullary region and loss of cortico-medullary boundary similar to the CSA 
treatment and TCR α knock out mice. On the other hand, this defect could also result from 
an inherent defect in the thymic medullary stromal cells due to the loss of VAMP8. 
An inherent defect in thymic stroma adequately explains the findings in this study. 
However, one point to be kept in mind is that the health status of the VAMP8-/- mice 
analyzed in this study was not normal. Therefore, it is possible the loss of VAMP8 does not 
directly affect the stroma rather there could be other health factors that indirectly affect the 
thymic stromal cells and render them incapable of supporting thymocytes development.  
4.2.2. Cell death in VAMP8-/- thymus and thymus cellularity  
The thymus from the small and sick VAMP8-/- and VAMP-/- Vti1b-/- mice showed an 
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lymphocytes could also explain this increased apoptosis. The developing thymocytes that 
fail to pass through the transitional boundaries are committed cell death. This includes the 
DN cells that fail to express a TCRβ chain, the DP cells that fail to rearrange and express a 
functional TCRαβ receptor, the DP cells that either do not recognize the self MHC or 
recognize it with a very high affinity. As has been discussed above, for all these processes, 
the T lymphocytes get signals from the stromal cells. Only about 5% of the thymocytes are 
allowed to exit into the periphery. Either a lack of stimulus or too strong signaling by the 
stromal cells to the thymocytes in VAMP8-/- small and sick mice could lead to an increased 
thymocyte death. The massive reduction in the CD4+CD8+ DP cells could also be in part 
explained due to an increased apoptosis of this subset. At the DP stage, the cells rearrange 
the α chain of the TCRαβ. Thymocytes that lack a productively rearranged TCRαβ are 
deleted from the T cell repertoire (Owen and Venkitaraman 1996; von Boehmer 1992). 
Hence this population is especially sensitive to apoptotic stimulus. In addition, the stromal 
cells that either fail to signal or could themselves be subjected to apoptosis.  
In vitro apoptosis induction assays show that thymocytes from the VAMP8-/- small not sick 
mice are highly susceptible to cell death. Although the apoptotic stimuli arise from several 
sources, the signaling cascades converge at the level of caspase activation. Glucocorticoid 
hormones play a major role in negative selection. The thymic epithelial cells serve as the 
intrathymic source of glucocorticoids (GC) (Ashwell et al. 1996; Pazirandeh et al. 1999). 
The level of GC remains constant in the thymus at steady state, the levels of GC receptors 
(GR) varies during thymocyte development (Brewer et al. 2002). Although the mechanism 
of GC mediated cell death is not clearly defined, according to a current view 
dexamethasone exerts its apoptotic effect primarily via diacyl glycerol (DAG) generation 
(Cifone et al. 1999). In this study, Dexamethasone, a synthetic GC was used to induce and 
study apoptosis. 
As a second stimulus, probably more relevant to thymocytes development, is the use of anti 
CD3 antibody. Crosslinking with anti CD3 antibody leads to clustering of CD3 molecules 
and mimicks the physiological condition where a very strong engagement of TCR: CD3 
complex leads to negative selection of the T-lymphocytes. In vitro activation of T 
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study anti- CD3 and -CD28 antibodies were used, which resulted in a stronger effect than 
anti CD3 treatment alone. As third stimuli, anti FAS antibody was used.  Treatment with 
anti-FAS antibody also triggers a constitutively active signaling that leads to apoptosis via 
caspase cascade. Interaction between FAS and FAS ligand is critical for negative selection 
in the thymus (Minter and Osborne 2003). In this study, irrespective of the stimulus used, 
the thymocytes of VAMP8-/- small not sick mice showed an increased sensitivity towards 
apoptosis. At physiological level this could mean that during the onset of the phenotype i.e. 
in the small not sick stage, the thymocytes become increasingly sensitized towards 
physiological apoptotic stimuli. This could result in the death of the most sensitive 
thymocytes populations in the VAMP8-/- small and sick mice. This could also explain the 
massive cell death and reduction in thymus cellularity seen in the VAMP8-/- small and sick 
mice. 
On the other hand, the sensitivity of the thymocytes to apoptotic stimuli could be a leading 
cause for reduced thymus cellularity and disruption of morphology in the VAMP8-/- sick 
mice. These affects could have probably been surpassed in the transplantation experiment 
since the transplanted RAG-/- γc-/- mice had normal levels of factors such as glucocorticoid 
hormones and cytokines which could be deregulated in the VAMP8-/- sick mice.  
4.2.3. Thymic morphology and T cell defect: Similarities to other knock out models 
How VAMP8 possibly regulates the thymus development and the mechanism by which the 
loss of VAMP8 causes a defect in the thymus can possibly be understood by co-relating the 
findings of this study with other similar studies on knock out mice. There are several knock 
out mouse models that share similar phenotypic manifestation with the VAMP8-/- mice.  
One of the most interesting studies involves c-Cbl mice. c-Cbl is a E3 ubiquitin ligase that 
recruits ubiquitin conjugating enzyme and is the main negative regulator of the level of 
TCR and its downstream signaling. After αβTCR engagement, the ζ chain of CD3 gets 
monoubiquitinylated by c-Cbl at its dileucin based motif. The ubiquitinylation acts as a 
signal for endocytosis of the TCR-CD3, their sorting into multivesicular bodies and 
eventual degradation in the lysosomes (Naramura et al. 2002; Panigada et al. 2002). Hence 
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internalization and degradation in the lysosomes. In line with this, a mouse mutant with 
loss of function mutation in the RING finger domain of c-Cbl gene showed enhanced levels 
of TCR and CD3 on the surface of the DP thymocytes (Thien et al. 2005a).  The 
thymocytes from these mice showed excessive signaling by the TCR-CD3 complex since 
the activated TCR is not endocytosed and degraded. In addition, the mice showed 
progressive loss of the thymus towards adulthood. The thymocyte cell count was reduced 
by 25% in 15 day old mice, by 85% in 29 days old and by upto 99% in 40 days old c-Cbl 
mutant mice. (Thien et al. 2005a). The phenotypic manifestation seen in this loss of 
function c-Cbl mutant is very close to what was seen in the VAMP8-/- mice. The VAMP8-/- 
mice had a progressive reduction in thymic cellularity. The VAMP8-/- small not sick mice 
showed 2 fold reduction in thymus cellularity at 9-10 days of age while the the VAMP8-/- 
small and sick mice (10-12 days of age) showed a 10 fold decrease. There was a massive 
decrease in absolute cell counts in the VAMP8-/- small and sick mice. Much like the 
VAMP8 -/- small not sick mice, the thymocytes from c-Cbl mutant showed increased 
sensitivity to anti-CD3 induced cell death (Thien et al. 2005a). However unlike the 
VAMP8-/- mice, the c-Cbl mutant mice did not show a major defect in thymocytes 
development and in progression of thymocytes through DN-DP and DP-SP stages. 
Although the authors did observe a slight increase in DN cells and a corresponding 
decrease in DP cells in the mice with maximum thymic loss (Thien et al. 2005a). Also 
unlike the c-Cbl mice, in this study the level TCR was found to be normal on the cell 
surface of T lymphocytes. Despite the few differences between phenotypic manifestation in 
the c-Cbl mutant and VAMP8-/- mice, it is interesting that some of the affects are similar in 
both the mice. It is known that VAMP8 is involved in the homotypic fusion of late 
endosomes. It is possible that the absence VAMP8 results in a blockage at the late 
endosomal fusion, hence the activated TCR is not trafficked to the lysosomes resulting in 
excessive signaling. Therefore, the deficiency of VAMP8 could lead to phenotypic 
manifestations by a mechanism similar to the c-Cbl mutant. 
Lymphostromal interaction is critical to the development of thymocytes and the stroma and 
hence the function of thymus. There are some knock out mouse models have an abnormal 
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mice. One such study that could give an insight into the possible role of VAMP8 in thymus 
development is the one involving Eph4A -/- mice. Ephrin receptors (Ephs) are receptor 
tyrosine kinases that interact with their ligands Ephrins (class A and/or B) and mediate cell-
cell contact, bidirectional signaling, cell movement and guidance in several developmental 
processes including morphogenesis, establishment of tissue domains  and neuronal 
networking (Palmer and Klein 2003). EphA4 is a receptor for ephrins A and B and activates 
the Jak/STAT pathway in the thymus. It was shown to be critical for generation of 
epithelial network and for the T cell development (Munoz et al. 2006). The thymus from 
EphA4-/- mice was smaller than the littermates and the mice showed a progressive increase 
in thymus abnormality. The thymus was very small with total cell count reduced to 40% of 
the EphA4+/+ by day 10 and to 15% by 3 weeks of age. The absolute cell number of all 
lymphoid cells was reduced. Interestingly, the transition from DN-DP and DP-SP was 
compromised in these mice and several developing subsets of thymocytes were disturbed. 
There was an increased cell death in the thymus of these mice. Additionally, the thymus 
morphology was disrupted in the EphA4-/- mice. There was a major disturbance in the 
cortex, with heavily reduced cortical epithelial cells and a very sharp cortico-medullary 
boundary (Munoz et al. 2006). The VAMP8-/- mice also had a massively reduced thymus 
with increased cell death and disturbed thymocytes populations. The morphology of the 
thymus was also disrupted in the VAMP8-/- small and sick mice, however the defect was 
different from what as seen in the EphA4-/- mice. These VAMP8-/- mice had normal cortex 
while the medulla was reduced to remnants and the cortico-medullary boundary was not 
clearly defined. Although there are some differences, it is interesting that most of the 
phenotypic manifestations of the loss of VAMP8 and EphA4 are similar. The similarity 
could indicate towards the involvement of VAMP8 in promoting cell-cell interaction either 
directly or indirectly. Besides, it is know that the Eph receptors are trafficked within the 
cell and the signaling via the Eph is terminated by subjecting the Eph receptors to 
endocytosis , traffic via late endosomal compartments finally to lysosomal degradation 
(Palmer and Klein 2003). It is also possible that the loss of VAMP8 results in a loss of 
recycling of the Eph receptors or similar receptors due to blockage at the late endosomal 
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Another example that shows the importance of lympho-stromal interaction is the SCID 
mice. These mice lack functional T- cell receptors molecule that results in the absence of 
medullary lymphocytes in these mice. This in turn, causes the medullary epithelium to 
reduce to rudiments in the SCID mice (Bosma et al. 1983; Shores et al. 1990). Hence, from 
the findings in SCID and TCRα -/- mice it is known that medullary stromal cells are highly 
dependent on the medullary T-cell population for their existence. In a similar way, the 
massive disturbance in DN1-4 subsets and an excessive loss of DP cells in the VAMP8-/- 
small and sick mice could also result in the observed disruption of the thymic medulla and 
cortico-medullary boundary.  
There are some studies involving defective signaling cascades in the thymus that also show 
similarities to the VAMP8-/- mice. One such study involves STAT3. STATs are activators 
of transcription that work downstream of the Janus kinases (JAKs). The activation of JAKs 
and consequently STATs occurs when cytokines bind to their receptors on the surface of 
the responsive cells. STATs have anti-apoptotic activity by modulating Bcl-2 family of 
proteins. STAT3 is a member of the STAT family that is involved in signaling by IL-6 type 
cytokines, epidermal growth factor (EGF), Platelet derived growth factor (PDGF), 
Hepatocyte growth factor (HGF) etc. The specific ablation of STAT3 in the thymic 
epithelial cells using a K5 tissue specific promoter to express the cre-recombinase resulted 
in a phenotype of the thymus similar to VAMP8-/- mice. The neonatal mice had a normal 
thymus. The thymocytes cell count reduced starting at 6 weeks of age and the affect was 
most severe after adolescence i.e. 10-12 weeks of age. After 9 weeks STAT3-/- thymii had 
no cortico-medullary distinction similar to what was seen in the VAMP8-/- mice at 9-12 
days of age. The mice had excessive cell death in the thymus and the thymocytes were 
highly sensitive to apoptotic stimuli such as Dexamethasone in vivo but this effect was not 
seen in vitro. The T cell progenitors were found to be normal in these mice however their 
thymic epithelial cells (TECs) were abnormal. The phenotype in these mice was atleast in 
part explained due to the inability of the thymic epithelial cells to signal to the developing 
thymocytes due to the loss of the signaling molecule STAT3 (Sano et al. 2001; Shen et al. 
2004). The similarity in phenotype between STAT3-/- and VAMP8-/- mice could point 
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signaling molecules or their receptors on the developing thymocytes and/or the stromal 
cells.  
In order to limit the signaling by cytokines, the activity of JAKs and STATs is 
downregulated by certain inhibitory proteins. One such protein is STAT induced STAT 
inhibitor-1 (SSI-1 also called SOCS-1). The SSI-1-/- mice fail to downregulate the cytokine 
signaling and interestingly, show phenotypic similarities to the VAMP8-/- mice (Kishimoto 
et al. 1998). In-vitro, the thymocytes show excessive proliferation in response to cytokines. 
The SSC-1-/- mice were healthy at birth but mice showed upto 40% weight loss at postnatal 
day 9and were dead within 3 weeks of age. At around 10 days of age, the mice had massive 
reduction in lymphocytes in the thymus and the spleen and upto 75-80% thymocytes were 
lost in the thymus of these mice. However, unlike the VAMP8-/- sick mice, despite the loss 
of massive reduction in thymocyte count, there was no disturbance in the CD4/CD8 subsets 
in the SSI-1-/- mice compare to SSI-1+/+ mice. Most interestingly, the SSI-1-/- mice had no 
clear cortico-medullary boundary at around 10 days of age just as in the VAMP8-/- mice. 
Similar to the VAMP8-/- small and sick mice, the SSI-1-/- mice had a high number of dead 
cells in the thymus which was explained due to an increased expression of the pro-apoptotic 
factor Bax (Kishimoto et al. 1998). These similarities between VAMP8-/- and SSI-1 mice 
point towards the involvement of VAMP8 in down regulation of certain signaling 
molecules or events in the thymus. Hence the loss of VAMP8 could lead to excessive the 
signaling and leading to the phenotypic manifestation just as seen in SSI-1-/- mice.  
Another model that bears phenotypic similarity to VAMP8-/- mice is the TCRα -/- mice.  
The expression of the α chain of the TCR starts at the CD4+CD8+ (DP) stage and is 
important for the transition of DP cells to SP T-lymphocytes and in turn the migration of 
the T lymphocytes from the cortex to the medulla. The TCRα -/- mice had normal numbers 
of all thymocytes before the DP stage. However there was a developmental block in the 
CD4+CD8+ stage. As a result, these mice had a normal thymic cortex while the medulla 
was reduced to rudiments (Philpott et al. 1992); (Ritter and Boyd 1993). Similar thymic 
morphology disruption was also observed in mice treated in vivo with anti CD3 antibodies 
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TSG is an antagonist of Bone morphogenetic protein 4 (BMP4) which is a member of 
transforming growth factor β super family. TSG is supposed to be a positive regulator of 
thymocytes development. Knock out mice for TSG showed impairment of thymus among 
other organs (Nosaka et al. 2003). 12% of the TSG -/- mice died at birth while the rest were 
10-20% smaller than their littermates. More than half the TSG -/- mice showed progressive 
growth retardation became severely sick and some died. The mice had poorly developed 
thymii with several mice between 10-40 days of age showing, upto two fold reduction in 
thymocytes number. It was interesting that these mice also exhibit heterogeneity in the 
phenotype similar to the VAMP8-/- mice. This heterogeneity was in part explained due to 
unbalanced distribution of soluble factors such as BMPs and Chordin in the absence of 
TSG (Nosaka et al. 2003). In addition, there was an increase in SP cells and a decrease in 
the DP cells in around 3 weeks old TSG -/- mice similar to what was seen in the VAMP8 -/- 
small and sick mice although the phenotype appeared much early (day 10-12) on the 
VAMP8-/- mice. The lymphoid deficiency in these mice was not due to an intrinsic defect 
in the T or B cells rather  due to the microenvironment such as stroma or cytokine 
production  (Nosaka et al. 2003). It is known that a constant BMP signaling is required for 
normal development of the stroma but the kinetics of thymocytes development is not 
affected in the absence of BMPs (Bleul et al. 2005). Hence the similarity of phenotype in 
VAMP8.-/- mice with BMP4-/- mice strongly indicates that VAMP8 is involved in the 
regulation of signaling molecules  in the thymus possibly in the trafficking these molecules.  
Mice lacking the activity of Rho GTPases in the thymus due to expression of Clostridium 
botulinum C3 transferase,also show a striking similarity in the phenotype to the VAMP8-/- 
sick mice. The mice show a progressively degenerating health status, reduced thymic 
cellularity and increased cell death at 5-8 weeks of age (Henning et al. 1997).  Additionally, 
there was a major alteration in the DN1-4 thymocyte subsets in the thymus of these mice. 
Interestingly, the thymus had no clear compartmentalization into cortex and medulla, very 
similar to what was observed in the VAMP8-/- mice. Rho proteins act on the actin 
cytoskeleton and mediate actin modulation. In addition members of the Rho family are also 
localize to the vesicular membranes and have been implicated in guiding vesicle movement 
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in part explained due to a cell cycle block during progression of DN thymocytes from G1 
phase in these mice (Henning et al. 1997). Thus Rho is though to be important for the 
signaling events that take the T lymphocytes through the G1 phase and give them the 
survival stimulus. Since the phenotypic manifestations of the VAMP8 deficiency 
completely coincides with the phenotypic manifestations of Rho deficiency, it could be that 
VAMP8 is involved in trafficking of certain factors that provide survival signals to the T 
lymphocytes by the stromal cells of the thymus.  
The above mentioned knock out studies involve molecules that are implicated either in 
regulation of intracellular traffic in the thymus, lympho-stromal interactions or signaling 
during thymocyte differentiation. From the observed phenotypic similarities between the 
VAMP8-/- mice and these knock out studies, it seems that VAMP8 could be directly or 
indirectly be involved in the regulation of thymo-stromal interactions or the traffic of 
certain signaling molecules in the thymus. Hence the disruption of VAMP8 leads to 
abnormal differentiation of T lymphocytes and abnormal thymus development in the 
VAMP8-/- mice. However the study could not point out which mechanism in the thymus is 
disrupted due to the loss of VAMP8 that results in the observed phenotype. 
4.2.4 Is thymus defect the cause of death of the mice? 
The thymus defect as being the singular cause of death is less likely in the VAMP8-/- mice.  
There are several mouse models that lack thymus such as nude mice or have an immuno-
compromised situation such as in the SCID mice that can survive under pathogen free 
conditions. This is an indicator that the loss of thymus or immuno-compromised state is not 
lethal.  
VAMP8 was initially identified as a late endosomal v-SNARE that forms complex with 
Syntaxin 7, Syntaxin8 and Vti1b and mediates homotypic late endosomal fusion (Antonin 
et al. 2000a). Additionally, VAMP8-/- has also been shown to form a  complex with SNAP 
23 and Syntaxin 4 and mediates regulated exocytosis of zymogen granules from the 
pancreatic acinar cells (Wang et al. 2004). VAMP8 has recently been shown to be the 
primary v-SNARE responsible for regulated exocytosis of alpha and dense core granules 
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also implicated in exocytosis of secretory granules from mast cells together with Syntaxin 4 
(Paumet et al. 2000a). It was shown that VAMP8 is important for the terminal step of 
cytokinesis in mammalian cells (Low et al. 2003). Hence, VAMP8 has gained increasing 
attention in recent years especially as a mediator of regulated exocytosis in several cell 
types. Therefore, loss of VAMP8 could result simultaneously in the failure of several 
critical cellular processes in different tissues. In addition, although the data from this work 
and also from previous study (Wang et al. 2004) suggests that VAMP8 is not essential for 
homotypic late endosomal fusion, however the role of VAMP8 in endosomal fusion events 
can not be completely ruled out. Considering the role of VAMP8 in endosomal and 
secretory pathways, its possible quite likely that early mortality in VAMP8-/- mice is not 
caused by the loss of thymus, rather by a wide spread defect in several trafficking and 
exocytic events in the mice. 
4.3 Endosomal trafficking in VAMP8 -/- mice  
Work from two independent groups showed the involvement of VAMP8 in late endosomal 
homotypic fusion (Antonin et al. 2000a) and in regulated exocytosis of secretory granules 
of the exocrine pancreas (Wang et al. 2004). VAMP8 forms a complex with Syntaxin7, 
Synatxin8 and Vti1b during late endosomal trafficking (Antonin et al. 2000a) while it is 
associated with SNAP23 and Syntaxin4 during exocytotic events (Wang et al. 2004).  
In vitro studies from Wang and co workers showed that the ablation of VAMP8 does not 
cause any defect in the late endosomal membrane fusion. Receptor mediated endocytosis 
and lysosomal degardation of LDL, trafficking of transferring and asialofetuin was found to 
be normal in the fibroblasts derived from VAMP8 -/- mice. On the other hand, they found a 
major defect in the secretagogue mediated exocytosis of zymogen granules (storage 
lysosomes) of panceratic acinar cells in the absence VAMP8 (Wang et al. 2004).  
In this work, the role of VAMP8 in late endosomal trafficking was studied by several in 
vitro assays in cells derived from VAMP8-/- and VAMP8-/- Vti1b-/- mice. Phagocytic 
uptake of latex beads by macrophages and its traffic to lamp1 stained lysosomal/late 
endosomal compartments was not affected in the VAMP8-/- Vti1b-/- macrophages. There 
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mice. In addition, the activity of lysosomal enzymes was studied by enzyme-substrate 
reaction assays with liver as the source of lysosomal enzymes. There was no defect in the 
activity of ß-Hexosaminidase, ß-Galactosidase and ß-Mannosidase in the liver of small and 
sick as well as small not sick VAMP8-/- mice and adult VAMP8-/- Vti1b-/-mice. This data is 
in line with the previous findings (Wang et al. 2004).  Apparently, the absence of VAMP8 
does not cause any major defect in the late endosomal trafficking in different cell types and 
tissues. It is possible that VAMP8 and some other v SNAREs  have redundant function and 
can replace each other in the endosomal trafficking.  
Recently it was shown that although VAMP8 is the primary SNARE in platelet exocytosis, 
some tetanus sensitive VAMPs (VAMP3/VAMP2) could promote fusion in its absence 
(Ren et al. 2006). This indicates towards a redundancy in the usage of VAMPs in a system. 
However, there are certain points to be considered in these experiments. Firstly, the 
fibroblasts were isolated from the embryos. At the embryonic stage, all the pups are 
phenotypically normal while the defect appears only after first postnatal day week. 
Therefore it could be that the studies on the embryonic fibroblasts do not reflect the real 
situation as it happens in the VAMP8-/- deficient small and sick mice. Similarly, the 
phagocytic assays were done on peritoneal macrophages derived from mice older than 3-4 
weeks. This means the macrophages investigated were from phenotypically normal mice. It 
would be interesting to study the cells derived from the sick stage of mice and see if the 
endosomal trafficking is normal or disturbed in these mice or not.  
4.4 What could functionally replace VAMP8?  
A SNARE complex always consists of four SNARE motifs (Qa,Qb,Qc,R). In principal it is 
possible for one SNARE to functionally replace another of the same type in a complex. 
Recombinant purified SNAREs have been shown form complexes in several combinations 
although the stability of the complexes varies greatly (Jahn and Sudhof 1999). 
Additionally, some SNAREs have been shown to be involved in more than one SNARE 
complex. Since there was no major defect in the late endosomal trafficking in the absence 
of VAMP8 (R), it was though that some other endosomal SNAREs could functionally 
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Out of other members of the v SNARE family, VAMP1 and VAMP2 are preferentially 
distributed in neuronal and exo- and endocrine cells (Jahn and Sudhof 1999). VAMP4 is 
localized to the trans-golgi network (Steegmaier et al. 1999b; Zeng et al. 2003) while 
VAMP5 is present largely in the plasma membrane of the skeletal muscles (Zeng et al. 
1998b; Zeng et al. 2003).  
VAMP7 is distributed at later compartments of the endocytic pathway similar to VAMP8 
(Advani et al. 1999). VAMP7 mediates the fusion between late endosomes and lysosomes  
in a complex with Syntaxin 7 (Qa), Syntaxin 8 (Qc) and Vti1b (Qb) (Pryor et al. 2004). 
Since VAMP7 and VAMP8 shares the same SNARE partners (Syntaxin 7 (Qa), Syntaxin 8 
(Qc) and Vti1b (Qb) it is quite likely the VAMP7 could compensate for the homotypic late 
endosomal fusion complex in the absence of VAMP8. In this study, attempts were made to 
raise antibodies against VAMP7 so as to enable detection of VAMP7 in thymus from 
VAMP8-/- mice. However despite several efforts, we could not obtain an anti VAMP7 
antibody that could detect the protein in tissue homogenates. 
Wang and coworkers (Wang et al. 2004) suggest that VAMP3 could have a redundant 
function with VAMP8 as these two v-SNAREs share similar properties. VAMP3 has a 
ubiquitous expression and preferential localization to endosomal compartments (Galli et al. 
1994; Mcmahon et al. 1993b). However, VAMP3 knock out mice showed no abnormality 
in the endosomal trafficking (Yang et al. 2001). In line with this hypothesis, it was shown 
that one of the toxin sensitive VAMPs (VAMP3/2) could compensate for VAMP8, though 
less efficiently; in platelet granule release (Ren et al. 2006). In addition, VAMP3 and 
VAMP8 double knock out mice are embryonic lethal which shows that these two R 
SNAREs can possibly compensate for each other functionally (mentioned in Ren et al. 
2006). 
It is known that VAMP4, syntaxin 6, syntaxin 16 and Vti1a form a complex during early 
endosomal fusion. To test the possibility whether this complex can compensate for the loss 
of VAMP8 and Vti1b in the thymus, western blot detection was done for syntaxin 16, Vti1a 
and VAMP4. There was no considerable increase in the expression of any of these 
SNAREs, indicating that the early endosomal SNARE complex does not compensate for 
the loss of the late endosomal complex. However, it is possible that Vti1a could replace 
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demonstrated by the fact that Vti1a-/- Vti1b-/- mice are postnatal lethal (Unpublished work 
from our lab).   
In addition the expression level of SNAP29 was tested. SNAP29 has two SNARE motifs 
that contribute two Glutamines (Qb and Qc) to the core complex. It lacks a poly-cystein 
rich domain hence it can not anchor to the membranes via palmitoylation of cystein 
residues. Therefore, SNAP29 could possibly interact with several other SNAREs. Vti1b is 
also a Qb SNARE, although SNAP29 bears only 24% amino acid identity with Vti1b, it 
was interesting to study whether or not SNAP29 has an increased expression in VAMP8-/-
Vti1b-/- tissues. However, there was no substantial increase in SNAP29 expression in 
thymus from VAMP8-/- mice.  
Atlashkin and co-workers reported that syntaxin8 is increasingly destabilized and degraded 
in absence of Vti1b (Atlashkin et al. 2003). In this study too, the level of syntaxin 8 was 
found reduced in the thymus of VAMP8-/-Vti1b-/- mice. In order to check if the loss of 
VAMP8 also causes destabilization of other complex members, levels of syntaxin7, Vti1b, 
syntaxin8 were check by western blot. However, there was no substantial decrease in any of 
these SNAREs in the thymus of VAMP8 -/- mice indicating that the loss of VAMP8 does 
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5. Summary  
 
VAMP8 also called endobrevin is an R SNARE protein involved in two distinct steps in the 
endosomal / lysosomal trafficking. VAMP8 forms a complex with syntaxin8, syntaxin7 and 
Vti1b that is involved in homotypic late endosomal fusion. In addition, VAMP8 together 
with SNAP23 and syntaxin4 regulates exocytosis of secretory granules in the acinar cells of 
the exocrine pancreas. VAMP8 was also shown to function in regulated exocytosis of 
secretory granules from mast cells and platelets.  
The aim of this study was to analyze the physiological role of VAMP8 in VAMP8 knock 
out mouse model. In addition, double knock out mice deficient in VAMP8 and Vti1b, a Qb 
SNARE partner of VAMP8 in late endosomal fusion complex, were also analysed to study 
the effect of deleting two SNAREs of the same complex. 
Both the VAMP8 -/- and VAMP8 -/- Vti1b -/- mice were born in expected mendelian ratios 
indicating a normal prenatal development. The mice showed phenotypic manifestation 
early in postnatal life however there was heterogeneity in the phenotype. Large percentage 
of VAMP8 -/- Vti1b -/- and VAMP8-/- mice showed progressively degenerating health and 
died within the first one month of post natal life. The remaining VAMP8 -/- and VAMP8 -/- 
Vti1b -/-survivors became fertile adults although they were a little lighter than their 
heterozygous littermates.  
At the onset of the phenotype, the mice started to loose weight (defined in this work as 
small not sick stage). After 2-3 days of consecutive weight loss, the mice became 
increasingly sick (defined as small and sick stage) and eventually died. At the time of 
death, these mice were half the weight of their littermates and had an unstable gait. 
Thymus from VAMP8 -/- and VAMP8 -/- Vti1b -/ small and sick mice showed gross 
abnormality. While normal wild type thymus had a well defined boundary between the 
cortex and medulla, the thymii from the VAMP8 -/- and VAMP8-/- Vti1b-/- small and sick 
mice had no clear compartmentalization, with medullary cells scattered within the cortical 
region.  Additionally, there was a progressive reduction in the thymus cellularity with the 
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Since the disruption of thymic morphology could result in aberrant T-lymphocyte 
maturation, different developmental stages of thymocytes were analyzed. In both, VAMP8 -
/- and VAMP8-/- Vti1b-/- small and sick mice, distribution of thymocyte progenitors DN1-
DN4 was disturbed. There was an increase in the percentage of DN1 (CD44+CD25-) and 
DN4 (CD44-CD25-) subsets while DN2 (CD44+CD25+) and DN3 (CD44-CD25+) cells were 
reduced. Further, there was an increase in the percentage of CD4+, CD8+ and CD4-CD8- 
cells while the CD4+CD8+ were reduced. In addition, the thymus showed an elevated 
number of dead cells. All these observation were observed only in the small and sick 
VAMP8 -/- and VAMP8 -/- Vti1b -/- mice and not in the small not sick and the adult mice.  
Reduction in thymus cellularity of VAMP8 -/- mice could be due to excessive cell death of 
the thymocytes. In vitro apoptosis stimulation assays showed that the thymocytes from 
small not sick stage were highly susceptible to death upon induction with dexamethasone, 
anti FAS (CD95) antibody treatment and CD3-CD28 crosslinking. While there was a very 
high number of dead cells (~60%) in the thymus of the small and sick mice and these 
surviving cells were more resistant to dexamethasone treatment. Hence, it seems that the 
thymus from the small not sick mice becomes increasingly sensitive to physiological 
apoptotic stimulus. Eventually, most of the thymocytes die by the time the mice reach the 
small and sick stage.  
In order to understand whether the thymus phenotype resulted due to an inherent defect in 
T-lymphocyte precursors or due to a defective thymic stroma, transplantation experiments 
were done. Bone marrow derived lymphoid progenitors from VAMP8-/- small and sick and 
VAMP8+/- controls were transplanted into recipient RAG2-/- γc-/- mice. Bone morrow cells 
from both, the VAMP8+/- and VAMP8-/- mice could repopulate the immune system of the 
RAG2-/- γc-/- recipient mice with both B and T lymphocytes after 4 and 6-9 weeks of 
transplantation respectively. This indicates that the T lymphocyte progenitors of VAMP8-/- 
small and sick mice do not have an inherent maturational defect. The thymic stromal cells 
in these mice are probably abnormal and therefore can not support proper maturation and 
development of T lymphocytes in these mice. 
In addition, endosomal trafficking was studied in the cells derived from VAMP8 -/- mice. 
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VAMP8 -/- and VAMP8 -/- Vti1b -/- fibroblasts. In addition, phagocytosis and the traffic of 
phagosome to lysosomes was studied in peritoneal macrophages from VAMP8 -/- Vti1b -/- 
mice using fluorescent beads in pulse chase experiments. The receptor mediated 
endocytosis and lysosomal degradation of fluorescently labeled LDL was studied in the 
embryonic fibroblasts of the VAMP8 -/- and VAMP8 -/- Vti1b -/- mice. These experiments 
showed no defect in the endosomal vesicular trafficking. A defect in late endosomal-
lysosomal trafficking could result in reduced amount of active lysosomal enzymes. To 
check this, activity of several lysosomal enzymes was studied in the liver of VAMP8 -/- and 
VAMP8 -/- Vti1b -/- mice. VAMP8 -/- small not sick as well as small and sick mice had 
normal enzyme activity in the liver homogenates. Hence this data indicates that the late 
endosomal fusion event is not compromised in the absence of VAMP8 and Vti1b. 
Additionally, VAMP8 seems non essential or can be compensated during homotypic late 
endosomal fusion events. However, western blot analysis of liver, kidney and thymus from 
the VAMP8 -/- and VAMP8 -/- Vti1b -/- mice did not reveal any major difference in the 
expression of other SNARE proteins that could possibly exert a compensatory role in the 
absence of VAMP8.  
Hence this study shows that VAMP8 is important for the development of thymus and 
possibly the function of the thymic stromal cells. A lack of VAMP8 probably results in a 
defective stroma that in turn leads to developmental and maturational defect in T 
lymphocytes. A lack of functional stroma could also explain the excessive cell death seen 
in the thymus from VAMP8-/- mice. From our data it seems that the absence of VAMP8 
does not hinder the late endosomal fusion events possibly due to a compensatory 
mechanism. However the mechanism by which VAMP8 exerts a regulatory role in thymus 
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6. Conclusion and Outlook 
The current work shows that VAMP8 or endobrevin, plays a role in thymus development 
and T lymphocyte differentiation in mice. VAMP8 probably regulates the function of 
thymic stromal cells that in turn support the thymic morphology as well as guide the 
thymocytes in their course of development through the thymus. Thus the loss of VAMP8 
results in disruption of thymus morphology and maturational defect in thymocytes. This in 
turn possibly commits increasing number of thymocytes to cell death. The study also shows 
that VAMP8 is not essential for late-endosomal fusion events.    
However there are several questions that still remain unanswered. From the bone marrow 
transplantation experiments it is certain that the T lymphocyte progenitors of the VAMP8-/- 
small and sick mice do not have an inherent defect of differentiation and maturation. 
However, since these mice have an abnormal health status, it can not be ascertained that the 
defect indeed lies in the stromal cells. This problem could possibly be solved by thymus 
graft experiments, where the thymus from VAMP8-/- small and sick mice could be grafted 
under the renal capsule of the SCID mice. The SCID mice can then be supplied with 
normal bone marrow from wild type mouse. The failure of the VAMP8-/- grafted thymus to 
get repopulated by thymocytes derived from wild type bone marrow could definitively 
suggest an inherent defect in stromal cells of thymus from VAMP8-/- sick mice. 
Further, it would be important to pindown whether the defect lies in the cortical or in the 
medullary stromal cells. It could be possible to answer these questions by using thymic 
cultures, either as complex organ cultures or as selective cultures of specific stromal cells 
from VAMP8-/- small and sick mice. The development, proliferation and survival of thymic 
stromal cells under the effect of stimulatory chemokines could be studied in vitro. Analysis 
of vesicular trafficking, cytokines, growth factors release and expression of adhesion 
molecules in the cultured thymic cells could give an indication towards to underlying 
reason for the thymus phenotype.  
VAMP8 is involved in regulated exocytosis of secretory vesicles from several cell types. 
Cytotoxic T lymphocytes (CTLs) are known to store the lytic proteins in specialized 
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could therefore serve as a model to study the role of VAMP8 in regulated exocytosis in T 
lymphocytes and could give an insight into the affect of VAMP8 ablation on mature T 
lymphocytes.  
Dendritic cells are antigen presenting cells that process and present the antigen to cell 
surface and stimulate the T lymphocytes.  It could be helpful to study whether or not the 
dendritic cells from VAMP8-/- sick mice are capable of processing the antigenic peptides 
and stimulating the T lymphocytes. It would also be interesting to check whether the T 
lymphocytes from the VAMP8-/- sick mice respond to stimulatory signals from wild type 
dendritic cells. This could give a clue whether the defect lies in dendritic cells derived from 
VAMP8 -/- mice.  
Lastly, in order to understand the compensatory mechanism of VAMP8, it would be 
interesting to carry out a study of systems which lack two or more R SNAREs 
simultaneously. This could either be done in by creating double knock out mice or by 
silencing of specific v-SNAREs in specific cell type. Studying the affect of ablating 
VAMP8 together with VAMP7 and VAMP3/2 would be specifically interesting. Such 
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